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THESIS OUTLINE
The work presented here contributes to the understanding of regulation and deregulation of 
epidermal stem cell homeostasis.  It describes some of the mechanisms controlling epidermal 
self-renewal and differentiation on the level of gene expression programs and how they can 
be disturbed in disease. There is an astonishing number of genes involved in maintaining the 
balance between these processes, working with high precision and in a carefully timed manner. 
They protect the cells from aberrant behaviour which could disturb barrier function of the skin 
and preserve their cellular identity. In the following chapters I will guide you through the work 
I got to do trying to understand facets of this system. This is not only from a single viewpoint 
but rather regarding the system as a whole with appreciation for cooperativity between genes.
 This is especially true for Chapter 2, in which we describe the role of chromatin and DNA/
RNA binding factors in epidermal differentiation and moreover the functional interactions 
between seemingly unconnected processes. We found functional connections between ZMAT2 
and genes that regulate diverse epigenetic mechanism and that they jointly regulate an adhesion 
related transcriptional program essential for maintaining a proliferative cell population. 
We showed that ZMAT2 is a component of the (pre-) spliceosome and discovered that it is 
physically associated with adhesion related transcripts through a RNA interaction experiment. 
This work provides evidence for an intricate regulatory mechanism linking transcriptional and 
post-transcriptional processes in the regulation of epidermal stem cell differentiation.
 In Chapter 3 we identified a long non-coding RNA, B1-adjacent long non-coding RNA or 
BLNCR, which is expressed in self-renewing cells and rapidly downregulated upon initiation 
of differentiation. This lncRNA captured our attention due to its proximity to the ITGB1 gene 
and its sensitivity to the EGF pathway. The presented results suggest that downregulation 
of BLNCR is an early event in epidermal differentiation, possibly marking the switch from a 
proliferative state towards terminal differentiation in epidermal stem cells.
 In Chapter 4 we considered the importance of the BMP signalling pathway in epidermal 
differentiation. Although its role in epidermal differentiation was already described, we here 
demonstrate the dependence of the late differentiation transcriptional program on activation 
BMP signalling. We also discovered that the MAF/MAFB/ZNF750 axis is downstream of BMP 
signalling, which controls a late differentiation transcription program. Signalling pathways are 
the most efficient lines of communication for cells and frequently disturbed in cancer or other 
malignancies. Understanding the impact of their deregulation on transcription factor networks 
and transcriptional programs can contribute to finding more comprehensive treatment 
strategies.
In Chapter 5 we show necessity of proper transcriptional regulation of epidermal differentiation 
through work done in patient cells with a mutation in master regulator p63. We discovered that 
the resulting altered p63 binding causes a loss in epidermal identity through upregulation of 
genes from other lineages. Interestingly, through silencing one of these genes, RUNX1, we 
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could partially revert the phenotype. This indicates the importance of studying which of the 
affected downstream processes contribute to the phenotype in light of the development of 
future therapeutic strategies. Theoretically, by not just considering the gene that is out of line 
but also the downstream offenders, the number of potentially druggable or therapeutically 
correctable genes increases. 
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1
We often marvel about the cleverness, complexity or simplicity of medical or technological 
advances, wondering about how people can dream up the most complicated structures to 
answer a question or perform a certain task. In 1969, we landed a manned mission on the 
moon, we have developed autonomous cars with computers that can perceive and interpret 
their surroundings and we are able to develop mechanical body parts that can be controlled 
intuitively (MPL, John Hopkins). We however forget sometimes to just look down at our own 
body, to marvel at the cleverness, complexity or simplicity of the tasks it can perform. From 
development to immunity, the intricate collaboration between cells, tissues and organs that is 
happening right under our noses is sometimes underappreciated and still not fully understood.
 Nature has optimised the coordination of these biological processes over time, resulting 
in complex regulatory mechanisms that enable our bodies to perform highly complex tasks in 
parallel. Reading this thesis for instance does not only require your eyes and brain to coordinate 
to interpret this text, but in parallel also requires the coordination of the muscles in your hands 
turning and not ripping the pages. Your skin is sensitive to the structure and temperature of the 
paper, while in the meantime your gastrointestinal tract is working through your latest meal. 
Years and years of research enabled us to capture some of these processes and their essence 
in an effort to understand how they are regulated and deregulated. This knowledge is applied to 
devise strategies to intervene when a deregulated process leads to disease. In some cases this 
proofs to be very efficient, for instance in enzyme replacement therapy, where a genetic defect 
is corrected by administration of the enzyme that is not working. However, in other cases it is 
less clear which biological processes contribute to disease or how they should be targeted.
By developing our fundamental knowledge of biological processes it becomes possible to 
better interpret, predict and potentially correct the ramifications of deregulated biological 
processes. This often requires different viewpoints, considering issues from a system-wide 
view up to molecular mechanisms of a disease. Over the years, we have found many important 
pieces of this puzzle and have generated a central dogma describing the basics of molecular 
biology. It describes how genes are transcribed from DNA into messenger RNA (mRNA), 
which is subsequently translated into a protein. Proteins are versatile molecules in charge 
of performing most tasks in the cell, providing for instance structural components, signalling 
molecules and enzymatic activity. On each of these levels (DNA, RNA and protein) a myriad of 
mechanisms that regulate DNA accessibility, transcription and translation. 
 All the components that support these levels of regulation find their origin in the genetic 
code in the DNA themselves, making the circle round again. The genetic code is composed out 
of long stretches of four different types of molecules or nucleotides, adenosine (A), thymidine 
(T), cytidine (C) and guanosine (G). Specific combinations of sequences of these nucleotides 
form genes and within a gene not only the protein itself but also important information about 
localisation, (post-) transcriptional regulation and specific binding sites for regulatory proteins 
that initiate and facilitate transcription is encoded. However, before these factors can bind the 
DNA needs to be made accessible. To store the massive amount of genetic information in the 
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limited space of the nucleus, the DNA is wrapped around proteins called histones which are 
further compacted via supercoiling into chromatin. Tightly packed chromatin makes binding of 
initiators of transcription impossible and leads to the closed off state of the DNA. The proteins 
that regulate the state of the chromatin (open or closed) through specifically modifying DNA or 
histones provide another layer of regulation on top of the genetic code. The proteins that deposit 
and remove these marks are studied in the field of epi- genetics (above- genetics). Only after 
specific epigenetic factors recognize and modify these marks the DNA is made accessible for 
transcription of a gene starting from its promotor. The promotor is a region where transcription 
factors bind their specific recognition sequence and where transcription machinery is 
recruited and assembled. The RNA transcript is built by the enzyme RNA polymerase II, which 
can interpret the DNA code and convert it into RNA. Immediately after starting transcription 
the emerging RNA transcript is bound by proteins regulating post-transcriptional processes 
such as splicing; editing the transcript by cutting out redundant pieces or using alternative 
parts. When transcription is completed the mature mRNA transcript is exported out of the 
nucleus it is translated into a protein by ribosomes. These cellular components facilitate the 
interpretation of the RNA code and subsequently the connection of amino acids producing the 
protein it encodes.
 This is a generalised description of the central dogma that is riddled with intricate feedback 
loops and presence of redundant proteins and pathways. This redundancy makes the system 
more robust, as deregulation of one (redundant) component does not necessarily cripple the 
biological process. Additionally, this description only describes regulation by protein encoding 
genes and ignores the contribution of non-protein-coding genes such as microRNAs and long-
non-coding-RNAs. The first part of this general introduction will describe different mechanisms 
controlling gene expression programs on transcriptional and post-transcriptional level in more 
detail. This includes transcriptional and epigenetic mechanisms as well as post-transcriptional 
processes such as splicing. 
 The second part will introduce the model system that has been used in all of the chapters 
of this thesis; the skin. The elaborate processes regulating epidermal differentiation provide an 
interesting scaffold to study transcriptional regulation and the insights gained through these 
studies might help understand regulation in other epithelial tissues.
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PART I: REGULATION OF GENE EXPRESSION
EPIGENETIC MECHANISMS AND TRANSCRIPTIONAL REGULATION
The different cell types in the human body all find their origin encoded in the same DNA molecule, 
which basically functions as a blueprint. Depending on the cell type, specific parts of the DNA 
are activated generating the proteins or components needed for different functionalities, 
timing or structural requirements. This is especially crucial in early development, where a 
specific sequence of activation of gene expression programs determines the identity of the 
newly formed tissues. At the start of such differentiation processes, cells with the same DNA 
code can adopt different fates by activating different gene sets using different epigenetic 
mechanisms. The concept of epigenetics was coined in 1942 by Conrad Waddington, who 
visualised this process in his Waddington landscape (Figure 1). This image features a cell atop 
of a landscape in which hills and valleys shape the different paths this cell can take. By fine-
tuning gene expression programs this cell specializes towards a certain fate, traveling down 
specific paths. So although the actual DNA code is not different, the cell choosing the left path 
over the right can end up as a heart cell, whereas the right path would have led to a muscle 
cell.
	
Figure 1: Waddington’s landscape. The hills and valleys shape the different paths the undifferentiated 
stem cell visualised by the ball at the top can take towards a terminally differentiated fate. Figure taken 
from (Ghaffarizadeh, Podgorski and Flann, 2014)
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The activation of gene expression programs is in the first place a matter of accessibility of the 
DNA for regulatory proteins. The massive amount of genetic information that is encoded in 
the DNA needs to be compacted dramatically in order to fit into the nucleus. To achieve this, a 
stretch of around 147 bp of DNA is wrapped around an octamer of histone proteins; a Histone 
3/Histone 4 (H3/H4) tetramer which is accompanied by two H2A/H2B dimers. This DNA-
protein complex is called a nucleosome. Another histone protein, H1, interacts with the DNA in 
between nucleosomes stabilises the formation of a 30 nm fibre, forming 300 nm loops which 
are compacted into a 250 nm wide fibre and the chromatid (Luger et al., 1997; Kouzarides, 
2007; Anthony T. Annunziato, 2008).
 When the DNA is tightly compacted and inaccessible for transcription machinery, the 
repressed region is referred to as heterochromatin. Chromatin that is accessible for transcription 
machinery and activation of gene expression programs is referred to as euchromatin. The 
transitions are mediated by proteins that deposit or remove chemical groups on the DNA or 
histone proteins that can recruit elements regulating gene expression activation or silencing.
Modifying the DNA: DNA methylation
The most common DNA modification is DNA methylation of cytosine residues, leading to the 
recruitment of proteins which facilitate the re-arrangements leading to a less accessible 
structure. Additionally, they directly interfere in the interaction between transcription factors 
and the DNA. DNA methyl transferases such as DNMT1,  DNMT3A and DNMT3B can deposit 
these methyl groups, whereas members of the TET-protein family are involved in removing 
them (Guo et al., 2011). Although dynamically regulated, DNA methylation is considered very 
stable and changes in early development in response to cues from the environment can persist 
throughout a person’s life. This is exemplified by the discovery of altered DNA methylation 
patterns associated with metabolism in children that were exposed to prenatal famine during 
the Dutch Hunger Winter in 1944-1945. Several studies linked poor nutrition during pregnancy 
to an increased susceptibility to coronary heart disease, blood coagulation disorders and 
obesity (Roseboom, de Rooij and Painter, 2006; Heijmans et al., 2008; Guo et al., 2011).
Modifications on histone proteins and their relation with DNA accessibility
Another important factor that is related to alterations in DNA accessibility is modification of 
histone proteins. Although their globular cores can also be modified, they are mainly modified 
on their N-terminal tail which protrude out of the nucleosomes. These so-called “histone-
tails” contain residues that can be modified adding or removing different groups. The most 
common modifications are methylation, acetylation or phosphorylation of residues, but they 
can also be ubiquitinated, sumoylated, ADP ribosylated, deiminated, or modified through 
proline isomerization. Methylation occurs on lysine and arginine residues in the histone tail, 
whereas acetylation occurs on lysine residues. Threonine and serine residues are targets for 
phosphorylation (Kouzarides, 2007). These post-translational-modifications (PMTs) can either 
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recruit or repel proteins that can mediate in activation or repression of transcription, or the 
conversion between eu- and hetero- chromatin. 
 The effect on transcriptional regulation depends on the type of modification, the amino acid 
that is modified and the location of the modification in the histone tail. Histone 3 has some PTMs 
that are well studied and mark the chromatin for specific purposes. An active gene promoter 
for instance is marked by methylation of lysine 4 (K4) and a silenced, heterochromatic area 
with methylation of lysine 9 or 27 (K9 or K27). Regulatory sequences that encode enhancers, 
which can enhance transcription of certain genes through recruitment of additional regulatory 
factors, are marked with acetylation of lysine 27.
 There are multiple histone methyl transferases (HMT) that can mono- di- or tri- methylate 
lysine’s in histone tails. These either mark the chromatin as open for transcription or silence 
gene expression. Methylation of H3K4 is associated with active genes and there are several 
HMTs that can deposit this mark. Whereas MLL HMTs methylate specific genomic regions, 
trimethylation of active genes is mainly deposited by a protein called SET1 (Kouzarides, 2007; 
Pradeepa, 2017; Soares et al., 2017). H3K9 and H3K27 methylation is associated with the 
repressive chromatin structure is also maintained by histone methyl transferases. SUV 39h, 
SETDB1 and G9a are methyl transferases that can methylate H3K9 which subsequently leads 
to recruitment of the HP1 protein and repression of gene expression (Zeng et al., 2010). The 
other repressive mark H3K27me3 is maintained by polycomb proteins. These proteins form 
two different Polycomb Repressive Complexes (PRC1 and PRC2) with different compositions 
and functions. PRC 1 is built up out of a CBX family protein that recognises H3K27me3 which 
interacts with members of resp. the PCGF-, HPH- and RING1- families of proteins, forming 
the canonical PRC1 complex. The E3 ligase RING1 protein ubiquitinates K119 on H2A, which 
is believed to contribute to the compaction of chromatin. The PCR2 complex consists out of a 
member of the enhancer-of-zeste (EZH) family, embryonic ectoderm development (EED) family 
and the suppressor-of-zeste (SUZ) family. Using the WD40 repeats in EED, PRC2 binds to 
polycomb responsive elements and facilitates methylation of K27 on neighbouring H3 histones 
through its EZH component. The H3K27me3 mark is propagated in a process which is known 
as heterochromatin spreading, yielding large regions that are transcriptionally repressed (Di 
Croce and Helin, 2013; Wang et al., 2014). 
 H3K27 is also liable to acetylation, which is often associated with enhancer functionalities. 
These DNA stretches are often also decorated by H3K4me1 and can recruit proteins that can 
enhance transcription at local or more distal sites. H3K27ac is deposited by histone acetyl 
transferases (HATs) such as MOZ/MORF, p300 and can recruit transcription factors and RNA 
polymerase II.
 It is also possible that a region is marked by both H3K4me3 and H3K27me3 indicating a 
promoter that is “poised” for action. This is also possible for enhancers, were a combination of 
H3K4me1 and H3K27me3 poises an enhancer for activity (Shlyueva, Stampfel and Stark, 2014).
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 DNA accessibility is not only regulated via DNA and histone modifications, there are also 
factors that mediate nucleosome remodelling. This remodelling is necessary, since the 
unwinding of the DNA during transcription costs energy and requires temporary disassociation 
from the histone proteins. These transitions are mediated through deposition or removal of 
histone marks, but also through ATP-dependent remodelling. The latter requires energy in 
the form of ATP that is used by proteins containing an ATPase domain that use this energy to 
reposition nucleosomes or expel histones. The SWI/SNF complex is an example of a very well-
studied chromatin remodelling complex, which can create nucleosome free regions in the DNA 
enabling activation of gene expression programs, DNA repair or replication (Tang, Nogales and 
Ciferri, 2010).
 These epigenetic mechanisms provide the system flexibility to adapt to internal and 
external cues by facilitating changes in gene expression programs. The conversion from 
heterochromatin to euchromatin is accompanied by another flurry of activity from different 
protein complexes that mediate the next stages of transcription.
REGULATION OF TRANSCRIPTION
The chapters of this thesis will brush upon mechanisms active in different stages of 
transcription regulation, which can be roughly divided into roughly 3 phases; initiation, 
elongation and termination. In the initiation phase, the promoter region is recognised based 
on sequence elements in the promoter recruiting transcription machinery towards the 
transcription start site (TSS). After the required proteins are in place, RNA polymerase II can 
start building the RNA transcript during the elongation phase. In the first, pre-mature version 
of the transcript (pre-mRNA), both exons and introns are included. Exons are the parts of 
a gene that are eventually translated into proteins which are interspersed with non-protein-
coding introns. In the termination phase, the transcript receives modifications at both its ends 
to protect it against degradation in a process called capping and it is subjected to (alternative) 
splicing. RNA splicing is a post-transcriptional process in which the RNA transcript is edited 
by removing introns or some exon parts or exons that are alternatively combined. The now 
“mature” transcript is ready for translation or can fulfil other regulatory functions as a non-
protein-coding RNA (Figure 2).
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Figure 2: From DNA to protein; transcription and translation. On the DNA level, a gene is surrounded 
by regulatory regions, which can enhance or silence transcription. The gene itself has a promoter region 
where transcription factors can bind and recruit RNA polymerase II. This enzyme can then start producing 
the pre-mRNA, including the untranslated regions, exons and introns. This RNA is capped to protect 
it from degradation and edited through a process called (alternative) splicing. This mature mRNA can 
subsequently be translated into a protein.
Initiation of transcription
Initiation of transcription is hallmarked by the recruitment of the RNA polymerase to the 
transcription start site. This is mediated by proteins or transcription factors which can 
recognize specific target sequences or motifs in the promoter region. 
 A well-studied motif is TATAA, also referred to as the TATA-box. This motif has a specific 
location in the promoter region, around 25 to 30 bases upstream of the transcription start site. 
It recruits the TATA-box Binding Protein (TBP) which in its turn recruits general transcription 
factors transcription factor IID (TFIID), TFIIA, TFIIB, TFIIE, TFIIF, TFIIH and RNA polymerase II. 
This group is joined by Mediator, which is a protein complex that mediates between activators 
or repressors bound to enhancers and RNA polymerase II and the general transcription 
factors. Together, these proteins form a large complex called the pre-initiation complex (PIC) 
(Krishnamurthy and Hampsey, 2009; Chung et al., 2013).
 When the TATA-box is present transcription is initiated from a well-defined site. However, 
promoters for some genes do not contain either of these elements and transcription starts 
from an extended region of around 20-200 bases. These regions often contain a CG rich stretch 
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of nucleotides (20-50 bases) called CpG islands. This sequence can be recognized by the SP1 
transcription factor. This TF can interact with co-factors and enable the recruitment of TBP 
for the formation of the PIC and recruitment of RNA polymerase II (Vizcaíno, Mansilla and 
Portugal, 2015).
 RNA polymerase II is a complex built up out of 12 subunits called RPB1 to RPB12. RBP1, 2, 
3, 6 and 11 form the core of this complex and RBP 4 and 7 which are specific for the initiation 
phase appear to interact with the general transcription factors. RBP1 carries a C-terminal 
domain (CTD) or tail composed out of repetitions of seven amino acids (Tyr1-Ser2-Pro3-Thr4-
Ser5-Pro6-Ser7). The phosphorylation state of the CTD is dynamic during transcription and these 
changes coincide with different stages of the process. RNA polymerase II is recruited to the 
promoter in an unphosphorylated, inactive form and only after phosphorylation of Ser5 by TFIIH 
transcription is initiated. Alternatively, the Ser2 residue is phosphorylated during elongation. 
The CTD has also been shown to be involved in termination, where it plays a role in 5’ capping, 
3’ poly-A addition and splicing through changes in phosphorylation status (Krishnamurthy and 
Hampsey, 2009).
 Next to the general transcription factors there are other, gene- or tissue- specific 
transcription factors involved in the initiation of transcription. These can also bind enhancer 
regions where they act as co-activators or repressors for the transcription machinery 
sometimes favouring tissue specific genes or gene sets. One example of a tissue specific 
transcription factor is p63, which is considered the master regulator of the epidermal gene 
expression program. 
 All these elements and proteins contribute to the assembly of the transcription initiation 
complex and recruitment of RNA polymerase II. The polymerase then starts building the RNA 
transcript based on the code it encounters in the next steps; elongation and termination.
Elongation and termination
After transcription is initiated by RNA polymerase II the transcription complex needs to shed 
some of the factors which were required for initiation, acquire those which are important 
for elongation and release the promoter. During elongation the complex remains in place by 
gripping the nascent RNA molecule and the template DNA as it moves along the template. The 
RNA transcript is subject to the post-transcriptional process of splicing during elongation and 
is capped to protect it from degradation as it leaves the RNA polymerase complex.
 During elongation, the DNA helix is partially unwound through helicase activity by one of 
the subunits of RNA polymerase II (TFIIH) which enables the formation of RNA:DNA nucleotide 
pairs. The RNA nucleotides are connected through passage through the active site of the RNA 
polymerase, where the 5’ end of the incoming nucleotide is fused to the 3’ end of the previous. 
Before the RNA molecule exits the polymerase, proofreading activity checks if the nucleotides 
have been incorporated correctly. In case it encounters a mistake, RNA polymerase II can 
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back-track, remove the offending nucleotide and incorporate the correct nucleotide (Saunders, 
Core and Lis, 2006).
 Similar as during initiation of transcription the CTD of the RNA polymerase also plays an 
important role in the coordination of elongation and termination of transcription. Its dynamic 
phosphorylation state recruits the factors necessary for consecutive steps and different 
functions of the RNA polymerase (Krishnamurthy and Hampsey, 2009). 
 A major post-transcriptional RNA editing event occurring in parallel with elongation is 
RNA splicing. As soon as the RNA transcript leaves the RNA polymerase splicing machinery 
is recruited, which can facilitate the excision of non-coding parts from the transcript. This 
is regulated by a very large and dynamic protein complex called the spliceosome, which is 
recruited in different phases. At the start, complex A recognizes the splice site, enabling the 
assembly of complex B. The first transesterification reaction is catalysed by an activated complex 
B, complex B*, which is activated through rearrangements in complex B via the intermediate 
complex Bact. Another round of rearrangements leads to the generation of complex C, which 
can catalyse the second transesterification reaction. This is followed by disassembly of the 
spliceosome and recycling of its subunits for a next round of RNA splicing. There are variations 
in the motifs and proteins that recruit (pre-) splicing machinery, which enables alternative 
splicing. This process can lead to a change in exon composition in the mature RNA transcript, 
effectively changing the composition and possibly the function of the protein it encodes.  
 At the end of the gene a hexamer sequence (AAUAAA) on the RNA recruits protein complexes 
which catalyse the cleavage of the RNA from the RNA polymerase and subsequent capping of 
the exposed 3’ end. One of these complexes is the polyadenylation specificity factor (CPSF) 
which recognizes this sequences and facilitates cleavage by its CPSF-70 subunit. Its CPSF-160 
subunits bind the sequence directly, together with poly adenylation polymerase (PAP) which 
produces the poly-A tail. This long stretch of adenine residues can be bound by poly-A binding 
protein (PABP) which can protect the RNA from degradation (Saunders, Core and Lis, 2006; 
Richard and Manley, 2009). After addition of the 3’ poly-A tail and the 5’cap, a guanosine group 
that is placed in the 5’end of the transcript directly after it leaves the RNA polymerase complex, 
the mRNA is ready for translation complex (Saunders, Core and Lis, 2006).
The role of non-coding RNAs; side stepping the central dogma
According to the next step in the central dogma, the mRNA molecule is then translated 
into a protein. The protein-encoding transcripts are exported from the nucleus and fed into 
ribosomes. In these RNA-protein complexes the RNA code is read and the right amino-acids 
coupled. From there on, the protein travels to its final destination and performs the tasks it 
was made for until it is inactivated or degraded. However, not all mRNAs are translated into 
proteins, as some have regulatory functions themselves. Although research initially focussed 
on protein encoding genes, it is now well established that non-coding RNAs also play an 
important role in the regulation of gene expression programs. They can function on different 
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regulatory levels, where they can interfere or stabilize biological processes. A well-studied 
group of non-coding RNAs are microRNAs, which are small RNAs (21 nucleotides) which can 
interfere with translation and affect mRNA transcript levels upon finding its complementary 
target.
 Less clear are the various functions of long non-coding RNAs (>200 nucleotides, lncRNA) 
encoded in the human genome which are almost as numerous as protein encoding transcripts 
in number of annotated transcripts (Derrien et al., 2012). They have been implicated in many 
biological processes ranging from dosage compensation (Xist), imprinting (Kcnq1, Airn), 
neuronal development (Peril, Evf) and stem cell differentiation of neuronal, cardiac, epidermal, 
endodermal, endothelial and hemapoietic cells (Perry and Ulitsky, 2016). Additionally, their 
importance is highlighted through their involvement in various types of cancer (Bolha, Ravnik-
Glavač and Glavač, 2017) and other types of malignancies (Feng et al., 2018).
 The formation of hairpins and other secondary structures allows them to interact with 
different types of proteins, acting as a scaffold recruiting proteins or as a decoy enabling the 
release of proteins. Through sequence complementarity they can also act as antagonists for 
other non-coding RNAs, for instance with miRNAs (Bolha, Ravnik-Glavač and Glavač, 2017).
 lncRNAs are also considered biomarkers, coupling their expression to disease stages, 
diagnosis or prognosis. Their presence and value as biomarkers has been recognised in 
Alzheimer’s disease (Feng et al., 2018) and several types of cancer; for instance gastric cancer 
(Zhu et al., 2017), urothelial cancer (Droop et al., 2017), prostate and breast cancer (Bolha, 
Ravnik-Glavač and Glavač, 2017). This and the different mechanisms through which they can 
mediate their effects makes this class of non-coding RNAs an interesting group to consider 
when trying to understand complex regulatory mechanisms.
Regulation of gene expression; more than the sum of its parts
As our understanding of gene expression regulation improves so does our awareness of its 
complex dynamics and timing. The expression of a gene requires coordination of coding and 
non-coding RNAs working on the level of DNA, RNA and proteins. This is managed through 
an intricate network of genes working together and contributing to the versatile functions of a 
cell. A high level of redundancy between some of these pathways or regulatory processes make 
the system as a whole more robust. This means that that perturbation of a certain regulatory 
mechanism controlling a biological process can be solved via compensation through another 
functionally related mechanism. The regulation of for instance cell growth or proliferation 
is riddled with redundant regulatory mechanisms, as over-activity of proliferation related 
processes can lead to serious malignancies. This is of particular importance in stratified 
epithelial tissues separating the external environment from organs such as the skin or 
breast and colon tissues. These tissues display a very high renewal rate which relies on a 
delicate balance between proliferation and differentiation. This is regulated by many genes 
that enable fine-tuning of the gene expression programs governing these processes, avoiding 
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the generation of aberrantly behaving cells. The importance of proper organisation of these 
processes is evident as the majority of all cancers find their origin in stratified epithelial tissues. 
Although the different epithelial cell types use alternative gene expression programs to 
establish their respective tissue identity, they are all depended on regulation of differentiation 
and proliferation. Studying these gene expression programs and their regulation can lead to 
important insights into how their deregulation can contribute to disease development. In the 
chapters following this introduction the role of some of the involved regulatory mechanisms 
are discussed in the context of proliferation and differentiation in the epidermal layer of the 
skin. Therefore, in the next part of this introduction the skin will be introduced, as well as the 
role of coding and non-coding genes that influence regulation of gene expression programs 
that govern epidermal biology.
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PART II: GENE EXPRESSION REGULATION IN THE SKIN
The skin is an important organ of the human body, providing a barrier between the external and 
internal environment. It fulfils a diverse array of physiological functions, offering insulation, 
active regulation of body temperature and protection against dehydration and pathogens. The 
skin is built up out of three layers; a fat layer, a dermal layer which includes blood vessels 
and the epidermal layer. Although paper-thin, the cells in the epidermal layer form a heavily 
interconnected layer covering the whole body, providing the barrier function. The development 
and maintenance of the epidermis and its appendages is regulated by the interplay between 
signalling pathways and other regulatory mechanisms controlling proliferation and 
differentiation.
SKIN DEVELOPMENT
Signalling pathways play and important role in the development and homeostasis of many 
organs and tissues. This is also the case for the epidermis, which is formed during early 
mammalian development from a single layer of neuro-ectoderm on the surface of the embryo. 
Through modulation of Wnt signalling, these cells can either progress into the neuronal fate, 
or become skin epithelium. The neuronal fate is acquired in absence of Wnt signalling during 
which cells can still respond to fibroblast growth factors (FGFs) which in their turn inhibit bone 
morphogenetic protein (BMP) signalling. Alternatively, after activation of Wnt signalling cells 
cannot respond to FGFs and start expressing BMPs leading to the generation of a single layer 
of multipotent epithelial cells (Fuchs, 2007). These multipotent cells contain cells that can 
differentiate into hair follicles and interfollicular epidermis.
 Hair follicles develop through Wnt signalling activity and inhibition of FGF and BMP 
signalling by the mesenchyme. Local condensation of the dermis leads to the formation of 
dermal papilla, where the epithelium invaginates and extends downwards. At the base of this 
developing hair follicle cells maintain a highly proliferative state until they start differentiating 
during follicle maturation. These so-called matrix cells in the hair germ give rise to the different 
cell types of the hair follicle, differentiating into a hair shaft, an outer root sheath and an inner 
root sheath. After birth, these hair follicles continue cycling throughout life via a growth phase; 
anagen, followed by a phase where the growth phase is exited; catagen, and eventually the 
resting phase; telogen, in which the hair is dead and fully keratinised. Finally, the hair is shed, 
making way for the next hair (Blanpain and Fuchs, 2006; Fuchs, 2007).
 Epithelial cells that fail to respond to Wnt signalling continue to develop into IFE under the 
influence of BMP- and EGF- signalling and the activation of Notch signalling (Blanpain and 
Fuchs, 2006). The embryonic stratification process of the IFE is started through asymmetric 
divisions of basal cells. Although most divisions occur orientating the mitotic spindle 
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laterally to the epidermis at mouse embryonic day E12.5 (E12.5) these cells sometimes divide 
perpendicular to the epithelium. This division results in a basal cell which remains attached 
to the basement membrane and a supra basal cell, which no longer contacts the basement 
membrane. As development progresses, there are more and more of these asymmetric 
perpendicular divisions, (22% at E12.5 to 70% at E15.5) resulting in a fully stratified epidermis on 
day E18.5. Interactions with the basement membrane through integrin B1 and A-catenin seem 
to be required for proper orientation of the spindles, as well as the presence of transcription 
factor p63 (Lechler and Fuchs, 2005). 
 After formation of the suprabasal layer, stratification is continued via an intermediate layer. 
This layer is transient and differentiates to the spinous layer and granular layer and eventually 
forms the cornified layer (Blanpain and Fuchs, 2009). Once the epidermis is stratified and 
differentiated the periderm, a transient protective layer, is shed from the skin (Fuchs, 2007; 
Koster and Roop, 2007) (Figure 3). 
 
Figure 3: The development of the epidermis and hair follicles. 
 
Figure 3: The development of the epidermis and hair follicles. The basal layer is composed out of 
multipotent epithelial cells which will form the epidermis and hair follicles. The epidermis is formed 
through stratification forming the different layers; starting from the basal layer, differentiation takes the 
cells through the spinous layer and the granular layer. They eventually end up heavily interconnected in the 
cornified layer completing the epidermal barrier. Hair follicles start developing after the multipotent cells 
differentiate into hair follicles (1). This induces the formation of dermal papilla (2), which instructs the hair 
germ to start forming the hair follicle and hair (3). The cells in the hair matrix give rise to the development 
of the inner and outer root sheath and eventually the hair shaft. Figure adapted from (Blanpain and Fuchs, 
2006).
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SKIN HOMEOSTASIS
Once the skin has been formed, the epidermal layer is completely renewed each month 
throughout adult life. This process is driven by proliferation and upward differentiation of 
epidermal stem cells or keratinocytes which replenish the epidermis from the bottom up. 
These stem cells reside in the basal layer, where they are attached to the basement membrane 
with integrins. These are part of focal adhesion (FA) and hemidesmosomal structures, which 
contain different types of α/β integrin pairs; α/β1 integrins form the core of FA structures, 
connecting the basement membrane or extra cellular matrix (ECM) to the actin cytoskeleton 
within the keratinocytes (Levy et al., 2000). The α6β4 pair forms the core of hemidesmosomal 
structures, which connect the ECM to the keratin cytoskeleton inside the keratinocytes (Hegde 
and Raghavan, 2013). These, adherens junctions and desmosomes structures which connect 
cells through respectively their actin or keratin cytoskeleton play important roles in adhesion, 
proliferation and differentiation (Hegde and Raghavan, 2013; Watt and Huck, 2013). Adhesion 
mediated through integrin β1, which is a component of focal adhesion complexes for instance 
is determinant for the differentiation state of a keratinocyte. The most proliferative cells 
express higher levels of ITGB1 and represent the epidermal stem cells. Transient progenitor 
cells express less ITGB1, represent a less proliferative population and cells that do not express 
the protein are terminally differentiating (P H Jones and Watt, 1993).
 These differences can also be captured in in vitro studies, where differences in adhesion and 
proliferation of cells can be used as a readout to monitor differentiation (or proliferation) state. 
In colony formation assays, primary keratinocytes are grown in the presence of mitotically 
inactivated fibroblasts and form morphologically different colonies. Based on their adhesive 
and proliferative capacities these cells form three types of colonies; holoclones, paraclones 
and meroclones. Holoclones are most proliferative, most likely derived from stem cells which 
attach readily and form bigger colonies with smaller, round cells which can be passaged 
long-term. Paraclones are abortive colonies which contain cells that display a more flattened 
morphology, reminiscent of terminally differentiated cells. Lastly, meroclones are smaller, 
have a more heterogeneous morphology and are least proliferative compared to the other two 
types (Barrandon and Green, 1987; Blanpain and Fuchs, 2006).
 The basal layer does not only contain highly proliferative stem cells, but also contains 
transient progenitor cells. These are the result of symmetric or asymmetric divisions of stem 
cells. Symmetrical divisions yield either two stem cells or two committed transient progenitor 
cells, whereas an asymmetrical division generates a stem cell and a committed transient 
progenitor cell (Blanpain and Fuchs, 2009). The transient progenitor cells are still proliferative 
but differ in mode of division, gene expression and ability to respond to tissue damage (Blanpain 
and Fuchs, 2014). After a limited number of divisions these cells initiate terminal differentiation 
in which the cells release the basement membrane and start upregulating differentiation 
markers. This causes a chain reactions of events in which their morphology changes as they 
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differentiate into the cornified layer and are shed off of the skin. This journey is marked by 
changed expression of different marker proteins and signalling pathway activity.
 In the first step the cells transfer from the basal layer into the spinous layer which is 
accompanied by a release of integrin anchors and a switch from expressing keratin 5 and 
keratin 14 (K5/K14) to K1/K10. The individual keratin-monomers form heteropolymers between 
type I and type II keratins, forming coiled-coiled fibres called intermediate filaments (Lee et 
al., 2012). These keratin intermediate filaments (IF) form an extensively interlinked keratin 
cytoskeleton that strengthens cell-cell junctions and provides protection against mechanical 
stress (Blanpain and Fuchs, 2009). 
 The transition into the granular layer is induced by the increase in Ca2+ concentration, 
which continues to increase in a gradient through the remaining layers of the epidermis. This 
triggers the cells to start expressing fillagrin and loricrin (Blanpain and Fuchs, 2006; Koster 
and Roop, 2007). Loricrin (LOR) is the most abundant protein in the cornified layer (70-85%) and 
considered the main reinforcement protein in this layer. It is located beneath the cell membrane 
and is cross-linked via small proline rich proteins (SPRR proteins) by transglutaminases (TG1, 
TG5 and TG3) in later stages of differentiation (Candi, Schmidt and Melino, 2005; Eckert et 
al., 2005). These TG proteins are enzymes that mediate in the formation of the very stable 
isopeptide bonds between their substrates, which also include involucrin, envoplakin and 
periplakin (Ruhrberg et al., 1997; Candi, Schmidt and Melino, 2005). Fillagrin mediates the 
aggregation of the formed keratin bundles, collapsing the keratin cytoskeleton and changing 
the cell shape to the characteristic flattened morphology (also called corneocytes). The rapid 
degradation of fillagrin into free amino acids furthermore increases local osmolarity leading to 
the retention of water in the cornified layer making it more flexible (Candi, Schmidt and Melino, 
2005).
 The dead, flattened, keratin-filled corneocytes strengthened by the heavily cross-linked 
protein beneath the cell membrane form the basis of the cornified envelope. These serve as 
a scaffold for lipid bilayer structures that protrude out between the former cells making the 
outer surface of the skin waterproof (Blanpain and Fuchs, 2009). The corneocytes themselves 
are connected through modified desmosomes called corneodesmosomes, which are formed 
during the transition from the granular layer to the cornified layer. The structures are eventually 
degraded in the final steps of cornification allowing desquamation or shedding of corneocytes 
(Candi, Schmidt and Melino, 2005).
 Throughout the transitions through the different layers of the epidermis, these cells 
constantly change and fine-tune their expression programs in a differentiation state dependent 
manner. This is regulated by both coding and non-coding RNAs, providing control over the 
balance between proliferation and differentiation. 
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REGULATION OF GENE EXPRESSION PROGRAMS GOVERNING EPIDERMAL 
DEVELOPMENT AND HOMEOSTASIS
The renewal of the epidermal layer of the skin is achieved through a carefully coordinated 
sequence of events, in which cells stop proliferating and start executing a terminal 
differentiation program. This puts a high demand on the epidermal stem cells as constant 
proliferation is required to replenish the continued shedding of dead corneocytes from the 
cornified layer. The balance between proliferation and differentiation is precisely regulated as 
errors or deregulation can impair the barrier functions of the skin. There are many genes 
involved in the regulation of gene expression programs governing these processes, working 
on transcriptional and post-transcriptional level. Transcription is regulated by epigenetic 
mechanisms and skin-specific transcription factors and post-transcriptionally, non-coding 
RNAs and splicing influence the outcome of gene expression programs.
Transcription factors in epidermal development and homeostasis
Tissue-specific gene expression is accomplished through epigenetic mechanisms and specific 
transcription factors. For the skin this means they control a transcription program involving 
different keratin proteins that are expressed in a differentiation state dependent manner as 
is the expression of the genes on the epidermal differentiation complex (EDC) which encodes 
important structural proteins as well as appendage specific components (Botchkarev, 2015). 
Throughout the process of epidermal differentiation, the cells adjust and fine-tune their gene 
expression programs to facilitate the transitions between the different layers. This is regulated 
by epigenetic mechanisms changing the accessibility of genomic loci and transcription factors 
which enable recruitment of transcription machinery.
 There are several key transcription factors that regulate expression of genes that are 
pivotal for keratinocyte biology. The AP-1 family of transcription factors for instance regulate 
expression of genes governing proliferation and differentiation in many different cell types. 
They consist of heterodimers composed out of subunits c-Fos, FosB, c-Jun, JunB, JunD, Fra-1 
and 2 which are expressed throughout the layers of the epidermis regulating different genes 
depending on differentiation state. Expression of different members of the keratin family (K1, 
5, 6, 8, 14, 18, 19) is regulated by AP-1 family and they have been implicated in the regulation of 
many other genes which are predominantly involved in epidermal differentiation (loricrin, pro-
fillagrin, transglutaminase). Some of the targeted genes not only require AP-1 binding but also 
other transcription factors to facilitate gene expression regulation. Co-activation of AP-1 and 
the Sp1 transcription factor is needed for maximal involucrin expression and the expression 
of differentiation associated SPRR1A and SPRR3 is co-regulated by AP-1 and members of the 
ETS family of transcription factors (Angel, Szabowski and Schorpp-Kistner, 2001). 
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Other transcription factors that are important for epidermal development and maintenance 
include; KLF4, ARNT and c-Myc (Botchkarev et al., 2012). However, the centre stage of 
transcriptional regulation in keratinocytes belongs to p63. This protein is encoded in the 
TP63 gene and is expressed in different isoforms (Soares and Zhou, 2018). This transcription 
factor is considered a master regulator of the epidermal fate through regulation of distinct 
gene expression programs governing both differentiation and proliferation processes (A. B. 
Truong et al., 2006). This includes direct control over expression of genes that functionally 
regulate differentiation but also genes that encode other important transcription factors such 
as ZNF750 and IRF6.
 ZNF750 is a direct p63 target which is considered a dominant mediator of epidermal 
differentiation. It is expressed in the suprabasal layer of the epidermis and increases during 
differentiation, with its expression peaking in the granular layer (Cohen et al., 2012). Functionally, 
it plays a role in the regulation of epidermal differentiation as silencing ZNF750 leads to a 
reduction in expression genes involved in barrier function and the EDC. Alternatively, its over-
expression in undifferentiated cells leads to the induction of terminal differentiation (Cohen 
et al., 2012). ZNF750 was identified as an important mediator of epidermal differentiation 
downstream of p63 after its expression was shown to restore loss of differentiation in p63 
depleted cells (Sen et al., 2012). It is in charge of a gene expression program that includes 
important late differentiation genes such as KLF4, SPINK5, FLG and LOR (Sen et al., 2012). 
 Another transcription factor that is regulated by p63 and important for epidermal biology 
is IRF6. Unlike the other members of the transcription factor family of IRF’s IRF6 does not 
regulate IFN but instead regulates genes involved in differentiation, cell adhesion and cell-cell 
contact in the skin (Botti et al., 2011). It is also important during development, as mice which 
are deficient of Irf6 display abnormal skin limb and craniofacial morphologies (Ingraham et 
al., 2006). In humans, this gene has been linked to the van der Woude syndrome, in which 
patients with mutations in the IRF6 gene develop cleft palate or cleft lip (Kondo et al., 2002). 
The expression of IRF6 is controlled by p63 and it has been shown that these two genes jointly 
contribute to the development of cleft palate/lip (Thomason et al., 2010). On a molecular level 
it has been shown that suprabasal cells deficient of IRF6 do not stop proliferating and fail to 
differentiate properly, which can contribute to the development and progression of squamous 
cell carcinoma (Ingraham et al., 2006; Botti et al., 2011). 
 As master regulator of the epidermal lineage, p63 is responsible for proper execution of 
the epidermal differentiation program. Although it is known that p63 regulates the relevant 
gene expression programs, the exact mechanism through which it regulates this is not clear. 
It facilitates transcription through its control of expression of other transcription factors and it 
has been implicated in epigenetic mechanisms. This includes regulation of gene expression of 
genes involved in chromatin remodelling such as members of the BAF complex through BGR1 
(Mardaryev et al., 2014) and physical interaction with ACTL6A (Saladi et al., 2017) and higher 
order chromatin organizer SatB1 (Fessing et al., 2011). Recently, an interesting theory has been 
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proposed, in which p63 regulates gene expression through binding of specific enhancers of 
genes important for the epidermal lineage. More specifically, it was shown that not its binding 
to enhancers but its binding to active enhancers (bearing the H3K27ac mark) is correlated with 
active gene expression. This means that its activity is likely to be dependent on recruitment 
of additional (transcription) factors and that p63 can be considered a bookmark, marking 
specific genomic loci for activation (or repression). Through binding to specific enhancers, p63 
might provide the spatial and temporal control of gene regulation that is required in the highly 
organized epidermal environment (Kouwenhoven et al., 2015). 
Epigenetic mechanisms in the skin
Transcription factors such as p63 and the AP-1 factors directly regulate gene expression by 
binding target sequences in the DNA and subsequent recruitment of transcription machinery. 
As in other tissues, these factors can only bind once the DNA is made accessible, which is 
regulated by diverse epigenetic mechanisms. Several of these have been implicated in the 
regulation of transcription programs governing epidermal differentiation, including proteins 
that modify DNA and histone proteins or chromatin remodelling. 
 DNA methylation in the skin this is regulated by DNMT1 and UHFR1, which are predominantly 
expressed in the basal cells. These DNA methylases are downregulated during differentiation 
suggesting DNA methylation is important to maintain an undifferentiated population. 
Moreover, when the expression of DNMT1 is perturbed in human epidermal cells xenografted 
on immune-deficient mice cells start to differentiated pre-maturely and displayed decreased 
proliferation and self-renewal capacity (Sen et al., 2010). Similar effects are observed when 
the expression of UHRF1 is knocked-down which also leads to decreased proliferation and 
upregulation of differentiation associated genes (Mulder et al., 2012). Interestingly, the DNA 
demethylase Gadd45 plays a role in epidermal differentiation as its knockdown prevents the 
upregulation of differentiation genes in vitro and its over expression induces differentiation (Sen 
et al., 2010; Perdigoto et al., 2012). Although these dynamics suggest that active demethylation 
is necessary for epidermal differentiation, there are also some genes that are activated during 
differentiation despite being methylated. The CpG methylation of genes that harbour a CRE 
sequence (TGACGTCA) in their promoter has been shown to enhance binding of the C/EBPα 
transcription factor, which activates their expression in differentiation (Rishi et al., 2010). This 
suggests that DNA methylation has a dual role in keratinocyte biology; it can either repress 
transcription via DNMT1 or activate transcription through recruitment of C/EBPα (Botchkarev 
et al., 2012; Perdigoto et al., 2012).
 Histone modifications also play an important role in the regulation of gene expression 
programs involved in epidermal self-renewal and differentiation. These marks are dynamically 
deposited and removed, changing accessibility for transcription machinery in a time- and 
differentiation state dependent manner. The previously described PRC1 and PRC2 complexes 
mediating H3K27 methylation are also involved in the fine-tuning of the expression of gene 
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expression programs. PRC1 subunits Cbx4 and Bmi are implicated in the regulation of 
keratinocyte senescence through repression of the p16INK4A locus (Luis et al., 2011) as is the 
PRC2 subunit Ezh2, which also inhibits recruitment of AP-1. Loss of Ezh2 leads to premature 
induction of differentiation during skin development and loss of PRC2 component Jarid2 leads 
to lower levels of H3K27me3, reduces proliferation and induces differentiation of progenitor 
cells (Botchkarev et al., 2012). Histone acetylation levels are also important for keratinocyte 
specific gene expression programs, as inhibition of histone acetylases globally led to inhibition 
of proliferation and induction of differentiation. Alternatively, conditional deletion of HDAC1/2 
in mouse epidermis leads to failure to differentiate properly, resulting in a single-layered 
epidermis (Botchkarev et al., 2012).
 Lastly, another important group of proteins involved in gene expression regulation in 
epidermal biology are chromatin remodelers. These enable the structural changes that are 
necessary for transcription such as sliding of nucleosomes, exchange of histone variants and 
eviction of histones. These complexes hydrolyse ATP in order to alter the interaction between 
histones and DNA within nucleosomes (Clapier and Cairns, 2009). There are different groups of 
chromatin remodelling complexes, subdivided based on the different core proteins they contain. 
The SWI/SNF containing complexes are most studied and have been shown to be crucial for 
proper execution of epidermal differentiation (Perdigoto et al., 2012). The complex is also 
known as the BRG1/BRM associated factor (BAF) complex and contains ATPases BRG1 or BRM 
and between eight and 14 other subunits (Clapier and Cairns, 2009). These catalytic subunits 
are needed for proper formation of the skin barrier as the SWI/SNF complex is responsible for 
proper expression of differentiation associated genes. Although BRG1 is expressed throughout 
the layers of the epidermis, the activity of the chromatin remodelling complex is restricted to 
the suprabasal layers. Binding of its ACTL6A subunit prevents the complex from binding its 
targets and protects the cells against premature differentiation (Perdigoto et al., 2012; Bao et 
al., 2013). Interestingly, ACTL6A is a physical interactor of p63 and jointly they regulate gene 
expression programs involved in proliferation and are frequently co-expressed in head and 
neck squamous carcinoma (HNSCC) (Saladi et al., 2017).
Other histone remodelling complexes contain ISWI or CHD groups, which have been implicated 
in epidermal differentiation through interacting with resp. the NURF and NuRD complex 
(Botchkarev et al., 2012; Mulder et al., 2012). Expression of genome organizer Satb1 is under 
control of p63 and is necessary for the remodelling of the EDC locus which is essential to 
ensure proper expression of the genes it encodes. It binds DNA and folds chromatin in loops 
and can recruit other chromatin remodelers and transcription factors (Fessing et al., 2011; 
Botchkarev, 2015).
 The high turnover of the epidermal stem cells and subsequent activation of the terminal 
differentiation program requires quick successive changes in gene expression programs. The 
activation of tissue specific gene expression programs is regulated through these epigenetic 
mechanisms, which dynamically regulate DNA accessibility in a differentiation state dependent 
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manner. These epigenetic mechanisms provide an extra layer of control ensuring the activation 
or repression of the right gene expression programs dynamically in a time- and differentiation 
state dependent manner.
POST TRANSCRIPTIONAL REGULATION IN THE SKIN
Next to several differentiation state dependent proteins providing transcriptional control, 
there are non-coding RNAs and post-transcriptional processes such as splicing regulating 
transcript (isoform) presence and composition. Their timing of expression, targeted transcripts 
or mechanisms can significantly influence the onset of epidermal differentiation and are 
therefore important to consider when studying keratinocyte biology.
Non-coding RNAs in the skin
A very well studied non-coding RNA in epidermal biology is miRNA miR-203. It targets p63 
RNA transcripts and other suprabasally expressed genes, positively regulating the induction 
of differentiation (Yi et al., 2008). There are various other miRNAs which regulate epidermal 
differentiation (ABERDAM et al., 2008) and there are also some lncRNAs which are involved 
in epidermal differentiation. TINCR was one of the first lncRNAs that was discovered to be 
important for keratinocyte biology. The lncRNA is expressed in the more differentiated layers 
of the skin and its knockdown caused disruption of expression of key epidermal differentiation 
genes (fillagrin, K1, K10 and loricrin) in organotypic human epidermis. The lncRNA associates 
with the STAU1 protein and interacts with differentiation related mRNAs, which seem to be 
stabilised through this interaction, ensuring their expression (Kretz, Siprashvili, et al., 2012).
 Another lncRNA discovered by the same group was shown to be involved in the regulation 
of self-renewal of epidermal stem cells. Silencing ANCR led to the induction of differentiation 
related proteins in more undifferentiated layers of the skin and global differential gene 
expression analysis showed that genes involved in epidermal differentiation and cornification 
were enriched (Kretz, Webster, et al., 2012). 
 These non-coding RNAs are only some examples that have been identified, but their 
involvement in various biological processes and their diverse modes of action highlights the 
importance of identifying and characterising more of these transcripts involved in keratinocyte 
biology.
Splicing in the skin
A mentioned before, splicing is an important post-transcriptional mechanism that enables 
alterations to mRNA transcripts after they have been transcribed by RNA polymerase II. This 
process generates several versions or isoforms of a transcript, which can end up as functionally 
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different proteins. In the skin, isoforms of several genes are expressed in a differentiation state 
dependent fashion. 
 The dermokine (DMKN) gene for instance encodes for several different isoforms; alpha, 
beta, gamma, delta and epsilon. The beta and gamma isoforms are restricted to the epidermal 
layer of the skin, in particular the granular layer. The alpha and delta form of the transcript 
are expressed throughout all the layers of the skin as well as the placenta (alpha) and in most 
organs (delta). Next to some isoforms having different TSS, there is also evidence of differential 
exon usage during differentiation. In the skin, DMKN plays an important role in the cornification 
process, as mice deficient of DMKN beta and gamma display transient cornification defects 
(Naso et al., 2007; Leclerc et al., 2014).
 Another example of a gene that encodes different isoforms in the skin is extracellular 
matrix protein 1 (ECM1). This is a basement membrane protein where is it part of structures 
that are composed out of perlecan, collagen IV and laminin 332. The two isoforms (alpha and 
beta) are expressed in different regions of the skin; alpha predominantly in the basal and 
suprabasal layers, and beta in the spinous and granular layer. The alpha isoform has been 
shown to specifically strengthen the binding of laminin 332 to collagen IV.   Next to its role in 
cell adhesion, the proximity of the gene to the EDC locus and differential splicing throughout 
differentiation does imply that these isoforms are involved in the regulation of epidermal 
differentiation (Smits et al., 2000; Sercu et al., 2008).
 These examples illustrate the dependence on the presence of certain isoforms during 
epidermal differentiation. This demonstrates the importance of proper regulation of splicing in 
the epidermis, identifying it as an important post-transcriptional process controlling epidermal 
biology.
FUNCTIONAL INTERACTIONS IN THE SKIN; HOW GENES WORK TOGETHER
It is clear that there are many coding and non-coding genes working together regulating gene 
expression programs transcriptionally and post-transcriptionally. This is not just between 
genes which share a physical interaction at some point, but also between genes that regulate 
similar processes or are functionally redundant. By investigating these functional interactions 
between seemingly unrelated genes or gene sets, important links between processes can be 
discovered. This enables the development of strategies that exploit or take these functional 
connections into consideration, making a treatment more efficient or preventing compensation 
by other mechanisms.
 To identify functional interactions between two genes, both genes are silenced individually 
and combined, where after the expected effect of the double knockdown is compared to the 
observed effect. The expected effect is based on the observations made in the individual 
knockdowns which are quantified and combined in the expected effect. This data can be 
CHAPTER 1
36
combined in several ways, using rules which are based on different mathematical theories 
(Mani et al., 2008). Typically, it is based on the product rule, in which the effects observed 
in the individual knockdown are multiplied before comparing them to the observed double 
knockdown phenotype (Baryshnikova et al., 2010). This comparison leads to classification of 
gene pairs of which double knockdown leads to a bigger, or aggravating, effect than expected 
and gene pairs of which this leads to a reduced, or alleviating, effect. Practically, this means 
that the effect combinatorial knockdown of genes that are active in the same pathway or 
biological process does not exceed the effect of the individual knockdowns. These alleviating 
interactions describe genes of which the individual knockdowns already impair the process in 
such a way that the double knockdown does not aggravate this effect. The other way around, if 
genes are active in more functionally distinct processes, the double knockdown might result in 
an aggravating effect compared to the individual knockdowns (Mani et al., 2008; Baryshnikova 
et al., 2010; Horn et al., 2011; Roguev et al., 2013). There are several phenotypic readouts to 
base the classification of functional interactions upon, including high throughput imaging that 
enables multi-parametric measurements (e.g. cell number, colony size) but most often, fitness 
is used (Baryshnikova et al., 2010; Horn et al., 2011; Laufer et al., 2013; Roguev et al., 2013).
 These experiments provide valuable information about how genes work together by 
considering all combinations which sometimes leads to the discovery of connections between 
previously unrelated mechanisms. In 2012, it was shown that these functional interactions 
can be predicted based on effects of individual knockdowns. Here, genes that work together 
regulating epidermal differentiation were identified by comparing the effect of perturbing 
their expression whilst inducing differentiation via different routes. This leads to an intricate 
network of genes that cluster based on regulating similar processes, sharing a functional 
connection. This theory was successfully applied to search for functional interactions between 
332 chromatin factors, which were silenced in primary human epidermal stem cells after 
which differentiation was induced. A Bayesian mixture model was subsequently used to predict 
functional interactions between all possible gene pairs, which were visualised in a network. 
This network displayed the most significantly enriched functional interactions, revealing 
interactions between chromatin factors involved in different epigenetic strategies. These 
interactions were experimentally validated, connecting genes that have opposing effects on 
transcriptional regulation but jointly regulate an adhesion related expression program (Mulder 
et al., 2012). 
 These experiments showed the power of these experiments, where perturbation based 
screens led to the discovery or confirmation of functional interactions. These interactions are 
important to consider, since redundancy between seemingly unrelated processes can lead to 
unanticipated or undesired effects in disease.
 To be able to truly understand this system we need to consider the complex interplay 
between signalling pathways, non-coding RNAs, transcriptional and post-transcriptional 
regulation. Moreover, we need to appreciate how these processes are interconnected and how 
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they influence each other. Studying epidermal homeostasis will not only teach us fundamentally 
about how these cells operate, but will also provide information about stem cell behaviour 
in general. Finding functional connections between genes in healthy cells can furthermore 
help to draw important parallels with deregulated systems. Additionally, by taking functional 
interactions or how genes work together into consideration we are implementing another way 
of tackling complex biological questions which might lead to the development of better or 
additional (therapeutical) strategies.
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GRAPHICAL ABSTRACT
In brief
Tanis et al. employed gene perturbation screens and multiple -omics approaches leading to 
the identification of ZMAT2 as a regulator of epidermal differentiation. Moreover, ZMAT2 works 
in conjunction with several epigenetic modifiers to control genes involved in cell adhesion 
processes.
Highlights
•   Gene-perturbation screens identify a role for ZMAT2 in the control of human epidermal 
differentiation.
•   ZMAT2 functionally interacts with known epigenetic regulators of epidermal differentiation.
 •   ZMAT2 interacts with the pre-spliceosome and transcripts involved in cell adhesion.
•   ZMAT2 mediated splicing and epigenetic control jointly target an adhesion related 
transcriptional program in human epidermal stem cells
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SUMMARY 
Epidermal homeostasis requires balanced progenitor cell proliferation and loss of differentiated 
cells from its surface. During this process cells undergo major changes in their transcriptional 
programs to accommodate new cellular functions. We found that transcriptional and post-
transcriptional mechanisms underlying these changes jointly control genes involved in cell 
adhesion, a key process in epidermal maintenance. Using siRNA-based perturbation screens, 
we identified novel DNA/RNA binding regulators of epidermal differentiation. Computational 
modelling and experimental validation identified functional interactions between the matrin-
type 2 zinc-finger protein ZMAT2 and the epigenetic modifiers ING5, SMARCA5, BRD1, UHRF1, 
BPTF, SMARCC2. ZMAT2 an interactor of the pre-spliceosome required to keep cells in an 
undifferentiated, proliferative state. RNA-Immunoprecipitation and transcriptome-wide RNA 
splicing analysis showed that ZMAT2 associates with, and regulates, transcripts involved in cell 
adhesion in conjunction with ING5. Thus, joint control by post-transcriptional and epigenetic 
mechanisms is important to maintain epidermal cells in an undifferentiated state.
INTRODUCTION
 
As our understanding of gene expression regulation improves so does our awareness of its 
complex dynamics and timing. The transcription machinery and its co-factors, chromatin 
state, RNA splicing and miRNAs are only some of the myriad of processes contributing to 
the versatile functions of a cell. Regulation of gene expression is of particular importance for 
governing the delicate balance between proliferation and differentiation in stratified epithelial 
tissues such as the skin, breast or intestine. The high renewal rate in these tissues requires 
tight regulation of gene expression programs to avoid the generation of aberrantly behaving 
cells giving rise to diseases. Here, we use primary human keratinocytes as a model to study 
the contribution of genes to the regulation of gene expression programs governing epidermal 
proliferation and differentiation. The epidermal layer of the skin is completely replenished each 
month in a process driven by epidermal stem cells (keratinocytes), which reside attached on 
the basal membrane. Upon initiation of differentiation these cells stop proliferating, release 
their integrin anchors and move through the different layers of the skin, traveling upwards 
through the spinous and the granular layers (Moreno-Layseca and Streuli, 2014). Eventually, 
they end up de-nucleated and heavily interconnected in the cornified layer, where they are shed 
from the surface. This process is marked by, amongst others, down regulation of integrins and 
up regulation of differentiation genes such as envoplakin (ENV), periplakin (PPL) (Ruhrberg 
et al., 1997), involucrin (INV) and transglutaminase (TGM1) (Eckert et al., 2005). Throughout 
this transition they continuously change and fine-tune their expression programs using 
transcriptional and post-transcriptional processes in a differentiation state dependent manner. 
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 These transitions in gene expression programs are controlled by regulatory mechanisms 
provided by epigenetic factors, transcription factors and post-transcriptional processes such 
as splicing. Epigenetic factors regulate chromatin accessibility through remodelling (BPTF, 
SMARCA5) or adding or removing histone or DNA modifications (ING5, UHRF1) (Mulder et 
al., 2012). Open chromatin structures allow for transcription factors to bind their motifs and 
enable activation of gene expression programs. There are several transcription factors which 
have a known role in keratinocyte biology (AP1, ETS-family (Eckert et al., 1997; Nagarajan et 
al., 2010) to regulate the expression of differentiation markers (e.g. IRF6 (Botti et al., 2011; 
Biggs et al., 2012) and MAFB (Miyai et al., 2016)). The emerging RNA transcript is then found 
by RNA-binding proteins that edit and protect it on its way to being translated into a protein. 
One of the most important RNA editing processes is RNA splicing, where introns are excised 
from the immature transcript generating a mature RNA transcript. More extensive editing via 
alternative splicing may be important in the skin, as there are several genes that display isoform 
specific expression in different keratinocyte cell states. For instance, dermokine, a gene that is 
highly expressed in the granular layer of the epidermis, is heavily spliced, generating multiple 
isoforms with different functions (Naso et al., 2007). Another example is desmoplakin (DSP) 
which has two major isoforms which seem to have distinct functions in controlling desmosomal 
adhesion in the skin (Cabral et al., 2012). These examples illustrate the importance of proper 
regulation of both transcriptional and post-transcriptional processes. However, our current 
understanding of how these processes co-ordinately govern epidermal biology is limited. 
 Here, we investigated the role of 145 putative DNA/RNA binding factors in human epidermal 
differentiation using siRNA-based perturbation screens. We identified the matrin type-2 zinc-
finger protein ZMAT2 to be important to maintain cells in an undifferentiated state and as a 
splicing regulator of adhesion related transcripts. Moreover, computational predictions and 
experimental validation uncovered a previously unappreciated connection between epigenetic 
and post-transcriptional control of keratinocyte differentiation.
RESULTS
Gene perturbation screens identify nucleic acid binding proteins involved in human 
keratinocyte renewal and differentiation
To investigate the role of putative nucleic acid binding factors in the regulation of epidermal 
stem cell renewal and differentiation, we performed siRNA-based knock-down screens (Figure 
1A). For this, we selected 145 genes based on their expression levels in keratinocytes (RPKM>5), 
differential expression during differentiation (Figure S1A and B, (Kouwenhoven et al., 2015)) 
and DNA or RNA binding potential. To test the contribution of these genes to the process of 
differentiation, we silenced each gene using a pool of three independent siRNAs in triplicate and 
subsequently induced differentiation. Transfected cells were cultured in different conditions 
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for 48 hours to induce differentiation with the EGF inhibitor AG1478, BMP 2/7, a combination 
of these compounds, 10% fetal bovine serum and a vehicle control, as previously described 
(Mulder et al., 2012). These treatments lead to robust induction of terminal differentiation 
marker transglutaminase I (TGM1) (Mulder et al., 2012). Endogenous TGM1 protein was 
quantified using a fluorescent In-Cell-Western assay with an antibody (BC.1), whose specificity 
was confirmed using two independent siRNAs (Figure S1C). To account for differences in 
cell number among the knock-down populations in the screen, TGM1 measurements were 
normalised on DNA content (DRAQ5 signal) for each well. After z-score transformation, the 
results were compiled into a single dataset covering all 145 genes, 5 conditions and replicates 
(Supplementary Dataset 1). High correlation between replicates highlighted the reproducibility 
of our findings and the quality of our dataset (Figure S1D). Using a random selection of 11 
genes, we estimate the median knock-down efficiency to be 88% (range: 28-93%) and the false 
negative rate at below 10% (Figure S1E). In addition, we performed deconvolution experiments 
where the individual siRNAs were tested in parallel with the pool of 3 siRNAs that was used 
in the screen. This indicated that 71-87% of the siRNA pools contained at least 2 siRNAs that 
recapitulated screen results (Figure S1F), arguing against widespread off-target effects. Taken 
together, our dataset constitutes a quality resource of nucleic acid binding factors to further 
characterise for their role in epidermal self-renewal and differentiation.
 From this data we identified putative nucleic acid binding factors that significantly affected 
TGM1 levels (Benjamini Hochberg (BH) FDR p<0.001) compared to the average across all 
siRNAs in the screen in any of the conditions (Supplemental Dataset 1, Figures 1B-F, blue data 
points). The normalised effect size per gene is plotted on the x-axis, whereas the statistical 
significance is depicted on the y-axis. These representations of the data highlight the factors 
that modulate differentiation in the top left and top right quadrants, respectively. Notably, the 
effects and significance of individual factors were condition dependent, indicating that not all 
identified factors play equivalent roles in the different conditions tested (Supplemental Dataset 
1, Figure S2A). This is represented by the partial correlation between the effect sizes across 
the conditions (Figure S2A, scatterplots in bottom half) and the significant differences when 
comparing different conditions (Figure S2A, volcano plots in top half). In total, our screens 
revealed 57 genes that display a significant effect in at least one of the conditions (Supplemental 
Dataset 1) indicating that our experiments identified factors that have a potential regulatory 
role in keratinocyte differentiation.
 To explore these individual hits, we first selected the top 5 most significant genes (BH 
FDR p<0.001) for each condition (Figure 1G). These represent 21 distinct nucleic acids 
binding factors, one third of which (7) have previously been implicated in epidermal renewal/
differentiation, confirming the validity of our approach. We sought to experimentally verify that 
the TGM1 measurements in our screen indeed represented bona fide differentiation and not 
solely regulation of TGM1 levels. To this end, we selected IRF6 and ETS1 as exemplars and used 
RT-qPCR as an alternative read-out of the expression of differentiation and basal cell markers 
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after siRNA mediated silencing. IRF6 has been shown to be important for the expression of 
genes important for epidermal differentiation (Botti et al., 2011). In addition, ETS1 is involved 
in keeping the cells in undifferentiated state by repressing genes involved in the formation of 
the cornified envelope (Nagarajan et al., 2010). RT-qPCR analysis confirmed the effects of the 
knock-down of these genes on TGM1 protein levels in our experiments (Figure S1G). Moreover, 
we found that silencing IRF6 resulted in lower expression of the differentiation markers PPL, 
ENV and IVL, whereas ETS1 silencing resulted in induction of these differentiation markers and 
a reduction in the basal cell markers ITGA6 and ITGB1. This is in line with literature where IRF6 
is thought to regulate differentiation and ETS1 is important in the self-renewing state. These 
results also confirm that the effects of silencing IRF6 or ETS1 in our screen indeed reflect the 
cellular differentiation state and not merely deregulation of TGM1 expression.
Figure 1: Gene perturbation screens reveal novel nucleic acid binding factors involved in epidermal 
differentiation (A) Schematic set-up of the screen; siRNA transfection (N=20) is followed by induction of 
differentiation (N=3, 5 conditions, 48h) and quantification of protein levels of transglutaminase I. (B)-(F)) 
Volcano plots describing the effects of siRNA-based perturbation on TGM1 protein expression (x-axis) and 
their significance (y-axis) (N=3). Data from chromatin factors (CF) is displayed in red, nucleic acid (NA) 
binding factors in blue. Bars on top of graphs indicate spread of z-scores for each condition. FDR=0.001 
(Benjamini-Hochberg). Differentiation induced for 48 hours, using the indicated treatments (Vehicle 
control, AG1478, BMP 2/7, AG1478 + BMP 2/7, Serum). (G) Top 5 most significant genes in each condition, 
of which knockdown results in down  or up regulation of transglutaminase I levels in the 5 different 
conditions. Significance  is added as -log10(p-value). Literature references for genes with a known 
function in keratinocyte biology are highlighted under References. See also Figure S1 and S2. 
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ZMAT2 maintains epidermal keratinocytes in an undifferentiated, proliferating state
A powerful feature of the approach we took is that our siRNA based screen set-up allows us to 
combine the current results on 145 DNA/RNA binding factors with published data characterising 
~330 epigenetic regulators (Mulder et al., 2012). Moreover, it enables us to use a previously 
developed a Bayesian statistical framework that reveals genes that functionally interact (Wang 
et al., 2012). This means identifying sets of genes that share functionality through regulation of 
similar cell biological processes, in this case epidermal differentiation. Applying this statistical 
approach on a combined epigenetic and DNA/RNA binding factor dataset should therefore 
allow identification of novel functional interactions among these groups of genes, leading to 
insights into their joint regulation of epidermal biology. The data distribution and variation of the 
two datasets are highly comparable, allowing us to combine them for further analysis (Figure 
1B-F boxplots, Figure S2B). This resulted in a rich dataset comprising 473 genes describing 
their effects on the expression of TGM1 in 5 conditions. Application of the Bayesian network 
algorithm to this joint dataset revealed strong predicted functional interactions between ZMAT2, 
a matrin-type 2 like zinc-finger with potential DNA or RNA binding capacity, and components 
of a previously identified network of epigenetic regulators involved in epidermal renewal 
(Mulder et al., 2012, Figure 2A, full network in Figure S3). This subnetwork contained multiple 
members of different protein complexes representing diverse epigenetic mechanisms such 
as MORF complex members ING5 and BRD1, NURF complex members BPTF and SMARCA5, 
as well as SMARCC2 and UHRF1 (Mulder et al., 2012). This implies that ZMAT2 plays a role in 
epidermal differentiation in conjunction with these epigenetic modifiers.
 These predicted functional interactions prompted us to functionally characterise ZMAT2 
further. RT-qPCR analysis showed that silencing ZMAT2 in keratinocytes resulted in increased 
expression of differentiation markers (PPL, EVPL, INV, TGM1) and concordant down regulation 
of basal-cell markers ITGB1 and ITGA6 (Figure 2B). In addition, depletion of ZMAT2 resulted 
in a strong reduction of the number and size of clones in colony formation assay (Figure 2B), 
reflecting a loss of cell renewal and proliferation capacity. These effects were not associated 
with increased cell death or induction of apoptosis following ZMAT2 depletion (Figure S4A and 
B).  Furthermore, cell cycle analysis showed that there was no immediate defect in proliferation 
(72 hours post siRNA transfection), indicating that the decrease in colony number and size in 
the CFA is caused by an effect on long term proliferation (Figure S4C). This is also recapitulated 
in 3D organotypic cultures (Figure 2C), showing that knockdown of ZMAT2 causes a marked 
decrease in the number of proliferative cells (KI67+ cells quantified by immuno-staining) and 
a disorganised epidermis compared to siControl (Figure 2D, 2-4 independent cultures with 2 
independent siRNAs). Together, these results indicated that ZMAT2 plays a role in maintaining 
epidermal cells in an undifferentiated, proliferative state and confirms our primary screen 
results. 
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Figure 2: Bayesian network prediction reveals a functional interaction network between epigenetic 
factors and ZMAT2 (A) The significant subnetwork predicting functional interactions between epigenetic 
factors ING5, SMARCA5, SMARCC2, BRD1, BPTF and UHRF1 and zinc-finger ZMAT2. (N=3, an empirical 
p-value was determined using a bootstrapping approach). (B) Colony formation assays (N=3, average -/+ 
sd) of ZMAT2 depleted cells. (C) RT-qPCR based characterisation (N=3, average log2 over siControl -/+ sd) 
of siZMAT2 depleted keratinocytes (no additional induction of differentiation was applied). (D) Left panel: 
RT-qPCR analysis of knock-down efficiency in 3D cultures. Right panel: Immunofluorescent staining of 3D 
organotypic cultures cultured after transfection with siZMAT2 in (N=3, average -/+ sd, blue represents DAPI, 
red KRT1 and green ColVII). Scale bar represents 50 µm. Asterisk indicates morphologically disorganised 
epidermis. (E) Quantification of KI67 positive basal cells per 100 µm (N=3, average -/+ sd) in the transfected 
3D organotypic cultures. P-value calculated with two-sided t-test. See also Figure S3 and 4.
ZMAT2 functionally interacts with epigenetic regulators of epidermal cell renewal
The Bayesian mixture model predicted that ZMAT2 functionally interacts with the epigenetic 
regulators ING5, SMARCA5, BPTF, UHRF1, BRD1. We aimed to confirm these predicted 
interactions using a double knock-down strategy. In this way, true functional  interactions can 
be identified (Mani et al., 2008; Costanzo et al., 2010; Horn et al., 2011; Roguev et al., 2013) by 
comparing the quantitative effects of combinatorial knock-downs on global gene expression 
with effects that can be expected based on the individual knock-down (Horn et al., 2011). In 
cases where two genes are functionally independent (i.e. do not functionally interact), the 
observed phenotype in the double knock-down is equivalent to the product of the individual 
knock-down phenotypes, or when working with log-transformed values their summed value 
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(Mani et al., 2008; Costanzo et al., 2010; Horn et al., 2011; Roguev et al., 2013). Using this 
‘product-rule’ as the null hypothesis (labelled ‘expected’ in Figure 3A), genetic interactions are 
statistically defined as aggravating (when the observed phenotype is greater than expected), 
or alleviating (when the observed phenotype of the combined knock-down is less pronounced 
than expected), respectively (Figure 3A). Generally, alleviating interactions occur between 
genes involved in the same process/pathway, whereas aggravating interactions tend to be 
associated with functionally redundant processes (Costanzo et al., 2010; Roguev et al., 2013).
 In previous work we showed that the epigenetic regulators within the predicted subnetwork 
(Figure 2A) display true functional interactions (Mulder et al., 2012). Therefore, we decided to 
experimentally test the predicted interactions between ZMAT2 and ING5, SMARCA5, BPTF, 
UHRF1 or BRD1 using a combined knock-down approach. As a control we included EZH2, 
which is only peripherally associated with the epigenetic factors in this network (Mulder et al., 
2012). To obtain a detailed quantitative phenotype representing the cell state, we performed 
RNA-sequencing expression profiling after silencing each of these epigenetic factors 
individually, as well as in combination with ZMAT2. Two independent siRNAs targeting each 
gene were used in all possible permutations in triplicate. We analysed a total of 156 knock-
down samples using a modified CEL-seq 2 method that enables high-throughput 3’-end tag-
counting RNA-sequencing (see materials and methods for details). It is important to note that 
the relatively shallow RNA-sequencing we performed does not allow us to directly interpret 
the molecular mechanisms underlying these interactions, but is powerful for discovery of 
functional interactions based on the obtained RNA expression profiles. We examined the data 
using DESeq 2.0 and identified transcripts that were significantly differentially expressed 
(p<0.05) compared to control siRNA-transfected cells. After quality control and filtering 
(see materials and methods), we labelled an interaction alleviating or aggravating for each 
detected transcript per interrogated combination. We identified the transcripts that displayed 
a statistically significant genetic interaction based on the product-rule criteria, as explained 
above (Figure 3A). For each of the factors we silenced in combination with ZMAT2, between 
55 and 197 genes displayed such interactions, where the peripherally associated factor EZH2 
showed only 17 functionally interacting transcripts (Figure 3B). The vast majority (>95%, in 
all cases) of the identified functional interactions were alleviating interactions (Figures 3C). 
Moreover, these alleviating interactions were highly enriched compared to randomly picked 
genes (Figure 3D). This suggests that ZMAT2, ING5, SMARCA5, BPTF, UHRF1 and BRD1 
function in a similar process/pathway to impact epidermal biology. Next, we performed GO-
term enrichment analysis on the genes contributing to the observed functional interactions 
and found an overrepresentation of factors involved in cell adhesion, a process required for 
anchoring epidermal stem cells to their niche (Figure 3E). These findings show that we were 
able to experimentally validate the predicted functional interactions between these epigenetic 
factors and ZMAT2 and that this group of genes jointly regulates an RNA expression program 
linked to cell adhesion. 
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Figure 3: ZMAT2 and the epigenetic factors regulate similar processes in epidermal differentiation (A) 
Schematic depiction of the definition of aggravating and alleviating functional interactions. obs, observed. 
exp, expected (statistical null model). (B) Heat maps visualising differential expression within the different 
samples. Scale represents log2 fold-change over siControl. Multiple testing corrected p-value <0.01, two-
sided t-test. (C) Distribution of the statistically significant aggravating and alleviating functional interactions 
for each of the combined knockdown experiments. (D) Enrichment of alleviating interactions in functionally 
interacting transcripts compared to random. P-value calculated using a hypergeometric test. (E) GO term 
analysis on the union of all significantly differentially expressed genes within the knockdown combinations 
(DAVID). Multiple testing corrected p-value calculated using a hypergeometric test. 
ZMAT2 associates with the (pre-)spliceosome in epidermal keratinocytes
 To gain insight into the potential molecular role of ZMAT2 in epidermal cell biology, we 
identified the proteins it associates with using immuno-precipitation and quantitative mass 
spectrometry (IP-MS, Figure 4A). Reminiscent of the epigenetic factors, the ZMAT2 protein 
localizes to the nucleus, as determined by immuno-fluorescence microscopy (Figure S5A). 
Antibody specificity was confirmed using siRNA-mediated knock-down, resulting in decreased 
nuclear ZMAT2 staining (Figure S5A). Next, we performed immuno-precipitation (IP) using 
control IgG (non-targeting/background binding) and antibodies targeting endogenous ZMAT2 
from nuclear extracts. Following IP, sample prep and desalting, these samples were subjected 
to label-free quantitative mass-spectrometry to identify associated proteins. The data is 
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Figure 4: ZMAT2 interacts with components from the pre-spliceosome (A) Schematic representation 
of the experimental set-up. Nuclear extract was prepared, one which IgG and ZMAT2 pulldowns were 
performed in triplicate. The peptides were quantified using label free mass-spectrometry. (B) Volcano plot 
displaying the physical interactors of ZMAT2, with the log2 fold enrichment of ZMAT2 associated proteins 
over non-specific IgG bound proteins plotted against their significance (N=3). Multiple testing corrected 
p-value calculated with a two-sided t-test. (C) GO term analysis (STRING) on proteins associated with 
ZMAT2. Multiple testing corrected p-value calculated using a hypergeometric test. (D) STRING interactions 
versus experimentally found interactions with their significance (as calculated in B) displayed in blue. See 
also Figure S5.
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represented as enrichment over IgG control versus the significance over the three replicates, 
with significant interactors located in the right upper quadrant (Figure 4B). Both Gene Ontology 
and protein interaction database analysis of the interacting proteins revealed that ZMAT2 
interacts with components of the (pre-)spliceosome (Figures 4C and D). These findings are in 
line with recent cryo-EM structures of the budding yeast pre-spliceosome, showing that the 
putative ZMAT2 ortholog snu23 associates with the B* (pre-catalytic) complex (Plaschka, Lin 
and Nagai, 2017; Ulrich and Wahl, 2017). Our biochemical experiments identifying ZMAT2 as 
an interactor of the pre-spliceosome in human keratinocytes, together with our screen and 
validation analysis implicate RNA splicing as a potential key regulatory process in epidermal 
renewal and differentiation.
ZMAT2 associates with a subset of cellular transcripts involved in epidermal biology
Even though mRNA splicing is a ubiquitous process, we wondered if ZMAT2 containing 
spliceosomes display selectivity towards specific transcripts, or whether ZMAT2 is associated 
with essentially all transcripts present in the cell. An indication for a more selective role for 
ZMAT2 stems from the observation that the ZMAT2 protein is expressed in tissue specific 
manner, whereas other pre-spliceosome components show much more ubiquitous expression 
in the human body (Figure S5B). Another indication comes from the GO-term analysis on 
the genes that are regulated by the functionally connected genes in our double knockdown 
experiments, where we found an enrichment of adhesion-related genes (Figure 3E). To identify 
ZMAT2-associated transcripts, we performed RNA-immunoprecipitation-sequencing (RIP-
seq) with non-specific control IgGs and ZMAT2 specific antibodies from nuclear extracts. RNA-
IPs were performed in triplicate and the isolated RNA was used to generate RNA-sequencing 
libraries using the modified CEL-Seq 2 protocol (Figure 5A). This specific form of library-prep 
focusses on poly-adenylated transcripts and allows analysis of the low amount of material 
retrieved after immuno-precipitation. To assess the specificity of enrichment, the recovered 
transcripts were compared to RNA-sequencing of the input material. Although the same 
amount of input material for IgG and ZMAT2 pull-downs was used, the IP with the ZMAT2 
antibodies yielded substantially more RNA compared to the control IgGs, as can be expected 
from its association with the spliceosome (Figure 5B). The library transcript diversity (number 
of different transcripts detected per 1000 reads) of the RNAs associated with the control IgGs 
was similar to that of the input, reflecting non-specific interactions. In contrast, the diversity of 
the ZMAT2 associated RNAs was lower, indicating that ZMAT2 associates with a subset of the 
total available transcripts, rather than binding RNAs indiscriminately (Figure 5C).
 Next, we used statistical analysis (DESeq 2.0) to identify significantly enriched transcripts 
for both the IgG and the ZMAT2 samples. None of the RNAs identified in the control IgG IP 
were significantly enriched compared to input, indicating that these indeed represented non-
specific background interactions (Figure 5D, inset). In contrast, nearly 100 transcripts were 
significantly enriched in the ZMAT2 pull-down (Figure 5D). We choose to use the IgG data as a 
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Figure 5: Adhesion related transcripts are associated with ZMAT2 (A) Schematic representation 
of the experimental set-up. Nuclear extract was prepared from non-differentiated cells and normal 
immunoprecipitation procedure was performed, up to the wash steps. RNA was isolated directly from 
the beads and prepped for sequencing using CEL-Seq 2. (B) RNA concentration samples before and after 
the IP procedure. Corrected for cell numbers, in ng/µL (N=3). (C) Transcript diversity of the CEL-Seq 2.0 
libraries after sequencing. Number of identified genes per 1000 counts (N=3). (D) Volcano plot displaying 
the transcripts that are significantly enriched in the ZMAT2-IP sample over the IgG-IP sample as called by 
DESeq 2.0. Inset represents significant hits identified in the IgG sample (N=3). Multiple testing corrected 
p-value calculated with a two-sided t-test. (E) qPCR validation of ZMAT2 associated transcripts in the IP 
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samples showing the enrichment over the input sample (N=3, average -/+ sem). (F) Expression of the 
ZMAT2 associated transcripts is differential during induction of differentiation using EGF inhibitor AG1478 
(10 µM) and BMP 2/7 for 48 hours (N=3, average -/+ sem). (G) Expression of ZMAT2 associated transcripts 
upon silencing ZMAT2 (70% KD, 5 days of culture) as determined via qPCR (N=3, average -/+ sd).
comparison for the ZMAT2 sample to ensure that we were comparing samples that had been 
processed in an identical fashion. Interestingly, many of the transcripts that were specifically 
and strongly associated with ZMAT2 are involved in cell-adhesion (e.g. ITGB1 (Levy et al., 2000), 
DSP (Cabral et al., 2012), DST (Michael et al., 2014) and ROCK2 (Lock et al., 2012) and proliferation 
processes (e.g. AREG (Stoll et al., 2016)). Because both the functional interaction and RNA-IP 
experiments point towards regulation of adhesion we decided to focus on these transcripts. 
We selected 7 of these transcripts for validation by RNA-IP followed by RT-qPCR and included 
GAPDH as a negative control. This confirmed that all 7 transcripts are indeed highly enriched in 
the ZMAT2 pull-downs whereas GAPDH is not, confirming the selectivity of RNAs associated with 
ZMAT2 (Figure 5E). The lack of enrichment of GAPDH, one of the most abundantly expressed 
transcripts, in the ZMAT2 pull-down indicated that the identified associations are not solely based 
on transcript abundance. Moreover, of these 7 transcripts ITGB1, AREG, DSP, DST and SPINK5 
are differentially expressed during differentiation (Figure 5F), suggesting that, at least some of, 
the ZMAT2 associated transcripts are also regulated at the transcriptional level. However, ZMAT2 
itself does not seem to be involved in regulation of their expression, as silencing ZMAT2 does not 
affect the expression of ITGB1, ROCK2, AREG and DST. The mild differential expression of KTN1 
(down regulated) and DSP and SPINK5 (up regulated) are likely an effect of ZMAT2 silencing on 
the differentiation state of the cell (Figures 5G and 2B). Together, these experiments indicate that 
ZMAT2 associates, presumably through its interaction with the pre-spliceosome, with a specific 
subset of transcripts in human epidermal cells.
ZMAT2 silencing leads to differential exon usage of selected genes
To investigate whether ZMAT2 silencing indeed affects splicing in our cells, we performed full-
length transcript RNA-sequencing on ZMAT2 knockdown samples in triplicate (Figure 6A). We 
included the ZMAT2 interacting pre-spliceosome component SRSF1 as a positive control for 
disruption of splicing (Figure 4B). Silencing SRSF1 is expected to lead to defects in splicing as 
it is involved in the first steps of assembly of the spliceosome by enhancing the binding of the 
U1 snRNP on the pre-mRNA (Kohtz et al., 1994). Additionally, we analysed samples in which 
we induced differentiation (48 hours, AG1478+BMP2/7), to put our findings in the context of 
keratinocyte differentiation. DEX-Seq (S. Anders, Reyes and Huber, 2012) was used to calculate 
and statistically assess differential exonic region usage for all identified transcripts to detect 
altered splicing activity. This revealed that fewer exonic regions are affected in their splicing by 
silencing of ZMAT2 compared to silencing SRSF1 or induction of differentiation, ~0.12 versus 
~1.5% for SRSF1 and 4% after induction of differentiation, respectively (Figure 6B). These 
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are consistent with the notion that that ZMAT2 regulates splicing of a more restricted set of 
transcripts than SRSF1 and the set that is differentially spliced in differentiation. Moreover, 
the majority of exonic regions that are differentially spliced upon silencing of ZMAT2 are 
also differentially spliced in differentiation (Figure 6C), indicating that ZMAT2 is involved in 
mediating splicing events associated with differentiation and that regulating splicing of specific 
subset of genes plays a role in epidermal biology. In line with this, organotypic cultures of 
cells depleted of SRSF1 displayed an expanded and disorganised epidermal layer, while also 
affecting proliferation as determined using KI67 staining (Figure S6B, C and D). Thus, silencing 
the spliceosome component SRSF1 (at least partially) phenocopies ZMAT2 depleted epidermis 
(Figure 2 C and D), confirming the role of splicing regulation in epidermal biology.
 Exon usage of nearly 200 transcripts was affected by both ZMAT2 and SRSF1. Of these 200 
transcripts, the exons that were differentially regulated by these factors were predominantly 
mutually exclusive (Figure 6D), further supporting the notion of specific functions for ZMAT2 
compared to the core pre-spliceosome component SRSF1 in epidermal keratinocytes. An 
exemplar of this is the DMKN gene, which we experimentally validated using exon specific 
RT-qPCR (Figure S6E and F). DMKN plays an important role in epidermal cornification and is 
extensively spliced during differentiation (Naso et al., 2007; Leclerc et al., 2014). We observed 
altered usage of exonic regions in the N-terminal part of the transcript in the absence of ZMAT2, 
which is also differentially spliced upon induction of differentiation (Figure S6E and F). Notably, 
we also observed specific ZMAT2 and SRSF1 dependent differentially spliced exonic regions. This 
further confirms that the observed differential splicing in the siZMAT2 samples are likely ZMAT2 
dependent, rather than general differentiation mediated splicing following ZMAT2 silencing.
 To investigate if there were differences in usage of specific splicing mechanisms between 
ZMAT2 and SRSF1, we used the MISO package, which enables a differential splicing analysis 
based on annotation files describing different splice events. This did not reveal major 
differences in splicing mechanisms (skipped exons (SE), intron retention (RI), mutually 
exclusive exons (MXE), alternative 5’ splice sites (A5SS), or alternative 3’ splice sites (A3SS)) 
affected by ZMAT2 compared to SRSF1 (Figure S6A). Moreover, computational analysis did not 
identify strong motifs specifically associated with ZMAT2 dependent splicing events compared 
to SRSF1 mediated splicing. Together, our experiments suggest that ZMAT2 regulates exon 
usage of a specific subset of transcripts, rather that functioning as a global splicing regulator 
in epidermal stem cells. We would like to note that our splicing analysis is unlikely to be fully 
comprehensive, as there is a slight enrichment of high expressed transcripts in our data, 
precluding interrogation of low expressed genes.
Functionally interacting genes jointly regulate an expression program involved in cell 
adhesion
The above presented results, together with the network prediction and functional interaction 
experiments (Figures 2 and 3), indicate that there is a link between epigenetic regulation and 
CHAPTER 2
54
ZMAT2-mediated splicing of genes involved in cell adhesion. Consistent with these functional 
interactions, we found that the transcripts that are affected in their exon usage upon ZMAT2 
silencing are highly enriched (p-value<10-8) in direct ING5 genomic binding targets, one of 
the epigenetic factors in the functional interaction network (Figure 6E) (Mulder et al., 2012) 
indicating that these genes regulate similar processes. In contrast, there was no clear 
evidence for overlap with genes marked by DNA methylation or the heterochromatin associated 
H3K27me3 histone modification. Moreover, only a slight enrichment (p=0.003) for targets of the
Figure 6: ZMAT2 regulates a similar gene set as the functionally interacting epigenetic factors through 
modulation of RNA splicing. (A) Schematic representation of the experimental set-up. ZMAT2 or SRSF1 
was silenced using siRNAs and cells were grown for 5 days or differentiation was induced (48 hours, AG1478 
+ BMP 2/7) after which RNA was isolated and sequencing libraries prepared. Analysis was performed 
using DEXSeq. (B) Percentage of total detected differentially spliced exonic regions as determined with the 
DEXSeq package in samples transfected with siZMAT2 or siSRSF1 or where differentiation was induced. 
(C) Overlap differentially spliced exonic regions for samples transfected with siZMAT2 or siSRSF1 or where 
differentiation was induced. P-values calculated with a hypergeometric test. (D) Differential usage exonic 
regions, plotting the fold change over siControl vs siSRSF1 or siZMAT2 (average of N=3). R = Pearson’s 
correlation. (E) Differentially spliced genes after knockdown of ZMAT2 are enriched for binding of ING5 
(ChIP-seq data (Mulder et al., 2012)) and keratinocyte master regulator TP63. GO term analysis on these 
genes shows enrichment for focal adhesion related terms. P-values calculated with a hypergeometric test. 
See also Figure S6.
SPLICING AND CHROMATIN FACTORS JOINTLY REGULATE EPIDERMAL DIFFERENTIATION
55
2
key epidermal transcription factor TP63 was found, suggesting that ING5 and ZMAT2 cooperate 
to regulate an RNA expression program important for epidermal biology. Notably, the gene-
program targeted by both ZMAT2 and ING5 was further enriched in genes associated with focal 
adhesion formation, a process that anchors epidermal stem cells to their niche. Overall, we 
conclude that joint epigenetic and splicing regulation of specific subsets of genes maintains 
epidermal stem cells in a proliferative, undifferentiated state.
DISCUSSION
Our results indicate that regulation of cell-cell adhesion related transcripts is at least 
orchestrated by a set of chromatin-associated epigenetic regulators and a splicing component. 
We were able to discover their joint contribution by considering how genes cooperate in the 
regulation of gene expression programs, starting from our siRNA-based screens. Through 
these experiments we generated a rich dataset describing the roles of DNA/RNA binding 
factors and epigenetic regulators in human epidermal stem cell differentiation. The specific 
set-up of the experiments enabled us to use our previously published network Bayesian 
algorithm that predicts functional relationships between genes, transcending the annotation 
of a gene as a transcription factor, chromatin modifier or splicing factor and providing insight 
into how genes and processes work together to shape epidermal biology. Using this approach, 
we uncovered a new functional interaction between chromatin factors representing different 
epigenetic mechanisms and the uncharacterised zinc-finger containing protein ZMAT2. 
Through interaction proteomics and RNA-sequencing approaches we found that ZMAT2 is 
involved in RNA splicing in epidermal keratinocytes. Moreover, RNA interaction experiments 
revealed an enrichment of adhesion related genes, suggesting there is a targeted process 
involved. Thus far, we did not find evidence for specific deregulated splicing mechanisms that 
could explain this selectivity, nor could it be explained simply through transcript abundance 
and or occurrence of specific RNA motifs.
 It is conceivable that ZMAT2 functions through fine-tuning the splicing mechanism of a 
subset of genes, especially when considering the different steps involved in splicing and the 
potential role for ZMAT2 in these. Splicing is an important post-transcriptional mechanism 
that catalyses the excision of non-coding parts in pre-mRNA transcripts, or in alternative 
splicing the exon composition in a mature mRNA transcript. It is regulated by the large and 
dynamic spliceosome complex, which facilitates the different steps of the splicing reaction 
through rearrangements in protein composition for each step. In the first step, the so-called 
complex A recognizes the splice site, after which complex B is assembled. This complex is 
catalytically activated to the B* complex, via the intermediate Bact complex. The B* complex 
catalyses the first transesterification reaction and, after more rearrangements, generates 
complex C which catalyses the second transesterification reaction. The spliceosome is then 
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disassembled and the subunits are recycled. ZMAT2 is an interactor of the B complex, were it 
accompanies the core complex B component tri-snRNP U4/U6.U5. In yeast, this tri-snRNP is 
already associated with ZMAT2 homolog Snu23 and pre-mRNA processing factor 38 (Prp38) 
strictly prior to integration into the yeast pre-spliceosome (Plaschka, Lin and Nagai, 2017). In 
contrast, in humans these two proteins are recruited independently from the tri-snRNP and are 
therefore considered non-snRNP proteins. There are seven more of these non-snRNP proteins 
in humans (Ulrich and Wahl, 2017) which are referred to as B-specific proteins. Although some 
of these proteins can influence splice-site selection (e.g. Smu1 and RED (Spartz, Herman and 
Shaw, 2004)) their exact function is not known. It is interesting to consider these proteins as 
mediators of alternative splicing through recognition of different splice-sites, which might 
explain the observed enrichment for adhesion related genes for ZMAT2. However, even though 
ZMAT2’s interaction with the human spliceosome seems less stringently required than in yeast, 
it might have an important function in enabling more general conformational changes from the 
B to C complex. In yeast, Snu23 is thought to influence activation of the Brr2 helicase via its 
stabilisation on the U4 snRNA, which is part of the U4/U6.U5 tri-snRNP. The Brr2 mediated 
unwinding of the U4/U6 duplex is an important step towards generating a catalytically active 
spliceosome as it frees the U6 snRNA to form an internal loop with the U2 snRNA. This 
enables the conformational changes needed for the branching step and subsequent exon 
ligation (Plaschka, Lin and Nagai, 2017). It is possible that ZMAT2 transiently interacts with the 
human spliceosome to facilitate and fine-tune these transitions. If this is the case, the timing 
of its association with the spliceosome might influence the efficiencies of competing splicing 
mechanisms, spliceosome composition or conformation (Ulrich and Wahl, 2017). Although we 
can only speculate about the exact molecular mechanisms behind our observations at this 
point, the combined evidence from our proteomic data and the literature, implicates ZMAT2 as 
a regulator of RNA splicing in epidermal stem cells. 
 Our results suggest that cell-cell adhesion is regulated by a previously unanticipated 
connection between transcriptional processes and post-transcriptional regulation. 
Experiments investigating the functional interactions between epigenetic modifiers and ZMAT2 
revealed mostly alleviating interactions, stressing the importance of proper splicing in parallel 
with epigenetic control of adhesion related transcripts. We confirmed these connections 
experimentally by showing that the genes that were differentially spliced upon silencing of 
ZMAT2 were enriched for binding of ING5. Moreover, these genes were also enriched for 
binding of p63, indicating that the functionally connected genes are in charge of regulating 
a gene set that is essential for epidermal biology. Considering the importance of proper 
regulation of adhesion signalling for maintaining the stem cell fate (Levy et al., 2000), it is not 
surprising that incorrect regulation leads to the severe effects observed upon silencing these 
genes individually. This in combination with the profound effect of silencing ZMAT2 individually 
on the differentiation state of the cells shows that the fine-tuning of splicing by ZMAT2 is of 
utmost importance for keratinocyte biology.
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 We have discovered that this group of epigenetic modifiers and ZMAT2 represent important 
hubs in the regulation of adhesion related transcripts and might be interesting to study more 
mechanistically in light of epidermal differentiation. We conclude that epigenetic and splicing 
factors jointly regulate processes that are essential for epidermal biology. Taken together, 
our work provides new insight into the regulation of epidermal differentiation and highlights 
the importance of cooperation among disparate cellular processes in the regulation of cell 
behaviour. 
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STAR METHODS
CONTACT FOR REAGENTS AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be 
fulfilled by the Lead Contact, Dr. Klaas W. Mulder (k.mulder@science.ru.nl) 
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Primary human foreskin keratinocytes were obtained from Lonza (00192906). They were 
cultured on a mitotically inactivated J2-3T3 layer as described previously (Mulder et al., 2012). 
Prior and during experiments where differentiation was induced, the cells were grown on 
keratinocyte serum-free medium (KSFM, Gibco) supplemented with 0.2 ng/mL epidermal 
growth factor (EGF, Gibco) and 30 ug/mL bovine pituitary extract (BPE, Gibco). Differentiation 
was induced using 10 µM AG1478 (Calbiochem), 200 ng/mL human recombinant BMP 2/7 (R&D 
systems) a combination of these or 10% fetal bovine serum (MP Bio) was added to the KSFM 
for 48 hours.
 For colony formation assays, J2-3T3 cells were seeded at 100.000 cells per well in a 6 well 
format and inactivated using mitomycin C (2 µg/mL, Santa Cruz Biotechnology) as described 
previously (Mulder et al., 2012). Transfected keratinocytes (500 cells) were seeded on top and 
grown for 2 weeks before fixation and immunostaining.
 For 3D cultures, pooled primary human foreskin keratinocytes from different donors were 
obtained from PromoCell and grown in a 1:1 mixture of KSF-M (Gibco) and Medium 154 for 
keratinocytes (Gibco), supplemented with Human Keratinocyte Growth Supplement, epidermal 
growth factor, bovine pituitary extract and 1x Antibiotic-Antimycotic (all supplements from 
Gibco). 
METHOD DETAILS
siRNA nucleofection
Passage 3 lip or foreskin keratinocytes were grown to 70% confluency in KSFM before they 
were used for nucleofection using the Amaxa system (Lonza). The cells were collected and 
resuspended in cell line buffer SF at 2*10^5 cells per 18 uL, mixed with 2 uM siRNA. After 
transfection using program FF113, the cells were incubated for 10 minutes at room temperature. 
Finally, the transfected cells were resuspended in pre-warmed KSFM and dispensed over the 
culture plates manually.
 For 3D culture transfection, 6 million primary human keratinocytes were electroporated 
with 1 nmol annealed siRNAs, using the Amaxa human keratinocyte Nucleofector kit (Lonza) 
according to the manufacturer’s instructions and the program T-018 of the Amaxa Nucleofector 
II device. After nucleofection, cells were let to recover for 12-24 hrs in KSFM.
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siRNA library
145 genes were selected based on differential expression and RPKM over 5 in a dataset 
published in Kouwenhoven et al., 2015. Additionally, literature was manually searched to select 
those factors that had DNA binding capacities. A custom silencer select siRNA library was 
obtained from Ambion including 3 siRNAs per gene divided over 2 plates. The siRNA screens 
were performed using the pooled siRNAs per gene. Information about individual siRNAs is 
included in Table S1.
siRNA screening and data processing
Passage 3 foreskin keratinocytes were grown up to 70% confluency in KFSM for nucleofection. In 
addition to the custom library, siRNA controls were transfected; scramble siRNAs and siRNAs 
targeting transglutaminase I. After transfection, the cells were manually dispensed onto 20 96-
well plates, generating quadruplicate plates for each differentiation inducing treatment plus 
control. The medium was refreshed the next day and after 72 hours and differentiation was 
induced (vehicle, AG1478, BMP 2/7, AG1478 + BMP 2/7 and serum) for 48 hours. The cells were 
fixed using 4% paraformaldehyde in PBS (10 minutes, at RT) and subsequently permeabilised 
using 0.1% Triton X-100 in PBS (10 minutes, at RT). The cells were blocked using 10% serum 
in PBS for 30 minutes at room temperature and subsequently stained with primary antibody 
targeting TGM1 (mouse anti-BC-1, 1:2000) for 1 hour at room temperature. Following 3 washes 
the cells were stained with mouse secondary antibody IR800 (IRDye 800CW, 1:2000) and DNA 
staining agent DRAQ5 (Biostatus, 1:4000) in blocking buffer for 1 hour at room temperature. 
After three washes a final volume of 100 uL PBS was added and the plates were scanned using 
the Licor Odyssey CLx system. The same settings were used for each screen.
 Signals were quantified using the Licor Odyssey CLx software and used for subsequent 
analysis. The signal was normalized using the DRAQ5 DNA stain and the background signal 
measured in the TGM1 KD samples was subtracted. The data was further processed to z-scores 
based on knockdown readouts only, transforming the data to a standardized format enabling 
compilation of all the experimental data. 
Bayesian mixture model and network visualisation
The phenotypic profiles extracted from the screen, describing the effect of knockdown of a 
certain gene on TGM1 expression in 5 different conditions, are compared in this model. The 
network is visualized using the R-package RedeR (Castro et al., 2012). The Bayesian mixture 
model is described in Wang et al. (2012). In short, we extracted the phenotypic profiles per 
gene from the z-score matrix, for which the cosine correlation between each gene pair 
was calculated. Under the assumption that there were three possible modes of functional 
association; positive, negative or a lack of association, there are three beta distributions in this 
model. To estimate the parameters α and β for the positive and negative distribution, maximum 
a posteriori probability (MAP) inference was applied with an uninformative prior (uniform 
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Dirichlet priors) using an expectation maximization (EM) algorithm. For the parameters of 
the lack of association distribution, the data set is permutated 100 times to create a random 
dataset. The data is fitted to these distributions, generating a matrix with probabilities for 
each gene pair belonging to one of the three distributions. This matrix is subjected to network 
inference, looking at functional interactions and their signal to noise ratio (SNR: probability 
positive or negative association/probability lack of association). We only considered functional 
interactions that have a SNR of 10 or higher and checked the significance of the inferred 
connections with multiscale bootstrap resampling. Using the approximately unbiased method 
(sample size between 0.5 to 1.4), we avoided a bootstrap resampling bias. The displayed 
p-values are defined as 1-AU.
Identification genetic interactions
Cells were transfected with 2 independent siRNAs per gene and the different combinations of 
these siRNAs in triplicate. RNA was isolated and CEL-seq 2.0 libraries were prepared. After 
sequencing and subsequent mapping using STAR ((Dobin et al., 2013) RRID:SCR_015899) 
the data was analysed using DESeq 2.0 ((Hashimshony, Senderovich, Avital, Klochendler, de 
Leeuw, Anavy, Gennert, Li, Kenneth J. Livak, et al., 2016) RRID:SCR_015687) to call differentially 
expressed genes versus siControl. We included all genes that were detected in at least 90% 
of the samples and significantly differentially expressed with p-value<0.05 in at least one 
comparison. Furthermore, samples in which more than 10% of these genes was not detected 
were excluded from further analysis to increase the robustness of the statistical analyses. For 
the remaining samples and genes, we calculated the fold change (FC) in expression compared 
to siControl (observed FC). The expected fold changes (NULL hypothesis in the absence of a 
functional interaction) were calculated using the product rule (Mani et al., 2008) multiplying 
the FC (equivalent to summing the log FC) for the individual knockdown samples for ZMAT2 
versus the other genes. To estimate the variation of the NULL hypothesis, we performed 
this calculation for all combinations of independent siRNAs and replicates. The expected FC 
was then compared to the observed FC using a multiple testing corrected two-sided t-test 
(Benjamini-Hochberg, FDR <0.01). Interactions were labelled alleviating when the expected FC 
was higher than the observed FC and aggravating when the expected FC was lower than the 
observed FC.
RNA extraction, RT-qPCR and expression profiling
RNA was isolated using the Quick-RNATM MicroPrep kit from Zymo Research and subsequently 
1 µg RNA was converted to complementary DNA.  Thermo Maxima Reverse Transcriptase 
was used for reverse transcription and the resulting cDNA was diluted to ~5pmol/µL for qPCR 
using SYBR Green Master mix. Data was normalised using 18s signal as a control, which was 
included on each plate.
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 For the samples generated for 3D organotypic cultures, total RNA from organotypic skin 
cultures was isolated using the RNeasy Plus mini kit (Qiagen) according to the manufacturer’s 
instructions. 1 µg total RNA was subjected to reverse transcription with the iScript cDNA 
synthesis kit (Biorad). For qRT–PCR measurements, the Takyon Mix (Eurogentec) was used 
with the CFX96 Touch Real-Time PCR Detection System (Biorad). Samples were run at least in 
duplicates and normalized to ribosomal protein L32 mRNA. Primer sequences are included in 
Table S1.
Colony formation assay analysis
The cells were blocked using 10% serum in PBS for 30 minutes at room temperature and 
subsequently stained DNA staining DRAQ5 (Biostatus, 1:4000) in blocking buffer for 1 hour at 
room temperature. After three washes a final volume of PBS was added and the plates were 
scanned using the Licor Odyssey CLx system. The images were processed as described in (van 
Buggenum et al., 2018) 
Organotypic human epidermal tissue
For the generation of organotypic human epidermal tissue, 500,000 human keratinocytes that 
have been nucleofected with siRNAs were seeded onto a devitalized dermal matrix and raised 
to the air–liquid interface to initiate stratification and differentiation, as described previously 
(Amy B Truong et al., 2006; Sen et al., 2010). Cultures were harvested after four days. Half of 
the tissue was used for RNA isolation and the other half for cryosectioning.
Immunofluorescence and tissue analysis
Seven micrometer thick cross sections of human organotypic skin cultures were fixed 
in either 100% acetone or methanol for 10 min at -20°C followed by blocking in PBS with 
10% bovine calf serum (BCS) for 20 min at RT. Antibodies were diluted in PBS with 1% 
BCS and incubated with the sections for one hour or overnight. The following primary 
antibodies were used: collagen type VII (MerckMillipore, MAB1345) at 1:800 dilution, keratin 
1 (BioLegend, Poly19052) at 1:300 dilution, and Ki67 (Thermo Fisher Scientific, RM-9106-S0) 
at 1:100 dilution. Alexa-555-conjugated goat anti-mouse and goat anti-rabbit IgG (Molecular 
Probes, 1:300 dilution), and Alexa-488-conjugated goat anti-rabbit and goat anti-mouse IgG 
(Molecular Probes, 1:300 dilution) were used as secondary antibodies. Unbound antibodies 
were washed off with PBS (3 times, 5 min, RT) and nuclei were stained with 4mg/L Hoechst 
33342 (ThermoFisherScientific, H1399) in PBS. Finally, slides were mounted in ProLong Gold 
antifade Mountant (ThermoFisherScientific) and analyzed with an Axiovert 200M fluorescence 
microscope and the AxioVision Software (Carl Zeiss).
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IP followed by quantitative mass spectrometry
Passage 3 foreskin keratinocytes were grown up to 70% confluency in KFSM before harvesting 
and counting. Nuclear extracts were prepared by adding 5 volumes of buffer A (10 mM HEPES 
KOH pH 7.9, 1.5 mM MgCl2, 10 mM KCl) and incubation of 1 hour on ice. The cells were 
centrifuged for 5 minutes at 450g before lysis by dounce homogenization in 2 volumes cell 
pellet buffer A with 0,5% NP40 and protease inhibitors. Cytoplasmic and nuclear extract were 
separated by centrifugation at 3200g for 15 minutes and collection of cytoplasmic fraction as 
supernatant. The nuclear pellet was washed with 10 volume PBS and centrifuged at 3200g for 
5 minutes. Nuclei were resuspended in 2 volumes extraction buffer C (420 mM NaCl, 20 mM 
HEPES KOH pH 7.9, 20% v/v glycerol, 2 mM MgCl2, 0.2 mM EDTA, 0.5% NP40, 0.5 mM DTT, 
protease inhibitors) and incubated 2 hours rotating at 4°C. The extract was centrifuged for 
30 minutes at 14.000 rpm and the nuclear extract was collected. Protein concentration was 
determined using a Bradford assay.
 500 ug nuclear extract was used in an overnight immunoprecipitation with 3 µg α-ZMAT2 
(DSHB, RRID:SCR_013527, PRCP-ZMAT2-1E5) in a total volume of 500 µL. PCRP-ZMAT2-1E5 
was deposited to the DSHB by Protein Capture Reagents Program, produced by JHU/CDI (DSHB 
Hybridoma Product PCRP-ZMAT2-1E5). This was mixed with 25 µL Dynabeads magnetic beads 
(Invitrogen) and incubated for 4 hours rotating at 4°C. After incubation, beads where washed 
three times using buffer A, two times using PBS, once using ABC buffer (25 mM ammonium 
bicarbonate) before final resuspension in 50 µL ABC buffer. Overnight digestion was performed 
using 350 ng trypsin where after samples were desalted using C18 stagetips (Rappsilber, Mann 
and Ishihama, 2007).
 The tryptic peptides were separated in a 120 minute acetonitrile gradient (7% to 32%, 
step-wise increase up to 95%) on an Easy nLC 1000 (Thermo Scientific) connected online to a 
Orbitrap Fusion Tribrid mass spectrometer. MS and MS/MS spectra were recorded as described 
in van Buggenum et al., 2018. Data analysis was performed as described before (Smits et al., 
2013) using MaxQuant version 1.5.1.0 (RRID: SCR_014485) (Cox and Mann, 2008) and protein 
database UniProt_201512\HUMAN. In brief, data was analysed using default settings of the 
MaxQuant software package, where after Perseus was used to filter out reverse hits and to 
impute missing values. Plots were made in R.
IP-RNA sample preparation
Passage 3 foreskin keratinocytes were grown up to 70% confluency in KFSM before harvesting 
and counting. After preparing the nuclear extract and determining the protein concentration 
by Bradford assay, the extract was divided over samples for input RNA isolation and 
immunoprecipitation in triplicate. For input RNA, RNA was isolated directly from the nuclear 
extract and stored at -20°C. Immunoprecipitation was performed as described in the IP-MS 
paragraph up to washing the beads. RNA lysis buffer was added to the beads and incubated 
for 5 minutes before removing the beads from the sample using the magnetic tray. RNA was 
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isolated from the supernatant as indicated in the protocol provided with the Quick-RNATM 
MicroPrep kit (Zymo Research). The isolated RNA was further processed for sequencing using 
the CEL-seq 2.0 library prepation protocol and subsequent analysis.
Epifluorescence localisation ZMAT2
Cells were transfected with scramble siRNAs or siRNAs targeting ZMAT2 seeded in 96-well 
glass bottom plates and cultured for 72 hours as indicated. Cells were washed, fixed using 4% 
paraformaldehyde for 10 minutes and subsequently permeabilised using 0.3% triton in PBS 
for 10 minutes. The cells were pre-blocked using 0.2M glycine for 20 minutes and blocked for 1 
hour using 1% BSA. Cells were incubated overnight at 4°C with primary stain, which included 
a no-primary-antibody control and 4 µg/mL α-ZMAT2 (DSHB, PRCP-ZMAT2-1E5). After three 
wash steps with PBS cells were stained with secondary antibody Alexa 488 rabbit α-mouse 
(1:2000) for 1 hour and DAPI (1:500) in the last 10 minutes. Cells were washed 3 times and 
imaged on a Leica DMI6000B automated high-content microscope.
Library preparation RNA sequencing
RNA sequencing libraries were prepared as described in the protocol supplied with the 
Illumina KAPA RNA HyperPrep Kit with RiboErase (HMR) – (KR1351), starting from 500 ng. The 
concentration of the libraries was determined using the Denovix HS dsDNA assay and library 
quality was checked using the Bioanalyser platform (Agilent). Samples were sequenced using 
the NextSeq500 (Illumina) platform.
CEL-seq 2
CEL-seq 2 libraries were generated using the protocol from (Hashimshony, Senderovich, 
Avital, Klochendler, de Leeuw, Anavy, Gennert, Li, Kenneth J Livak, et al., 2016) with the 
following adaptations. 100pg purified RNA was directly added to a reverse transcription 
mixture containing Maxima H Minus (ThermoFisher) reverse transcriptase and CEL-seq 2.0 
primers with a 6-nucleotide sample barcode and 8-nucleodide UMI. After reverse transcription 
samples were pooled and purified using AmpureXP beads (Beckman Coulter). Second strand 
synthesis was performed according to the original protocol, libraries were amplified using 2 
consecutive PCR reactions.
Data analysis sequencing data
CEL-seq 2.0 data was processed using the Yanai pipeline (Hashimshony, Senderovich, Avital, 
Klochendler, de Leeuw, Anavy, Gennert, Li, Kenneth J Livak, et al., 2016) up to count tables which 
were further processed using DESeq 2.0. RNA sequencing data from KAPA RNA HyperPrep kit 
generated libraries was aligned (hg38, annotation: ensembl genecode basic annotation V27) 
and sorted using STAR and analysed using DEXSeq ((Simon Anders, Reyes and Huber, 2012) 
RRID:SCR_012823). For the analysis using MISO ((Katz et al., 2010) RRID:SCR_003124) the 
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sequencing data was aligned to hg19 using STAR where after the collection annotations under 
the Human genome (hg19) alternative events v1.0 was used to call alternative events. Data 
regarding the siRNA knockdown of ZMAT2 and SRSF1 is deposited in GEO (RRID:SCR_005012) 
under accession code GSE114529, and data regarding the induction of differentiation is 
deposited under accession code GSE117562.
Expression ZMAT2 in different tissues
Expression of ZMAT2 and other spliceosome components was taken from the EMBL expression 
atlas, which extracts its raw data from the PRIDE proteomics database. Website open source 
database: https://www.ebi.ac.uk/gxa/home/
FACS analysis
Viability, apoptosis and cell cycle state were analysed using the MUSE Cell Analyser (EMD 
Millipore). Cells were counted and subsequently stained using MUSE Count and Viability 
Reagent (EMD Millipore) as indicated in the protocol for 5 minutes. In parallel, cells were 
stained using annexinV-PE (BD, 1:25 in PBS) for 15 minutes before analysis on the MUSE Cell 
Analyser (EMD Millipore). Pre-programmed software allowed easy setting of the gates in the 
Count and Viability protocol and the AnnexinV and Cell Death protocol. For cell cycle analysis, 
cells were counted, fixed using 70% ethanol overnight at -20°C and stained using 50 µg/mL 
propidium iodide, 100 ug/mL RNase A, 0,1% Triton and 0,1% BSA in PBS for 1 hours at room 
temperature. Pre-programmed software was used to set the gate in the Cell Cycle Assay 
protocol.
QUANTIFICATION AND STATISTICAL ANALYSIS
Quantification and statistical analysis was performed as described in the sections describing 
the applied techniques. Statistical tests and parameters were performed as reported in the 
appropriate figure legends and sections of the manuscript.
DATA AND SOFTWARE AVAILABILITY
Data resources
RNA sequencing data is available via the GEO database (RRID:SCR_005012) under accession 
codes: GSE114529 (siRNA knockdown of ZMAT2 and SRSF1) and GSE117562 (induction of 
differentiation). The data that was generated in the siRNA screen and subsequent processing 
steps can be found in Dataset S1.
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SUPPLEMENTAL FIGURES
Figure S1: siRNA screen quality controls, related to Figure 1. (A) Expression of DNA/RNA binding 
proteins in human epidermal keratinocytes. (B) Expression changes DNA/RNA binding proteins after 
confluency induced of differentiation, as described in Kouwenhoven et al., 2015. (C) DRAQ5 normalised 
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protein expression transglutaminase I after silencing using siRNAs (N=4, error bars indicate average -/+ 
sd) showing antibody specificity. Knockdown efficiency: 64%. (D) Pearson correlation between replicate 
samples within one experiment for the different differentiation inducing conditions (N=3). (E) DRAQ5 
normalised expression of TGM1 after silencing targeting the indicated genes in the 5 different conditions 
(N=3, error bars indicate average -/+ sd). Knockdown efficiencies individual siRNAs vs pooled siRNAs 
targeting the indicated genes (N=3, error bars indicate average -/+ sd). (F) Estimation of the FDR, plotting 
the knockdown efficiency (percentage) versus the effects (z-scores) observed in the screen (N=3). (G) qPCR 
validation of expression of differentiation markers transglutaminase I (TGM1), envoplakin (ENV), involucrin 
(INV), periplakin (PLL) and self-renewal markers integrin alpha-6 (ITGa6) and integrin beta-1 (ITGb1) (N=3, 
error bars indicate S.D.). ZMAT2 KD percentage (72h): 91%, ETS1 knockdown percentage (72h): 90%, IRF6 
knockdown percentage (72h): 92%. Errorbars indicate average -/+ sd.
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Figure S2: Data distribution of screen data shows conditional effects and overlap between descriptive 
parameters such as z-score range standard deviation and coefficient of variation, related to Figure 1. 
(A) Left-lower panels display correlation between replicate samples between conditions, and right-upper 
panels show effect size and significant differences between indicated conditions (N=3). (B) Overlap between 
descriptive parameters such as z-score range and standard deviation, as well as the coefficient of variation. 
Upper plots show ranked z-scores and standard deviations for the combined dataset, with data origins 
coloured with NA binding factors in blue and chromatin factors in red (N=3, average -/+ sd). Lower plots 
describe the distribution of variation of each dataset, with coefficient of variation of the chromatin factor 
dataset in red and the coefficient of variation of the NA binding factor dataset in blue (N=3).
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Figure S3: The complete functional interaction network as determined using the Bayesian mixture 
model, related to Figure 2. Purple lines circle enriched functional interactions and in edges in green 
indicate the SNR. Displayed significance indicates the approximately unbiased (AU) p-value after 10.000 
rounds of bootstrapping. CF: chromatin factors, NA: nucleic acid.
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Figure S4: Knockdown of ZMAT2 does not lead to more cell death, induction of apoptosis or an altered 
cell cycle profile, related to Figure 2. (A) Cell death in cultures transfected with control siRNAs (siControl) 
or siRNAs targeting ZMAT2 (siZMAT2) (N=2, 96 hours culture, propidium iodide stain). (B) Induction of 
apoptosis visualised through staining with Annexin-V-PE, comparing siControl with siZMAT2 (N=2, 96 
hour culture). (C) Cell cycle analysis, showing a DNA content histogram and associated quantification 
comparing siControl with siZMAT2. (N=3, 72 hours culture, propidium iodide stain).
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Figure S5: ZMAT2 is localised in the nucleus of human epidermal stem cells, related to Figure 4. (A) Cells 
treated with mock siRNAs or ZMAT2 targeting siRNAs were stained with 4 µg/mL antibody supernatant and 
a no primary control sample was also included. Scalebar represents 500 µm. (B) Distribution of expression 
of ZMAT2 and other spliceosome components over different cells and tissues in the human body. Colour of 
the circles indicates expression level if detected, as downloaded from the EMBL expression atlas.
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Figure S6: Characterisation of effects of siSRSF1 and siZMAT2 on splicing mechanism, 3D organotypic 
culture and the dermokine gene, related to Figure 6.  (A) Epifluorescence stainings of 3D organotypic 
cultures cultured after transfection with siControl, siSRSF1 and siZMAT2 (N=3, blue represents DAPI, red 
KRT1 and green ColVII, * highlights abnormal phenotype, scale bar represents 50 µm). (B) Knockdown 
efficiency siSRSF1 (N=3) in 3D organotypic cultures as determined by qPCR. Errorbars indicate average -/+ 
sem. (C) Quantification ki67 positive cells per 100 µm for siControl (N=2) and siSRSF1 (N=3) in 3D organotypic 
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cultures. Errorbars indicate average -/+ sem. (D) Plot displays percentage significant events versus total 
detected events using the annotations provided on the MISO webpage under: Human genome (hg19) 
alternative events v1.0, describing skipped exons (SE), alternative 3’/5’ splice sites (A3SS, A5SS), mutually 
exclusive exons (MXE) and retained introns (RI). (E) RNA sequencing tracks (N=3) showing expression of 
DMKN exons upon silencing SRSF1 or ZMAT2, or induction of differentiation (AG1478+BMP2/7, 48 hours) 
with below them differential exons as called by DEXSeq. (F) qPCR validation of differential expression 
of exons, from left to right: exon_1, exon_2, exon_3 (see Table S1 for oligo sequences) (N=3, error bars 
indicate average -/+ sd). 
Supplemental Dataset 1, related to Figure 1:
Excel file describing the data obtained in the screening experiment and subsequent processing, 
as described in the Methods section.
This file is available online at https://www.cell.com/cell-reports/fulltext/S2211-1247(18)31580-
8#secsectitle0225
Supplemental Table 1, related to Figure 1, 2, 5, 6:
Excel file which includes information on the used Silencer Select siRNAs and qPCR primer 
sequences, as described in the Methods section.
This file is available online at https://www.cell.com/cell-reports/fulltext/S2211-1247(18)31580-
8#secsectitle0225
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GRAPHICAL ABSTRACT
In brief
Tanis et al., validated the expression of 26 lncRNAs in epidermal stem cells and showed that 
some are differentially expressed during differentiation. Characterisation of BLNCR showed 
that it is downstream of EGF signalling, located close to stem cell marker ITGB1 and rapidly 
downregulated upon initiation of differentiation.
Highlights
•   BLNCR is rapidly downregulated upon initiation of differentiation possibly marking it an 
early event in this process
•   BLNCR and epidermal stem cell marker ITGB1 are closely space neighbouring genes 
controlled by AP1 and P63
•   Expression of BLNCR is downstream of MEK mediated EGF signalling
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SUMMARY
As our understanding of transcriptional regulation improves so does our appreciation of its 
complexity. Both coding and (long) non-coding RNAs provide cells with multiple levels of 
control and thereby flexibility to adapt gene expression to the environment. However, few 
long non-coding RNAs (lncRNAs) have been studied in human epidermal stem cells. Here, 
we characterized the expression of 26 lncRNAs in human epidermal keratinocytes, 7 of which 
we found to be dynamically expressed during differentiation. We performed in depth analysis 
of a lncRNA located proximal to the epidermal stem cell marker integrin beta-1 (ITGB1) and 
transcribed in the opposite direction. We dubbed this gene B1-adjacent long non-coding RNA, 
or BLNCR, and found that its expression is regulated by p63 and AP1 transcription factors. 
Furthermore, BLNCR expression is regulated downstream the integrin and EGF signalling 
pathways that are key to epidermal stem cell maintenance. Finally, we found that BLNCR 
expression is rapidly reduced upon induction of differentiation, preceding the down regulation 
of integrin beta-1 expression. These dynamics closely mirror the loss of proliferative and 
adhesion capacity of epidermal stem cells in colony formation assays. Together, these results 
suggest that loss of BLNCR expression marks the switch from a proliferative state towards 
terminal differentiation in human epidermal stem cells.
INTRODUCTION
Although historically research has predominantly focused on protein encoding genes, it is 
now evident that non-coding RNAs play important roles in the regulation of many, if not all, 
biological processes. MicroRNAs are a well-studied class of non-coding RNAs that is involved 
in regulation of transcript levels and translation of mRNAs. Less clearly defined are the various 
functions of long non-coding RNAs (>200 nucleotides, lncRNA), which are almost as numerous 
as protein encoding transcripts in number of annotated genes in the human genome (Derrien 
et al., 2012). LncRNAs have been implicated in many developmental processes ranging 
from dosage compensation (e.g. Xist), imprinting (e.g. Kcnq1, Airn), neuronal development 
(e.g. Peril, Evf) and stem cell differentiation of neuronal, cardiac, epidermal, endodermal, 
endothelial and hematopoietic cells (Perry and Ulitsky, 2016). In addition, their involvement 
in various types of cancer and other pathologies highlight the importance of identifying and 
characterizing these transcripts (Esteller, 2011). Diverse modes of action have been identified 
for lncRNAs, including functioning as a decoy preventing protein-DNA interactions, a scaffold 
for the assembly of protein complexes (e.g. HOTAIR) or a guide leading protein complexes to 
specific DNA sequences (Tsai et al., 2010; Wang and Chang, 2011; Rinn and Chang, 2012; Fan et 
al., 2015). Recently, it has been shown that the transcriptional activity of lncRNA promoters can 
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regulate transcription of neighboring genes in cis and that such regulation is not necessarily 
restricted to lncRNA genes (Engreitz et al., 2016).
 The versatility of the mechanisms through which lncRNAs contribute to the regulation of 
biological processes provides the cells with yet another layer of (post-) transcriptional control. 
In light of this, we are particularly interested in their role in stem/progenitor cell differentiation 
in the epidermal layer of the skin. The high renewal rate of the epidermal layer requires tight 
regulation of gene expression programs governing proliferation and differentiation in human 
epidermal stem cells. These cells are anchored to the basement membrane by integrin 
subunits and are released upon initiation of differentiation, enabling them to traverse several 
stages of differentiation to eventually be sloughed from the surface of the epidermis. During 
these transitions, many genes are dynamically expressed to play regulatory roles, for instance 
directly influencing transcription programs (transcription factors), indirectly via signaling 
pathways (EGF, Notch, adhesion) or through (post-)transcriptional regulation (ncRNAs). To 
date, only a few lncRNAs have been implicated in keratinocyte biology, with ANCR being the 
first well-defined one. This lncRNA was found to be necessary for the maintenance of the 
undifferentiated state via the regulation of differentiation genes across the genome (Kretz, 
Webster, et al., 2012). Another lncRNA identified by the same group, TINCR, was shown to be 
required for epidermal differentiation by its involvement in stabilizing mRNA transcripts from 
differentiation genes (Kretz, Siprashvili, et al., 2012).
 Here, we validated the expression of 26 lncRNAs identified by the GENCODE consortium, 
and found that several of these genes are differentially expressed during keratinocyte 
differentiation. Although some are most likely enhancer RNAs, most have their own promoters 
that are decorated with active histone marks as well as RNA polymerase II activity, indicating 
that they are independently transcribed genes. Furthermore, we characterized a lncRNA that 
is immediately adjacent to ITGB1 and named it B1-adjacent-lncRNA (BLNCR). We found that 
ITGB1 and BLNCR are closely spaced genes that are transcribed from opposite strands of the 
DNA and that the p63 and AP-1 transcription factors are involved in regulating their expression. 
We also investigated the contribution of signaling pathways, where inhibition of MEK and 
knock-down of ITGB1 indicated that both EGF and integrin signaling impact BLNCR and ITGB1 
expression. Interestingly, BLNCR expression seems more attuned to MEK mediated EGF 
signaling, possibly via an AP-1 mediated enhancer interaction. The timing of down regulation 
suggests that BLNCR is involved in the earlier events towards differentiation as it coincides 
with the point of no return in proliferation arrest while preceding the loss of adhesion capacity 
in colony formation assays. Together, we identified BLNCR as a new epidermal progenitor cell 
marker that is rapidly down regulated upon induction of differentiation, potentially marking 
early events of epidermal stem cell differentiation.
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RESULTS
Expression of 26 lncRNAs in proliferating and differentiated epidermal keratinocytes
The function of only a few lncRNAs have been studied and characterized in primary human 
epidermal stem cells (keratinocytes) (Kretz, Siprashvili, et al., 2012; Kretz, Webster, et al., 
2012). Of these, ANCR and TINCR were found to be dynamically expressed and are important 
for self-renewal and differentiation, respectively (Kretz, Siprashvili, et al., 2012; Kretz, Webster, 
et al., 2012). To explore other lncRNAs that may be functionally relevant in this system, we 
selected 26 lncRNAs that were identified in primary human keratinocytes in the context of 
the GENCODE consortium (Derrien et al., 2012). Our selection covered both polyAdenylated 
and non-polyAdenylated transcripts, as well as lncRNAs that were (predominantly) nuclear or 
cytoplasmic in their localization (Figure 1A). We found a broad dynamic range of expression 
for these transcripts, covering more than three orders of magnitude (Figure 1B). The low 
coefficient of variation (triplicates, generally <50%, Figure 1B, inset) indicated that even the 
low expressed lncRNAs were reproducibly and reliably detected. We confirmed the accuracy 
of detection for several of the transcripts across the range of expression levels using multiple 
independent qPCR primer pairs (Figure 1B, numbers between brackets). 
 After corroborating the expression of the lncRNAs in undifferentiated keratinocytes, we 
wanted to know if they were differentially expressed during differentiation. When we induced 
differentiation using the EGFR inhibitor AG1478 for 48 hours (Mulder et al., 2012), we noted 
that several lncRNAs exhibited pronounced differential expression upon differentiation (Figure 
1C). We choose seven lncRNAs for further characterization based on their strong expression 
dynamics with low variation upon induction of differentiation, as this might indicate that they 
are involved in this process. To evaluate their expression kinetics, we performed a time-course 
of AG1478 induced keratinocyte differentiation, extracting mRNA at 0, 6, 24, 48, 72 and 96 
hours after treatment. Strong activation of the late differentiation marker transglutaminase I 
confirmed the induction of differentiation in our assay (Figure 2A). All seven lncRNAs showed 
differential expression concordant with the previous results (Figure 2A-B and Figure 1C). 
Moreover, this experiment revealed that lncRNAs TP53TG1, RP11-732M18 and RP11-379B8 
were up regulated during differentiation with comparable kinetics (Figure 2A). In contrast, 
the four down regulated transcripts (BLNCR, Z83851, RP11-554I8 and RP11-6F2) exhibited 
different types of kinetics, especially at the early (6 and 24 hour) time-points (Figure 2B). 
Together, our analysis highlighted seven lncRNAs that are differentially expressed during 
keratinocyte differentiation, suggesting that they may be linked to this process.
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Figure 1: Selected lncRNAs are expressed in self-renewing and differentiating keratinocytes. (A) 
Percentage of reads with cytoplasmic or nuclear localization of selected lncRNAs. PolyAdenylated lncRNAs 
are indicated with black squares. Numbers between brackets indicate the number of primer sets used 
in panel B and C. (B) Expression of selected lncRNAs in self-renewing keratinocytes. The expression is 
normalized based on 18s expression. n=3, mean -/+ SD. The small inset graph shows that the coefficient of 
variation is generally below 30%. (C) Fold change differentially expressed lncRNAs after 48 hours AG1478 
mediated EGFR inhibition. n=3, mean -/+ SD.
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Figure 2: Time-course induction of differentiation using AG1478 shows different expression kinetics. (A) 
Expression dynamics of upregulated terminal differentiation marker TGM1 and lncRNAs TP53TG1, RP11-
732M18 and RP11-379B8 over time. Expression is shown relative to T=0. n=3. (B) Expression dynamics of 
downregulated lncRNAs BLNCR, Z83851, RP11-554I8 and RP11-6F2 over time. The expression is shown 
relative to T=0. n=3, mean -/+ SD.
ITGB1 and BLNCR are closely spaced neighboring genes transcribed in opposite direction 
We wondered whether the expression of these lncRNAs was a consequence of transcriptional 
activity of neighboring loci or if these genes are independently transcribed (Ebisuya et al., 2008; 
Engreitz et al., 2016). We confirmed expression of the lncRNAs and their neighboring genes 
using an independent public dataset on RNA expression on day 0, 3 and 6 of differentiation 
(Kretz, Webster, et al., 2012). We then mined publicly available epigenomic profiling datasets 
to see if there were indications of histone modifications associated with active transcription 
and/or enhancer activity at the dynamically expressed lncRNA loci. This analysis supported 
the notion that RP11-554I8 and RP11-379B8 were genes driven by their own independent 
promoters. Even though these genes seemed to be embedded in active enhancer regions (as 
identified by the H3K4me1 and H3K27ac histone modifications) of adjacent genes, the presence 
of the active promoter associated H3K4me3 modification, as well as RNA polymerase II, shows 
that these lncRNAs are independent transcription units (Figure S1A and B, upper panels). 
Moreover, published RNA-sequencing data and genome annotation data from the GENCODE 
and HAVANA projects (Derrien et al., 2012) revealed distinct intron-exon structures for these 
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genes, arguing against these transcripts being enhancer-derived RNAs (data not shown). In 
contrast, the putative lncRNA Z83851 is located just upstream of the known lncRNA LOC388906 
in a region which does not contain H3K4me3, but does harbor H3K4me1 and H3K27ac signal, 
indicating that it is likely to be an enhancer RNA (Figure S1C, upper panel). 
 As some lncRNAs regulate transcription of other genes in cis (Engreitz et al., 2016), we 
investigated whether genes that were immediately adjacent to the identified lncRNA genes 
were also differentially expressed. Using our previously published expression profiling data on 
keratinocytes treated with vehicle, AG1478, BMP 2/7, or a combination of these compounds 
(Mulder et al., 2012), we assessed the expression of genes close to BLNCR, RP11-554I8, RP11-
379B8 and Z83851. In addition, we measured the expression of the non-coding RNAs under the 
same conditions by RT-qPCR for comparison (bottom panels of Figure 3A, Figure S1). We found 
that these four non-coding RNAs are indeed differentially expressed under these conditions, 
consistent with the results presented in figures 1 and 2. Moreover, the genes adjacent to 
BLNCR and RP11-379B8 were also differentially expressed (Figure 3A, Figure S1).
 The gene proximal to BLNCR is of particular interest, as it encodes the key epidermal 
progenitor marker integrin beta-1 (ITGB1/CD29). This cell surface protein is important 
for epidermal adhesion to the underlying basement membrane and is a commonly used 
marker to identify, and select for, human epidermal stem cells in culture and in vivo (P H 
Jones and Watt, 1993). To validate that these genes are indeed downstream of EGF signaling, 
we treated the cells with AG1478 and a MEK inhibitor for 24 hours. MEK is a protein kinase 
that works downstream of the activated EGF receptor in the Ras-Raf-MEK-ERK pathway. 
We found a clear reduction in ITGB1 and BLNCR expression, indicating that these genes are 
indeed downstream of EGF signaling (Figure S2). Further exploration indicated that the ITGB1 
and BLNCR transcription start sites are located near each other (~500 bp apart, Figure S3), 
which we subsequently confirmed using 5’-RACE (Figure S4). This suggests that these genes 
potentially share their promoter region. Additionally, BLNCR is not an enhancer derived RNA 
as it is spliced post-transcriptionally (Figure S3). Finally, we established that ITGB1 and BLNCR 
are indeed transcribed from opposite strands of the DNA template using strand-specific RT-
qPCR analysis (Figure 3B).
 There are several ways via which lncRNAs can regulate transcription of genes in cis, 
including transcript specific mechanisms. To evaluate if expression of BLNCR is dependent 
on the presence of the ITGB1 transcript, we knocked-down ITGB1 mRNA levels using siRNAs. 
We found that ITGB1 knock-down consistently reduces the expression of BLNCR about two-
fold (Figure 3C). This relatively mild effect on BLNCR levels, notwithstanding a very efficient 
ITGB1 knock-down, suggests that this reduction is likely to be an effect of impaired integrin-
mediated signaling, rather than in cis transcriptional regulation. Despite repeated and 
extensive attempts, we were unable to obtain efficient (>50%) silencing of the BLNCR lncRNA 
are were therefore not able to conclusively investigate cis-regulation of ITGB1 expression by 
the adjacent lncRNA.
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Figure 3: lncRNA gene BLNCR is located nearby epidermal stem cell marker ITGB1 and is transcribed 
independently. (A) Upper panel: Publicly available data of RNA-sequencing show expression of both 
transcripts (Kretz, M. et al., 2012 (GSE35468)) and histone marks (NHEK tracks, ENCODE). Lower panels: 
Expression of ITGB1 and BLNCR during differentiation. n=3, mean -/+ SD. Statistical significance was 
assessed using a t-test: * p<0,05; ** p<0,01; *** p<0.001. (B) Detection of RT-product by qPCR of ITGB1 
and BLNCR after strand-specific RT-qPCR. n=3, mean -/+ SD. (C) Relative expression of ITGB1 and 
BLNCR after 48h knockdown of ITGB1. Percentage knockdown ITGB1: 96%, n=3, mean -/+ SD. Statistical 
significance was assessed using a t-test: * p<0,05; ** p<0,01; *** p<0.001.
P63 and AP-1 transcription factors regulate BLNCR and ITGB1 expression
Next, we set out to explore potential DNA binding transcription factors involved in the 
regulation of ITGB1 and BLNCR expression. P63 is a key transcription factor essential for skin 
development and plays a pivotal role in both keratinocyte proliferation and differentiation (A. 
B. Truong et al., 2006). We noticed that p63 binds to a proximal and a distal enhancer region of 
ITGB1 and BLNCR in a publicly available dataset on a time-course of keratinocyte differentiation 
(Kouwenhoven et al., 2015) (Figure 4A). This dataset covers p63, RNA-polymerase II, H3K27ac 
ChIP-seq experiments for day 0, 2, 4 and 7 of growth factor deprived and confluency induced, 
differentiated keratinocytes. We confirmed that expression of both ITGB1 and BLNCR was 
strongly down regulated in this differentiation system using RT-qPCR (Figure S4).
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 To assess if p63 is indeed involved in the regulation of BLNCR and ITGB1 we knocked down 
p63 in proliferating primary keratinocytes (Figure S6A). In absence of p63, the expression 
of both BLNCR and ITGB1 is down regulated, as is the expression of other stem cell- and 
differentiation- markers (ITGA6, PPL, and TGM1, Figure 4B, Figure S6). This suggests that 
p63 is involved in the transcriptional regulation of ITGB1 and BLNCR, although we cannot 
formally exclude the possibility that these results may arise from an effect of cell state in 
general by silencing p63. Furthermore, the binding of p63 to this enhancer region does not 
change during differentiation, whereas the expression of ITGB1 and BLNCR does. This is in line 
with the previously described role of p63 as a bookmarker of genes important for epidermal 
development (Kouwenhoven et al., 2015). Interestingly, in the timespan that ITGB1 and BLNCR 
are down regulated in differentiation, RNA polymerase II remains bound their promoter, 
indicating that the enzyme is possibly stalled in an inactive state (Adelman and Lis, 2012). 
The discrepancy between the down regulation of these genes during differentiation and the 
retention of p63 binding to their proximal and distal enhancer elements (Figure 4A, Figure 2B), 
suggests that there might be additional transcription factors or mechanisms involved. 
 To search for other transcription factors possibly regulating expression of ITGB1 and 
BLNCR, we looked for dynamics in promoter and enhancer marks on and around the genes 
and transcription factors binding there. We identified a peak in the H3K27ac signal in the 
second intron of BLNCR that disappeared decreased during differentiation (Figure 4A). The 
absence of H3K4me3 and presence of H3K4me1 indicates that this region functions as a 
dynamic enhancer (Figure 4A). As both the BLNCR and the ITGB1 gene are located in the same 
topologically associated domain (TAD), such a regulatory interaction is likely to occur and affect 
one, or both, of these genes (Figure S7A). Unfortunately, the close proximity of the ITGB1 and 
BLNCR promoter to this enhancer precludes reliable chromosome conformation capture (3C 
or 4C) experiments due to high local background signals. Instead, we looked at transcription 
factor binding hotspots (ENCODE transcription factor ChIP-seq, 161 factors, with Factorbook 
Motifs) in a DNase I cluster (ENCODE, 125 cell types) in this dynamic enhancer region and 
found several which are expressed in our keratinocytes (Figure S7B). Our interest was sparked 
by binding of several AP-1 transcription factor family members as they are known downstream 
effectors of EGF and integrin signaling, two important renewal signals in keratinocyte biology 
(Moreno-Layseca and Streuli, 2014). We found that treating cells with the AP-1 family inhibitor 
tanshinone II (John T. Connelly et al., 2010) resulted in decreased expression of both BLNCR 
and ITGB1 (Figure 4C). Together, our experiments suggest that both BLNCR and ITGB1 are, at 
least in part, regulated by p63 and AP-1 family transcription factors.
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Figure 4: Expression of ITGB1 and BLNCR is regulated by p63 and AP-1 factors. (A) ChIP-sequencing 
tracks of p63, RNA pol II and H3K27ac signal in promoter region of BLNCR and ITGβ1 during a time-course 
of differentiation; day 0, 2, 4 and 7(Kouwenhoven et al., 2015). Non-differentiated NHEK H3K4me3 and 
H3K4me1 tracks from ENCODE, DNase clusters (ENCODE, 125 cell types) and transcription factor ChIP-
seq tracks (ENCODE transcription factor ChIP-seq, 161 factors, with Factorbook Motifs) are also included. 
(B) 18s normalized expression of indicated genes in p63 knockdown samples. Percentage knockdown p63: 
82,5%. n=3, mean -/+ SD. Statistical significance was assessed using a t-test: * p<0,05; ** p<0,01; *** 
p<0.001. (C) 18s normalized expression of indicated genes after 24 or 48 hours of AP-1 inhibition using 
tanshinone IIA. n=3, mean -/+ SD. Statistical significance was assessed using a t-test: * p<0,05; ** p<0,01; 
*** p<0.001.
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BLNCR expression mirrors loss of proliferative capacity during initiation of differentiation
EGF receptor inhibition with AG1478 induces keratinocyte differentiation in vitro, recapitulating 
the process in the epidermis where the cells stop proliferating before releasing their integrin 
anchors and embarking on their differentiation journey (Mulder et al., 2012). To understand 
the relative contribution of ITGB1 and BLNCR regulation with respect to these processes, 
we first compared the dynamics of ITGB1 and BLNCR down regulation in a time-course of 
AG1478 induced differentiation. As shown in figure 2b as well, BLNCR was essentially entirely 
down regulated within the first 24 hours (Figure 5A). In contrast, ITGB1 mRNA levels started 
to decrease between 24 and 48 hours of treatment. Thus, regulation of BLNCR responds to 
the differentiation signals earlier than ITGB1. To see if we could put the expression dynamics 
of BLNCR in the context of proliferation and adhesion capacity of the cells, we used a colony 
formation assay set-up (Figure 5B). We treated primary keratinocytes for 0, 24, 48 or 72 hours 
with AG1478 in defined serum-free medium, where after they were seeded on inactivated 
feeders under standard colony forming assay conditions (without AG1478)13. This allowed us 
to assess at which time point after induction of differentiation the cells will lose their adhesion 
and proliferative capacity, respectively. This revealed that dynamics of down regulation of 
ITGB1 expression mirrors the potential of the cells to adhere in the colony formation assay 
(as monitored by quantifying the number of colonies), which is starting to decrease after 24 
hours of AG1478 treatment (Figure 5B, left panel). In contrast, the proliferative capacity of 
the cells (as monitored by the size of the colonies that are formed) is essentially entirely lost 
within the first 24 hours of AG1478 treatment (Figure 5B, right panel) and very closely follows 
the dynamics of down regulation of BLNCR. This observation suggests that loss of BLNCR 
expression may be an early event in epidermal differentiation and could be associated with the 
loss of proliferative potential of epidermal stem cells committed to differentiate.
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Figure 5: BLNCR expression is regulated by EGF signalling and downregulation precedes the point-of-
no-return in differentiation. (A) Relative 18s normalized expression of ITGB1 and BLNCR in a time-course 
experiment with AG1478 treatment. Data on BLNCR is already visualized in figure 2. n=3, mean -/+ SD. 
Statistical significance was assessed using a t-test: * p<0,05; ** p<0,01; *** p<0.001. (B) Upper panel: 
Overview of the assay set-up. Lower panels: Number of colonies and colony area. Cells were treated with 
10 µM AG1478 for the indicated times before they were seeded in the CFA. n=3.
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DISCUSSION
In this work, we validated the expression of 26 lncRNAs in keratinocytes and showed that seven 
were dynamically expressed during differentiation. BLNCR caught our attention because of its 
proximity to ITGB1, a critical stem cell marker. Although we could not conclusively investigate 
cis-regulation, we discovered that the expression of both ITGB1 and BLNCR is, at least in part, 
regulated by p63 and AP-1 factors binding to a presumed shared enhancer region. It seems 
plausible that BLNCR and ITGB1 are co-regulated to a degree, especially considering their 
proximity and localization in the same TAD. This could be through the transcriptional activity 
around a shared promoter region, which can increase local concentration of transcription 
machinery (Engreitz et al., 2016). In line with this, the expression of both genes involves p63 
and AP-1 factors. Interestingly, neither p63 nor RNA-polymerase II binding to BLNCR and 
ITGB1 seems to be dynamic in the early stages of confluency induced differentiation, whereas 
the expression of both genes does decrease. For p63, it has been described that it can also 
function as bookmarker, marking genes important for epidermal development without binding 
dynamics (Kouwenhoven et al., 2015). RNA polymerase II binding might be unchanging in the 
early stages of differentiation because its activity might be stalled and remains bound in an 
inactive state (Adelman and Lis, 2012). 
 The responsiveness of BLNCR expression to EGF and adhesion signalling makes BLNCR 
an interesting marker that could be used to monitor the proliferative state of the cell. The 
interplay between these pathways is essential in maintaining a proliferative population, as 
cells do not proliferate in absence of adhesion even in the presence of growth factors and 
just adhesion is not enough to trigger proliferation (Moreno-Layseca and Streuli, 2014). Using 
colony formation assays we showed that although AG1478 treated keratinocytes still display 
normal adhesion efficiency after 24 hours of treatment, their long-term proliferative capacity 
is already lost. This is also recapitulated in the more rapid down regulation of BLNCR in case of 
EGF inhibition compared to ITGB1. As the expression of BLNCR is also dramatically reduced in 
the first 24 hours of differentiation, its expression is potentially associated with the proliferative 
potential of epidermal stem cells and suggests that the down regulation of BLNCR is an early 
event leading up to initiation of terminal differentiation.
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METHODS
Cell culture
Human primary keratinocytes from two different body sites (LKA; oral and KNP; foreskin) were 
cultured on an mitotically inactivated layer of J2-3T3 fibroblast as described before(Gandarillas 
and Watt, 1997). Prior to induction of differentiation, the cells were grown feeder-free in 
Keratinocyte Serum-Free Medium (KSFM, Gibco) supplemented with 30 µg/mL bovine pituitary 
extract (BPE, Gibco) and 0.2 ng/mL epidermal growth factor (EGF, Gibco). Colony formation 
assays were performed for seven days on inactivated feeders after AG1478 treatment on KSFM 
for the indicated times.
Induction of differentiation and kinase inhibition
Differentiation was induced using 10 µM EGFR inhibitor AG1478 (Calbiochem) and/or 200 ng/
mL human recombinant BMP 2/7 (R&D systems) in KSFM for the time indicated in the figure 
legends. In the kinase-inhibitor experiments MEK inhibitor PD0325901 (MEKi, Axon Medchem) 
was used at a concentration of 1 µM for the indicated time.
Nucleofection of siRNAs
Keratinocytes were grown to 70% confluency in KSFM, where after they were harvested, 
counted and 200.000 cells were mixed with siRNA 2 µM final in a 20 µL transfection reaction. 
Nucleofection was performed using the Amaxa 4D 96 well nucleofector (program FF113). The 
cells were rested for 10 minutes before seeding.
RNA extraction and RT-qPCR
Prior to RNA extraction cells were washed once with PBS and lysed using RNA lysis buffer 
provided with the RNA extraction kit. RNA extraction was performed using the Quick RNA 
Microprep kit (Zymo Research) according to manufacturer’s protocol. Reverse transcription was 
performed using Maxima RT enzyme (Thermo Fisher Scientific) according to manufacturer’s 
protocol followed by qPCR. In short, RNA was annealed with 0,5 µg/µL hexamer primers in 
the presence of 0.5 mM dNTPs for 5 minutes at 65°C, where after the reverse transcriptase 
reaction was performed using maxima RT enzyme and RNase inhibitor RNasin plus. Samples 
were incubated 10 minutes at 25°C, 45 minutes at 50°C and finally 5 minutes at 80°C. Samples 
were treated with RNaseH (2U per sample) for 20 minutes at 37°C before being diluted to 5 
ng/µL for qPCR. qPCR reactions of 20 µL contained 10 ng cDNA, mixed with 10 µL 2x SYBR 
green Supermix (Biorad), 5 pmol forward primer, 5 pmol reverse primers and MQ to 20 µL. A 
standard qPCR protocol was run (3 min 95°C, [10 sec. 95°C, 30 sec. 60°C] x 39) and data were 
analyzed in Excel.
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Publicly available ChIP sequencing data and RNA sequencing data
Previously published p63, RNA polymerase II and H3K27Ac ChIP sequencing tracks were 
used from Kouwenhoven et al., EMBO Reports, 2015, 16(7):863-78(Kouwenhoven et al., 2015). 
Publicly available RNA sequencing tracks were used from Kretz, M. et al , 2012 (GSE35468)
(Kretz, Webster, et al., 2012)
Colony formation assays
Cells were cultured as described under “cell culture”, harvested and put on KSFM for AG1478 
treatment. After the indicated times the cells were harvested and passaged onto inactivated 
J2-3T3 fibroblasts. After 7 days, the fibroblasts were washed away and the remaining colonies 
were fixed using 4% formaldehyde. Cells were permeabilised using 0.1% Triton. The cells 
were blocked and stained in PBS + 10% serum with DRAQ5 (1:4000, Biostatus) and anti-TGM1. 
DRAQ5 signal was measured in Image Studio V5.0 using the Odyssey CLx system and colonies 
number and size was determined using CellProfiler. Data analysis and visualisation was 
performed in R.
5’ RACE
Performed as described in Scotto-Lavino et al., 2006(Scotto–Lavino, Du and Frohman, 2007) 
[17406509]. In short, the 5’ end of BLNCR was targeted in a primed RT reaction and after 
polyadenylation of the cDNA a universal anchor was attached. This was followed by a nested 
PCR strategy amplifying the 5’ end of the cDNA specifically (see Table 1 for primer sequences). 
The PCR products are were purified using an TA cloning strategy (source) and the 5’-end 
determined using Sanger sequencing.
Table 1: Primers (5’-3’)
Name in figure Sequence
RT CCCAGGCACAGAGAAATGGT
GSP1 CACATCTGGCAGGGTGTCTT
GSP4 CTTCGCTTAAGGTCCCCCTG
GSP5 TGGCTGCTGGTGACAAAGAA
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Figure S2: Both BLNCR and ITGB1 are downstream of the EGF receptor. 18s normalized expression of 
ITGB1 and lncRNA after 24 hour treatment with 10 µM EGFR inhibitor AG1478 or 1 µM MEK inhibitor 
PD0325901. N=3, t-test indicated no significant differences.
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Figure S4: 5’ RACE shows TSS to be located in exon 2. (A) Schematic overview of the experimental setup 
and primer combinations. (B) Sanger sequencing results show TSS to be located in exon 2 of the annotated 
transcript.
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Figure S5: Rapid downregulation of BLINCR in confluency induced differentiation assay. Expression of 
ITGB1 and BLNCR in PCK19 adult keratinocytes upon confluency induced differentiation and removal of 
growth factors.
Figure S6: Knockdown of p63 affects differentiation and self-renewal markers. (A) Expression of p63 
in the knockdown samples (knockdown of p63 is 82,5%, N=3, t-test based significance is indicated in the 
figures: * p<0,05; ** p<0,01; *** p<0.001). (B) Periplakin (PPL), transglutaminase I (TGM1) and integrin α6 
(ITGα6) expression in control and p63 knockdown samples (N=3, t-test based significance is indicated in 
the figures: * p<0,05; ** p<0,01; *** p<0.001.
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Figure S7: Transcription factor binding in ITGB1 and BLNCR containing TAD. (A) Topology associated 
domain containing both genes, from Javierre et al., 2016. (B) Transcription Factor ChIP-seq (161 factors) 
from ENCODE with Factorbook Motifs, AP-1 factors in red and H3K27Ac tracks during differentiation 
(Kouwenhoven et al., 2015 EMBO).
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GRAPHICAL ABSTRACT
In brief
Using single cell ID-sequencing and transcriptomic approaches the authors show that the 
activation of the BMP signalling pathway enables coordination of gene expression programs to 
ensure proper execution of the epidermal differentiation program.
Highlights
•  scID-seq allows quantification of 70 (phospho-)proteins at single cell level
•  Pseudo-time inference reveals signalling dynamics during epidermal differentiation
•  BMP signalling drives a late differentiation transcription program
•  BMP signalling activates the MAF/MAFB/ZNF750 transcription factor network
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SUMMARY
Epidermal homeostasis requires balanced and coordinated adult stem cell renewal and 
differentiation. These processes are controlled by both extracellular signalling and by cell 
intrinsic transcription regulatory networks, yet how these control mechanisms are integrated to 
achieve this is unclear. Here, we developed single-cell ID-seq and simultaneously measured 69 
proteins (including 34 phosphorylated epitopes) at single-cell resolution to study the activation 
state of signalling pathways during human epidermal differentiation. Computational pseudo-
timing inference revealed dynamic activation of the JAK-STAT, WNT and BMP pathways along the 
epidermal differentiation trajectory. We found that during differentiation, cells start producing 
BMP2-ligands and activate the canonical intracellular effectors SMAD1/5/9. Mechanistically, 
the BMP pathway is responsible for activating the MAF/MAFB/ZNF750 transcription factor 
network to drive late stage epidermal differentiation. Our work indicates that incorporating 
signalling pathway activation into this transcription regulatory network enables coordination of 
transcription programs during epidermal differentiation.
INTRODUCTION
The human epidermis is continuously turned-over throughout life, a process that requires 
precise control and coordination of stem cell renewal and differentiation. During epidermal 
homeostasis, proliferating stem/progenitor cells residing in the basal layer replenish 
terminally differentiated cells that are shed from the skin surface (Blanpain and Fuchs, 2006; 
Watt, Lo Celso and Silva-Vargas, 2006; Solanas and Benitah, 2013). Human epidermal stem 
cells can be maintained in culture and used to regenerate functional epidermis in vivo upon 
transplantation and retain their capacity to differentiate in vitro (Rheinwald and Green, 1975; 
Green, 2008; Barrandon et al., 2012; Hirsch et al., 2017). The process of differentiation is driven 
forward by consecutive activation of transcriptional programs, yet the mechanisms underlying 
their sequence and timing are not well understood. In the epidermal basal layer, cells receive 
proliferative signals, predominantly via the epidermal growth factor receptor, and contact 
the underlying basement membrane (Watt, 2002; Watt and Huck, 2013). These contacts are 
mediated by focal adhesions and hemi-desmosomes that contain integrin β1 and integrin 
α6, respectively (Watt, 2002; Watt and Huck, 2013). As cells stop proliferating and initiate 
differentiation, these structures are resolved, allowing the cells to detach from the basement 
membrane and migrate up towards the epidermal surface. During this migration, the cells 
undergo major transitions in transcriptional programs, eventually producing the terminally 
differentiated keratinocytes that form the outermost protective layer of our skin.
 TP63 is a key DNA-binding transcription factor in epidermal stem cell renewal and upon 
differentiation its expression is decreased (Amy B Truong et al., 2006; Kouwenhoven et al., 
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2010). In contrast, other transcription factors, including KLF4, OVOL2, GRHL3, MAF/MAFB and 
ZNF750, are induced (Koster and Roop, 2004; Wells et al., 2009; Sen et al., 2012; Bhaduri 
et al., 2015; Lopez-Pajares et al., 2015). Of these, MAF and MAFB cooperatively regulate a 
transcription program that includes ZNF750, which subsequently drives expression of terminal 
differentiation genes (Lopez-Pajares et al., 2015). This concept of sequential activation of 
transcription factors (also called transcription regulatory networks) explains cell intrinsic 
progression of epidermal differentiation. Indeed, human keratinocytes differentiate when 
placed in conditions where they are not in contact with other cells, for instance in suspension 
in methylcellulose or on micro-patterned islands, (Adams and Watt, 1989; J T Connelly 
et al., 2010). However, this does not take into account the need for regional coordination of 
differentiation in a tissue context. For instance, the basal, spinous, granular and cornified layers 
of the epidermis are morphologically distinct and can be distinguished using specific markers, 
reflecting differences in transcriptional programs. The fact that these are sequentially formed 
layers indicates the need for a form of coordination that is not immediately explained by the 
function of cell intrinsic transcription factor networks.
 Extracellular signalling pathways generally depend on binding of a peptide ligand to the 
extracellular part of a transmembrane receptor. This receptor then relays this interaction 
into an intracellular cascade, usually involving multiple kinases and phosphorylation events 
to regulate specific transcription programs. As such, activation of extracellular signalling 
pathways may serve as a self-contained timing mechanism to drive differentiation forward 
in a tissue and safeguard the irreversibility of the process. Several signalling pathways (e.g. 
Integrins, EGF, TGFβ, Notch and BMP) have been implicated in epidermal biology, yet their 
temporal dynamics and mechanistic contributions to the control of specific transcription 
programs are largely unknown, especially in the context of human epidermis (Watt, 2002; Li, 
Koster and Wang, 2003; Blanpain and Fuchs, 2006; Watt, Lo Celso and Silva-Vargas, 2006; Beck 
and Blanpain, 2012). For example, the importance of the Bone Morphogenetic Protein (BMP) 
pathway in the embryonic morphogenesis of mouse hair follicles and bulge stem cell behaviour 
during postnatal hair differentiation and cycling in mice is well established (Botchkarev and 
Sharov, 2004; Guha et al., 2004; Blanpain and Fuchs, 2006; Lewis et al., 2014; Mou et al., 2016), 
yet the contribution of this pathway to human epidermal renewal and differentiation is still 
poorly understood (Yang et al., 2006; Gosselet et al., 2007; Fessing et al., 2010).
 To study the role of signalling in human epidermal differentiation, we recently described 
the Immuno-Detection by sequencing (ID-seq) technology to simultaneously quantify 
>70 (phospho-)proteins in many cell populations in parallel (van Buggenum et al., 2018; 
van Buggenum et al., 2016). This allowed us to screen hundreds of small molecule kinase 
inhibitors for their impact on keratinocyte biology. The ID-seq technology entails highly 
multiplexed immuno-staining with DNA-barcoded antibodies followed by signal quantification 
through high-throughput sequencing. A 10nt antibody-specific barcode enables deconvolution 
of the measured epitope, whereas inclusion of unique molecular identifiers allows accurate 
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count-based quantification. The fact that these 10nt barcodes are discrete and specific for 
each antibody facilitates multiplexed detection of 70 (or more) epitopes per treated population 
of cells. Thus, using ID-seq, the activity of a range of processes and signalling pathways can 
be monitored through the activated (phosphorylated) states of its components (Buggenum et 
al., 2018). However, populations of cells rarely display homogeneous timing of differentiation 
(Altschuler and Wu, 2010; Wu and Singh, 2012), making it difficult to investigate the signalling 
dynamics underlying this process. We therefore set out to study signalling pathway activity and 
dynamics during human epidermal cell differentiation at the single-cell level.
RESULTS
scID-seq allows robust, reproducible and highly multiplexed protein detection in single 
cells
To reach single-cell sensitivity and resolution, we redesigned and significantly modified our 
original ID-seq technology. Our final single cell (sc) ID-seq workflow includes immuno-
staining of cells in suspension followed by flow cytometry-based single-cell distribution into 
96-wells PCR plates to prepare samples for sequencing (Figure 1A and Figure S1). A key 
improvement was the addition of a pre-amplification step prior to adding the cell-specific 
barcode. Again, the inclusion of a 15-nt unique molecular identifier (UMI) allowed counting-
based quantification and ensured that potential duplication artefacts introduced during sample 
preparation could be accounted for (Kivioja et al., 2012). We found that unique barcode counts 
from wells containing a single sorted cell were 100-fold higher than empty wells, indicating 
that only 1% of the signal constituted technical background (Figure 1B). Next, we sought to 
characterize the reproducibility/confidence of quantification of antibody-derived UMI-counts 
within single cells. For this, we generated a panel of five antibodies against cell surface (ITGA6 
and ITGB1), cytoplasmic (Actin and TGM1) and nuclear (RNApol2) epitopes, each of which were 
independently conjugated to 9 distinct DNA-barcodes, generating a total pool of 45 antibody-
DNA conjugates. Each of these barcodes serves as a technical replicate and their concordance 
therefore reflects the reproducibility of single cell ID-seq measurements. All of the barcodes for 
each of these five antibodies showed very good correlation across cells (R=0.95-0.99), indicating 
a low level of noise in scID-seq measurements (Figure 1C and S2). To further validate scID-
seq, we stained human epidermal stem cells simultaneously with ITGB1 antibodies containing 
either a fluorescent group, or the DNA-barcode. We recorded the FACS-based ITGB1 signal, as 
well as the ITGB1 DNA-barcode counts for individual cells. This revealed that scID-seq counts 
indeed reflect standard FACS measurements for the same cell (R=0.76, Figure 1D). Together, 
these results establish single-cell ID-seq as a robust and reproducible method to measure 
proteins at individual cell resolution. Moreover, the fact that each DNA-barcode is unique to a 
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specific antibody allows antibodies to be multiplexed and measured in each individual cell at 
an unprecedented level. 
Figure 1: Single-cell Immuno-Detection by Sequencing (scID-seq) enables robust and reproducible 
protein detection in individual cells. (A) Schematic overview of the scID-seq workflow. (B) Single cell 
derived antibody counts indicate low technical noise levels in scID-seq. Single cells stained with antibody-
DNA conjugates sorted into individual wells of a 96-well plate and compared to wells were no cells were 
sorted into using scID-seq (n=132 with 84 cells and 48 empty wells). (C) scID-seq reproducibly measures 
antibody signals in single cells. Independently generated antibody-DNA conjugates were used to stain 
human epidermal stem cells. Barcode counts derived from the two barcodes were plotted against each 
other, indicating high reproducibility of the protein measurements from the same cell. (D) scID-seq reflects 
Fluorescent Activated Cell Sorting measurements. ITGB1 levels were measured in human epidermal stem 
cells using FACS and scID-seq. Fluorescent signal and scID-seq counts for each cell (n=84) showed a good 
correlation (R=0.76).
scID-seq distinguishes renewing and differentiated epidermal cells
We applied single-cell ID-seq to monitor the activity of signalling pathways and other cellular 
processes during epidermal differentiation using a panel of 70 antibody-DNA conjugates (van 
Buggenum et al., 2016; Buggenum et al., 2018). These antibodies cover a broad range of cellular 
processes including cell cycle, DNA damage, epidermal self-renewal and differentiation, as 
well as the intracellular signalling status for the EGF, G-protein coupled receptors, calcium 
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signalling, TNFα, TGFβ, Notch, WNT and BMP pathways (van Buggenum et al., 2018 and 
supplemental Table 1). This panel includes 34 antibodies against phosphorylated epitopes and 
was extensively validated (Buggenum et al., 2018). For 11 of the phosphorylated epitopes we 
also measured the non-phosphorylated protein, allowing us to correct for total protein levels 
by calculating the phosphorylated to total protein ratio per cell. Most of the targeted processes 
are measured using multiple (3-5) independent validated antibodies (Buggenum et al., 2018).
 The surface level of ITGB1, reflects a cell’s potential to proliferate and self-renew (Adams 
and Watt, 1989; Philip H. Jones and Watt, 1993; Watt and Jones, 1993; Jones, Harper and Watt, 
1995; Watt, 2002). We used FACS isolation of single cells based on their ITGB1 levels to capture 
the transitions that underlie the differentiation process (Figure 2A, see Figure S3 for details 
of the FACS-isolation). Colony formation assays confirmed the loss of proliferative capacity 
in cells expressing low levels of ITGB1 (Figure S4A). After staining with the 70 antibody-DNA 
conjugates, cells were sorted into ITGB1 positive (ITGB+) and ITGB1low populations based on 
their fluorescent ITGB1 antibody signal and subjected to scID-seq. After quality control and 
filtering (see methods for details) we obtained a dataset of 220 single cells (163 ITGB1+ and 57 
ITGB1low, respectively) in which 69 antibody-DNA conjugates were quantified. For each cell, 
antibody-DNA counts were normalized for differences in sequencing depth by subsampling. To 
avoid downstream analyses from being dominated by the most abundant epitopes, we scaled all 
antibody counts between 0 and 1 across all cells. Unsupervised principal component analysis 
separated the ITGB1low (differentiated) cells from the ITGB1+ cells, confirming the notion that 
these represent distinct cell states (Figure S4B). Although we isolated cells only with respect 
to their cell surface expression of ITGB1, we found that other proteins displayed concordant 
dynamics. For instance, the basal cell markers ITGA6 and TP63 were also decreased in the 
ITGB1low population (Figure 2B). In contrast, this population exhibited higher expression of 
the differentiation-associated proteins TGM1, Notch1 Intracellular Domain (NICD) and KLF4 
(Figure 2B). Furthermore, cell cycle markers, such as Rb-p and cdc2 (reflecting the G1-S and 
G2-M transitions, respectively), distinguished these populations very well (Figure 2B). This 
is consistent with the loss of proliferative capacity during differentiation as observed in our 
colony formation assay (Figure S4A) and demonstrates that scID-seq captures molecular 
events underlying cellular function. Indeed, other antibodies in our panel also showed 
quantitative differences between these two cell states in either all, or in a subset of the cells 
(Figure S4C). Interestingly, many of the measured proteins displayed multimodal distributions, 
suggesting underlying subpopulation structures that could reflect transitions over the course 
of differentiation. This highlights the richness and complexity of our dataset and indicates the 
need to incorporate information on multiple parameters simultaneously in further analyses.   
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Pseudo-timing reveals dynamic signalling pathway activity over the course of 
differentiation
To obtain insight into the progressive changes in signalling pathway activity that occur over 
the course of epidermal cell differentiation, we aimed to order the cells by their relative 
differentiation state. We hypothesized that this state can be inferred by examining the 
combination of expression of known basal and differentiation markers. We performed PCA 
on selected markers (ITGB1, ITGA6, TP63, NICD, KLF4 and TGM1) with established roles 
and dynamics during epidermal differentiation, and ranked the cells based on the resulting 
principal components. This revealed that principal component 1 (PC1; explaining 50% of 
the variance) recapitulated the expected trajectory of the epidermal differentiation process 
(Figure 2C). We calculated the average of 10 cell bins to smoothen the data, revealing that the 
basal markers ITGA6 and TP63 are indeed down regulated with distinct kinetics (Figure 2D). 
Immunohistochemical analysis of human epidermis showed that this PCA-derived ordering 
of the cells closely resembles the relative order and timing of changes of these markers 
in vivo (Figure S5). Thus, we interpret the scaled and binned PC1-score as a ‘pseudo-time’ 
approximation of epidermal differentiation dynamics (Figure 2D). 
 Next, we mined our data for signalling pathways of which the included antibodies showed 
concordant effects over pseudo-time and were statistically significantly different between the 
ITGB1low and ITGB1+ (Figure S4C, Kolmogorov-Smirnov (K-S) test, p<0.001). This uncovered 
several signalling pathways that displayed dynamic behaviour over pseudo-time. For instance, 
PKB/Akt phosphorylation, measured by two independent antibodies, was increased upon 
differentiation as previously described (Figure 2E, (Janes et al., 2009)). Besides these expected 
effects, we found previously unappreciated dynamics in 3 additional pathways. The JAK-STAT 
pathway was activated during differentiation, as evident from increased phosphorylation of 
JAK1, STAT1 and STAT5, but not the EGFR activated STAT3 (Figure 2F). In addition, the level 
of the WNT receptor Frizzled-3 gradually increased with differentiation, as did the activated/
phosphorylated form of its co-receptor LRP6 (Figure 2G). Moreover, the inactivating serine-9 
phosphorylation of GSK3-β increased and then reached a plateau. This modification helps 
stabilize cytoplasmic β-catenin in response to WNT-pathway activation (van Kappel and 
Maurice, 2017). Finally, the Bone Morphogenetic Protein (BMP) pathway was activated at 
multiple levels (Figure 2H). Our scID-seq panel included antibodies for the BMP2/4 ligand, 
the type 2 BMP receptor, total SMAD1 levels, as well as two distinct antibodies against 
phosphorylated SMAD1/5/9. Over pseudo-time we observed increasing levels of the ligand, the 
receptor, as well as phosphorylated SMADs, reflecting activation of the BMP pathway during 
differentiation (Figure 2H). As our cells are cultured in a defined medium in the absence of 
feeder cells the signals that activate these pathways are therefore likely to be generated by the 
cells themselves. Indeed, the increase of the BMP2/4 ligand is consistent with such regulation 
by the BMP pathway (Figure 2H).
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Figure 2: Pseudo-timing reveals dynamic signalling pathway activity over the course of epidermal 
differentiation. (A) Combining scID-seq with FACS-based sorting on ITGB1 levels. Cells were immuno-
stained with fluorescent ITGB1 antibodies in combination with a panel of 70 Ab-DNA conjugates, FACS 
sorted based on their ITGB1 levels and subjected to scID-seq. (B) scID-seq distinguishes ITGB1+ 
and ITGB1low sorted cells based on known epidermal basal, differentiation and cell-cycle markers. 
Distributions of normalised and scaled scID-seq counts of selected proteins verified the separation of the 
ITGB1+ and ITGB1low populations. (C) Principal Component Analysis on known markers orders epidermal 
cells on their renewal and differentiation status. Top panel - markers used for the temporal ordering, 
colour intensity represents scaled antibody counts. Bottom panel - cells were ranked on their (scaled) 
PC1 loading. Vertical lines indicate the 10-cell bins used to smoothen the data in subsequent analyses. (D) 
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Dynamics of the markers used for PCA, ordered by pseudo-time (scaled PC1 loading) after smoothening. 
Data points indicate 10-cell bin mean and solid lines represent model fit of the data (3rd order polynomial 
regression). (E) Dynamics of two independent phosphorylated Akt/PKB antibodies over pseudo-time. 
(F,G,H) Dynamics of antibodies reflecting the JAK-STAT, WNT and BMP signalling pathways over pseudo-
time.
BMP signalling stimulates a terminal epidermal differentiation transcription program
To validate our findings on the activation of the BMP pathway, we induced differentiation of 
proliferating epidermal cells in culture by inhibiting EGF signalling (Kolev, Mandinova, Guinea-
Viniegra, Hu, Lefort, Lambertini, Neel, Dummer, Erwin F. Wagner, et al., 2008; Mulder et al., 
2012). Samples were collected at 6, 12, 24 and 48 hours after the addition of either vehicle 
(DMSO) or the EGFR inhibitor AG1478. RT-qPCR analysis showed that mRNA expression of 
the early differentiation marker periplakin (PPL) and the late differentiation marker TGM1 
reflected the progression of differentiation over time (Figure 3A). In line with our scID-seq 
results, mRNA expression of the BMP2 ligand was activated upon induction of differentiation 
(after the 12-hour time-point), whereas the classical BMP-pathway target gene ID2 was 
induced at a subsequent stage (after 24 hours, Figure 3A). This induction was dependent on 
both BMP-ligand binding to the extracellular part of the receptor and on intracellular BMPR 
kinase activity, as a recombinant version of the natural BMP-antagonist noggin and the small 
molecule kinase inhibitor DMH1 blocked ID2 expression (Figure S6A and B). Moreover, the 
observed induction of BMP2 and ID2 was further validated in cells undergoing calcium induced 
differentiation (Figure S6C, data from (Kretz, Webster, et al., 2012)). Thus, the BMP pathway is 
indeed activated during epidermal differentiation in vitro. To investigate BMP pathway activity 
in vivo, we performed immuno-staining with antibodies against phosphorylated SMAD1/5/9 on 
human skin. The epidermal basal layer was visualised through co-staining with a keratin-14 
antibody and we counterstained the DNA of all cells with DAPI (Figure 3B). Consistent with our 
scID-seq and RT-qPCR results, the signal from the p-SMAD1/5/9 antibody was increased in the 
differentiated (keratin-14 negative) layers of human epidermis, confirming that BMP signalling 
is activated during differentiation in vivo. 
 These results suggest that BMP signalling may serve as a positive feed-forward loop to 
stimulate epidermal differentiation gene expression. To test this hypothesis, we treated cells 
with AG1478 for 96 hours in the absence or presence of the small molecule BMP receptor 
inhibitor DMH1 and monitored global gene expression by RNA-sequencing. Vehicle treated 
cells -/+ DMH1 were included as controls. Principal component analysis (PCA) indicated that 
the transcriptomes of non-differentiated and differentiated cells were markedly different 
(Figure 3C, PC1; explaining 76% of the variance). In addition, PC2 (5% of variance) distinguished 
the DMH1 treated and non-treated differentiated cells, reflecting a transcription program 
that depends on the BMP pathway (Figure 3C). Notably, vehicle control cells were virtually 
indistinguishable from control cells treated with DMH1, indicating that BMP signalling 
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Figure 3: BMP signalling stimulates a terminal epidermal differentiation transcription program. (A) 
BMP2 ligand and its downstream target gene ID2 are activated during in vitro keratinocyte differentiation. 
Human keratinocytes were induced to differentiate with AG1478 (or DMSO as a control) and samples were 
harvested at the indicated time-points. RT-qPCR analysis was performed for PPL, TGM1, BMP2 and ID2 
(n=3, data represented as mean-/+SD) (B) BMP signalling is activated during epidermal differentiation in 
vivo. Sections of human foreskin were stained with antibodies against phosphorylated SMAD1/5/9. DAPI 
and K14 antibodies were used to counterstain all nuclei and basal cells, respectively. Scale bar denotes 50 
µm. Dashed line indicates the basement membrane separating the dermis and epidermis. (C) Activation of 
BMP signalling regulates a transcriptional program during epidermal differentiation. Principal component 
analysis of human keratinocytes induced to differentiate with AG1478 (or the DMSO control) for 96 hours 
in the presence of the BMP receptor inhibitor DMH1, followed by RNA-sequencing analysis (n=3, except 
DMSO control n=2). (D) BMP dependent genes are involved in late differentiation processes. Top enriched 
terms from a gene ontology overrepresentation analysis (hypergeometric test, FDR<0.01) of differentially 
expressed genes between the AG1478 and AG1478+DMH1 samples.
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specifically regulates differentiation, but not proliferation/renewal programs. Moreover, the 
genes that were dependent on the BMP pathway activity showed highly significant enrichment 
of genes involved epidermal keratinization and cornification, indicating that BMP signalling 
drives transcriptional changes towards terminal differentiation (Figure 3D).
The terminal differentiation transcription factors MAF/MAFB are downstream targets of 
the BMP pathway
 We further explored the mechanistic role of the BMP pathway in epidermal differentiation by 
investigating the gene expression program that is influenced by stimulation with recombinant 
BMPs. First, we treated cells with different BMP ligands and measured the induction of the 
late differentiation marker transglutaminase I (TGM1) at the protein level. This indicated 
that most recombinant ligands led to a robust increase of TGM1 (Figure S7A). Moreover, 
simultaneous treatment of cells with the EGFR inhibitor AG1478 and BMP ligands resulted in 
a synergistic increase of TGM1 protein levels, highlighting opposing roles for these pathways 
in epidermal biology (Figure S7B). Next, we performed RNA-sequencing analysis on cultured 
human epidermal cells treated with vehicle, AG1478, BMP2/7 or AG1478+BMP2/7 for 48 hours 
(Figure S7C,D). Comparing the mRNA profiles of these conditions revealed the genes that 
were responsive to the addition of recombinant BMP2/7 and were also dynamically expressed 
during AG1478 induced differentiation (S7E). As expected, the top most BMP responsive genes 
included the ID gene family. Moreover, genes involved in terminal differentiation, including 
TGM1, MAF, MAFB and ZNF750 displayed BMP induced expression changes (Figure S7F), 
confirming the results obtained with the BMP pathway inhibitor DMH1 (Figure 3D). The MAF/
MAFB and ZNF750 transcription factor axis drives the epidermal terminal differentiation 
transcription program (Lopez-Pajares et al., 2015). These results imply that activation of BMP 
signalling functions upstream of this axis.
 To identify potential transcriptional targets downstream of the BMP pathway, we performed 
chromatin immunoprecipitation followed by sequencing (ChIP-seq), using H3K4me3 ChIP-seq 
signals at the transcription start site (TSS) as a proxy for changes in transcriptional activity of 
a gene. We did not manage to obtain high quality SMAD1 ChIP-seq profiles and reasoned that 
the changes in H3K4me3 signals might provide a first indication of downstream BMP signalling 
targets. Proliferating epidermal stem cells were treated with vehicle or recombinant BMP2/7 (in 
combination with AG1478) for 6 hours, after which they were harvested for ChIP-seq analysis. 
This identified 135 genes that showed a significant increase in H3K4me3 signal (FPKM, p<0.01, 
outlier statistics) at their transcription start site (TSS), suggestive of increased transcriptional 
activity (Figure 4A and B). De novo motif discovery on the 2.5 kb up and downstream of these 
TSS regions revealed enrichment of a SMAD-like motif (p<10-31, Figure 4A). This is in line with 
the notion that these genes are responsive to BMP signalling. This set included the classical 
BMP targets ID1, 2 and 3, demonstrating that our experimental approach identified known 
direct BMP pathway target genes (Figure 4B). Additional to this, the terminal differentiation
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Figure 4: The terminal differentiation transcription factors MAF/MAFB are downstream targets of the 
BMP pathway. (A) ChIP-sequencing of the active gene mark H3K4me3 identifies potential downstream 
targets after BMP stimulation. Scatter plot of normalised, log-transformed H3K4me3 ChIP-seq signals 
from cells incubated with and without recombinant BMP2/7 in the context of EGFR inhibition. Genes 
with increased or decreased H3K4me3 signals (p<0.01, outlier statistics) at their transcription start site 
CHAPTER 4
112
are highlighted in red and blue, respectively. Examples of relevant activated and inhibited genes are 
indicated. (B) Gene promoters of genes with induced H3K4me3 levels are enriched in a SMAD-like motif. 
The sequences (TSS -/+ 2.5 kb) of the genes with induced H3K4me3 levels were subjected to a de novo 
motif enrichment search. One of the enriched motifs showed high similarity to a known SMAD motif. (C) 
H3K4me3 genome-browser tracks of ID2, MAF, MAFB and ZNF750. (D) MAF and MAFB, but not ZNF750, 
are immediate early responding genes downstream of BMP stimulation. RT-qPCR analysis of the indicated 
genes two hours after treatment with vehicle, or recombinant BMP2/7 (n=3, data represented as mean-
/+SD). (E) Model of the transcription regulatory network activated by BMP signalling during epidermal 
differentiation.
regulating transcription factors GRHL3, MAF and MAFB were among the top set of immediate 
BMP targets (Figure 4B and C). In contrast, the key MAF/MAFB target gene ZNF750 was not 
directly regulated downstream of the BMP pathway as determined by H3K4me3 ChIP-seq 
signal (Figure 4C). A limitation of this experiment is that we performed ChIP-seq analysis after 
6 hours of treatment. Some of the observations may therefore reflect secondary effects of BMP 
treatment. In general, we would expect direct BMP target genes to show an immediate early 
response to activation of the pathway. We tested this by treating proliferating keratinocytes 
with recombinant BMP2/7 for 2 hours followed by RT-qPCR analysis. This revealed that both 
MAF and MAFB mRNA levels were induced at this early time point, as was the classical BMP 
target gene ID2 (Figure 4D). In contrast, ZNF750 was not induced, nor were the differentiation 
markers periplakin (PPL) and TGM1. These results place BMP pathway activation immediately 
upstream of the MAF/MAFB transcription factors. These factors subsequently drive terminal 
differentiation programs through, among others, ZNF750 (Figure 4E, (Lopez-Pajares et al., 
2015).
DISCUSSION
We developed single-cell Immuno-Detection by sequencing (scID-seq) as a highly multiplexed 
single-cell (phospho-)proteomics approach based on our previously published ID-seq method. 
The combination of these two related techniques constitutes a toolbox spanning cell population-
based drug screens to single-cell follow-up. This allows exploration of the heterogeneity of 
drug effectivity within a cell population, as well as effects on signalling and other cellular 
processes within individual cells after drug treatment. In principle, scID-seq can be applied 
to any biological system where single cells can be obtained and high-quality antibodies are 
available. Moreover, scID-seq in combination with FACS-based sorting allows enrichment of 
specific and/or rare cell types a priori. Using this approach, we enriched for spontaneously 
differentiating cells based on their surface ITGB1 levels to study signalling pathway activity in 
individual human epidermal cells with distinct differentiation states. Measuring 69 (phospho-)
proteins per cell demonstrated that, amongst others, Bone Morphogenetic Protein signalling 
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is activated along the differentiation trajectory. Mechanistically, the BMP pathway stimulates 
the MAF/MAFB/ZNF750-axis to induce a transcriptional program during late stage epidermal 
differentiation. Previous studies provided indications that stimulation with exogenous BMP 
ligands increases the expression of cell cycle inhibitory factors and selected differentiation 
associated genes, suggesting involvement of this pathway in human epidermal differentiation 
(Botchkarev, 2003; Li, Koster and Wang, 2003; Yang et al., 2006; Gosselet et al., 2007; Fessing et 
al., 2010). However, its timing and function during the differentiation process remained unclear. 
Using RNA-sequencing and H3K4me3 ChIP-seq analysis in combination with inhibition 
and stimulation, we found that BMP signalling activation drives a terminal differentiation 
transcription program and the MAF/MAFB/ZNF750 transcription factor axis (Figures 3 and 
4). Our findings have implications for our view on the progressing nature of keratinocyte 
differentiation. First, regional signalling pathway activity plays crucial roles in patterning and 
tissue specification during (early) development. Our findings implicate BMP pathway activation 
as an integral part of the transcription factor network stimulating epidermal differentiation. As 
the BMP ligand is produced and excreted by the cells into their local environment, our results 
provide a mechanistic explanation for coordinated expression program progression in a zonated 
fashion in a tissue context. Second, the identification of the cell intrinsic activation of the BMP 
pathway through up regulation of its ligand BMP2, in combination with our observation that the 
BMP pathways is responsible for the stimulation of a specific transcriptional program including 
late differentiation regulators (e.g. MAF/MAFB, DLX3 and OVOL2), suggests that this pathway 
is involved in a self-sustaining loop that keeps driving epidermal differentiation forward. 
Taken together, our results reveal a mechanistic role for BMP signalling in human epidermal 
differentiation and indicates that activation of (potentially autocrine) signalling loops enables 
cells to coordinate their transcriptional programs and ensure progressive differentiation.
Limitations of the Study
scID-seq has the potential to quantify many antibodies can be measured with high sensitivity. As 
with any antibody-based approach, the quality of the antibodies is a limiting factor and should 
be defined carefully. Our current iteration of scID-seq, which includes FACS-based single cell 
isolation, is limited in the number of cells that can be practically processed in parallel.  A 
solution would be replacing the FACS and sample preparation with  droplet-microfluidics like 
in the Ab-seq approach (Shahi et al., 2017). With regards to our biological question, our data 
contains a comparatively low coverage of intermediate differentiation stages for the pseudo-
timing analysis. As a consequence, the relative timing of the pathways that show dynamics 
during that stage cannot, currently, be temporally segregated at high resolution. Finally, the 
H3K4me3 ChIP-seq we performed is taken as a proxy for transcriptional changes and we cannot 
exclude some contribution of secondary or indirect responses that are not defacto immediately 
downstream of BMP activation. We therefore chose to include additional experiments to provide 
further indications of direct effects on the MAF/MAFB/ZNF750-axis.
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METHODS
Cell culture and reagents
Primary pooled human epidermal stem cells derived from foreskin were obtained from Lonza. 
Cells were cultured and expanded as previously reported (Gandarillas and Watt, 1997). Briefly, 
cells were cultured on a feeder layer of J2-3T3 cells in FAD medium (Ham’s F12 medium/
Dulbecco’s modified Eagle medium (DMEM) (1:3) supplemented with 10% batch tested fetal 
calf serum (FCS) and a cocktail of 0.5 µg/ml of hydrocortisone, 5 µg/ml of insulin, 0.1 nM cholera 
enterotoxin, and 10 ng/ml of epidermal growth factor) supplemented with Rock inhibitor (Y-
27632, 10 µM). J2-3T3 cells were cultured in DMEM containing 10% bovine serum and inactivated 
with Mitomycin C (SCBT) upon seeding the epidermal stem cells. For experiments epidermal 
stem cells were transferred to Keratinocyte Serum Free Medium (KSFM) supplemented with 
0.2 ng/ml Epidermal Growth Factor and 30 µg/ml bovine pituitary extract from Life Technology 
until 70% confluent. Cells were treated with AG1478 (10 µM, Calbiochem), DMH-1 (1 µM, 
RND systems) or BMP2/7 (200 ng/ml, R&D systems). All media were supplemented with 1% 
penicillin/streptomycin antibiotics.
Antibody conjugation with dsDNA barcodes
Antibodies and dsDNA were functionalized and conjugated as described (van Buggenum et 
al., 2016). Antibody details are provided in supplemental Table 1. In short, antibodies were 
functionalized with NHS-s-s-PEG4-tetrazine (Jena Bioscience) in a ratio of 1:10 in 50 mM borate 
buffered Saline pH 8.4 (150 mM NaCl). Then, N3-dsDNA was produced and functionalized with 
DBCO-PEG12-TCO (Jena Bioscience) in a ratio of 1:25 (oligo list). Finally, purified functionalized 
antibodies were conjugated to purified functionalized DNA by 4-hour incubation at room 
temperature in borate buffered saline pH 8.4 in a ratio of 4:1 respectively. The reaction was 
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quenched with an excess of 3,6-diphenyl tetrazine. The conjugation efficiency and quality were 
checked on an agarose gel, confirming that a substantial amount of DNA conjugated with the 
antibody. Ultimately, conjugates were equally pooled for staining’s in scID-seq.
Immunostaining and single-cell sorting
Cells (> 3 x 106) were harvested with trypsin and cross-linked in suspension by incubating for 
10 minutes with 4% paraformaldehyde (PFA) in PBS following a quenching step of 5 minutes 
with 125 mM Glycine in PBS. Removal of PFA and Glycine occurred through washing twice 
with wash buffer (0.1x Pierce™ Protein-Free Blocking Buffer from Thermo in PBS). Then, cells 
were blocked in 500µl blocking buffer (0.5x 0.1x Pierce™ Protein-Free Blocking Buffer, 200 µg/
ml boiled salmon sperm DNA, 0.1% Triton-X 100, in PBS) at room temperature for 30-60 min. 
Staining with the conjugate mix occurred overnight at 4°C in 500 µl blocking buffer and pre-
staining’s were performed at room temperature for 1-2 hours. After each staining, cells were 
washed 3x in 5ml wash buffer. Cells were sorted single cell with the BD FACSAria SORP flow 
cytometer (BD biosciences) in 96 well PCR plates containing 1µl release buffer (10 mM DTT in 
15mM Tris, pH 8.8) and 7µl Vapor-lock (Qiagen). For selection of ITGB1 negative cells, a primary 
and secondary pre-stain was done with 2.5 µg/ml anti-ITGB1 (P4D1) and 1:1000 Alexa488 goat 
anti-mouse (Life technology, 1484573). Plates were stored at -20°C until use.
Barcoding and library preparation for next generation sequencing
For the library preparation 3 PCR steps were performed to amplify the antibody barcodes 
and to add barcodes specific for the well and the plate of each cell. The barcoding occurred 
with the same sequences used in ID-seq (Buggenum et al., 2018). For the first PCR step 
15 cycles were run after adding to each well a 4 µl reaction mix containing the Herculase 
II Fusion DNA Polymerase (Agilent), dNTPs, 5x Herculase buffer and 0.1µM amplification 
primers (Forward 5′-CACGACGCTCTTCCGATCT-3′, Reverse 5′- TCGCTTATCTGTTGACTGAT-3′). 
Directly after the first PCR step, 5 extra cycles were run after adding 1 µl mix containing 
Herculase buffer 0.2 µM forward amplification primer and 0.2 µM reverse well barcoding 
primer. Then all material was pooled per plate, Vapor-lock was removed and a clean-
up was performed with the QIAquick PCR Purification Kit, an EXO1 treatment to degrade 
remaining primers followed by another purification. Another 5 cycles were run in PCR 3 with 
a 20 µl reaction containing pooled and purified plate sample and 0.1 µM plate barcoding 
primers (Fw_long 5′- AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGC 
TCTTCCGATCT -3′ and specific plate reverse). After repeating the clean-up, the libraries were 
checked on agarose gel and with the Bioanalyzer (Agilent) to confirm the size of the DNA 
fragments (expected size around 185 bp).     
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scID-seq data analysis
Sequence data from the NextSeq500 (Illumina) was demultiplexed using bcl2fastq software 
(Illumina). Then, all reads were processed using our dedicated R-package (Buggenum et al., 
2018). In short, the sequencing reads were split using a common “anchor sequence” identifying 
the position of the UMI sequence, Barcode 1 (antibody specific) and Barcode 2 (well specific) 
sequence. After removing all duplicate reads, the number of UMI sequences were counted per 
barcode 1 and 2. Finally, barcode 1 (“antibody)” and barcode 2 (‘well’) sequences were matched 
to the corresponding. For scID-seq, a threshold was set based on the total UMI count per well 
difference between high- and low-quality cells or empty wells. Antibodies with a median of 
<10 counts per cell were removed from the dataset. Cells that displayed strong outliers for a 
single antibody (cut-off > 5x standard deviation of the mean of the population) were removed 
from the analysis. After this, cells were normalized through subsampling and antibody counts 
were normalized on a scale from 0 to 1 using the formula (x-min(x))/(max(x)-min(x)). Principal 
component analysis was done with the R-package “pcaMethods”. Additional statistical analysis 
and visualization of the data was done in R and Excel.  
Colony formation assays
Epidermal stem cells were sparsely seeded on a feeder layer in a 6 well plate (500 cells/well) 
and cultured for at least 7 days to form colonies. After colony formation, cells were washed with 
PBS and fixed by incubating 10 minutes with 4% paraformaldehyde (PFA) in PBS. PFA removal 
occurred with 3 PBS washes. For the imaging of the colonies, a DNA stain was performed with 
DRAQ5 (1:4000, Biostatus) for 1 hour at room temperature. After 3 PBS washes, plates were 
scanned with the Odyssey system and the number of colonies quantified.
Immunostaining of human skin sections
Frozen sections of human foreskin were a kind gift from Prof. Fiona Watt and were obtained 
with informed consent and appropriate ethical review. Sections were fixed for 15 minutes 
with 4% paraformaldehyde, followed by 3 washes with PBS and permeabilisation with 0.2% 
triton-X100 in PBS for 10 minutes at RT. After blocking with 10% Bovine Serum in PBS for 1 
hour, the sections were stained with antibodies against phosphorylated-SMAD1/5/9 (41D10, 
Cell Signaling Technologies) at 1:200 dilution in blocking buffer overnight at 4 degrees Celsius. 
Sections were washes 3x with PBS and stained with secondary antibodies (1:2000 dilution) 
and DAPI (1:5000) for 90 minutes at RT. After mounting on a microscopy slide, images were 
acquired using a Leica IR laser confocal microscope.
RT-qPCR
Isolated RNA (Quicki-RNA TM MicroPrep, Zymo Research) was used for quantitative PCR 
analysis using iQTM SYBR Green Supermix with 20µM reaction volume, scanned on CFX-96 
machine. Per gene, -2^Ct values were calculated and normalized to 18S RNA levels. 
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Transcriptome analysis with CEL-seq2 
Isolated RNA (Qucki-RNA TM MicroPrep, Zymo Research) was used for transcriptome analysis 
via a slightly modified CEL-seq2 procedure (Hashimshony, Senderovich, Avital, Klochendler, 
de Leeuw, Anavy, Gennert, Li, Kenneth J. Livak, et al., 2016). See Table 1 primer sequences. In 
short, 100 pg purified RNA was used in 2 µl reverse transcription reactions containing Maxima 
H minus reverse transcriptase (ThermoFisher). The reactions were covered with Vapor-Lock (7 
µl, Qiagen).  Different primer sequences were designed and used (Table 1), allowing 63 nt long 
read 1 of mRNA, and 14 nt long read 2 with the sample barcode and UMI. NextSeq500 (Illumina) 
was used for sequencing.  
Table 1. Primer sequences used during CEL-seq2 procedure.
Reverse transcription 
primer
5’GCCGGTAATACGACTCACTATAGGGGTTCAGACGTGTGCTCTTCCGATC 
TNNNNNNNN[6ntsamplebarcode]TTTTTTTTTT TTTTTTTTTTTTTTV3’
random-octamer-primer  
for reverse transcription  
of amplified RNA
5’CACGACGCTCTTCCGATCTNNNNNNNN3’
library PCR Primers 5’AATGATACGGCGACCACCGAGATCTACA 
CTCTTTCCCTACACGACGCTCTTCCGATCT3’
5’CAAGCAGAAGACGGCATACGAGAT[6ntind ex]
GTGACTGGAGTTCAGACGTGTGCTCTTCCGATC3’
CEL-seq2 data analysis
CEL-seq2 sequencing data was processed using as described (Hashimshony, Senderovich, 
Avital, Klochendler, de Leeuw, Anavy, Gennert, Li, Kenneth J. Livak, et al., 2016). In brief, 
high quality reads were filtered, and used for mapping. In brief, the count matrix was loaded 
as Seurat object, and used to visualize number of total UMI counts, number of genes and 
number of mitochondrial genes per sample. One out of three vehicle controls in the DMH-
1 experiment did not pass the QC checks (with 50% less reads/sample) and was removed 
from further analyses. The count matrix was loaded into DESEq2 data object, to allow easy 
normalization, filtering, PCA and differential expression analysis. For analysis of the CEL-
seq2 data, the DESeq2 R-package (Love, Huber and Anders, 2014) was used to normalize UMI 
counts, perform PCA analysis and determine differential expressed genes. Gene Ontology 
overrepresentation analysis was performed using the GeneTrail webtool (Backes et al., 2007)
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ChIP-sequencing
Cells in KSFM (2.5x106) were incubated with vehicle/DMSO or BMP2/7+AG1478 for 6 hours. 
After harvesting by trypsinisation, the cells were cross-linked with 1% formaldehyde in PBS 
for 10 minutes, quenched for 5 minutes with 125 mM glycine in PBS and washed in PBS at 4 
degrees Celsius. Cross-linked cells were incubated 4 hours in lysis buffer (5 mM Tris-HCl pH 
8.0, 85mM NaCl, 0.5% NP40, 1X PIC) on ice, following 50 strokes with a dounce homogenizer 
to enrich for nuclei. Nuclei were sonicated in sonication buffer (50 mM Tris-HCl pH 8.0, 10 
mM EDTA, 0.1% SDS, 150mM NaCl and 0.5% deoxycholic acid) to get an average chromatin 
fragment length of 500 bp. Chromatin extracts were incubated with 1 µg H3K4me3 antibody 
(ab8580, AbCam) overnight. Antibodies were captured for 4 hours with 100 µl protein G-coated 
magnetic beads (Life Technology). Subsequently, beads were washed 5X in RIPA buffer. 
The retrieved chromatin was reverse cross-linked overnight at 65°C followed by a 1-hour 
incubation step with proteinase K (1µg/µl) and RNAse A (1µg/µl) at 37°C. The DNA was purified 
with the Qiaquick PCR purification kit. Using the KAPA Biosystems kit (#KK8504), between 
0.5 and 5ng ChIP-derived DNA was trimmed, A-tailed, provided with Nextflex adaptors and 
amplified with 10 PCR cycles. Subsequently, DNA was size-selected with the E-Gel® iBase™ 
Power System (Invitrogen) to purify for fragments between 300 and 400bp. The libraries were 
quantified on the Agilent 2100 Bioanalyzer and evaluated by qPCR to confirm representation of 
enrichments at specific loci. The libraries were sequenced with the Nextseq500. Reads were 
quality checked and aligned to the human hg19 genome with the Burrows-Wheeler Alignment 
tool (BWA) and processed with SAMtools to generate BAM files. Peaks were called from BAM 
files using “Model-based analysis of ChIP-Seq version 1.4” (MACS14) with a p-value cut-off of 
1x10-8. The ratio of the fragments per kilobase per million reads (FPKM) values of the called 
H3K4me3 peaks were z-score transformed and subjected to outlier statistics assuming a 
normal distribution. De novo motif discovery was performed with the Trawler software (Dang et 
al., 2018). The enriched motifs were compared to known motifs in the JASPAR database using 
PWMtools (http://ccg.vital-it.ch/pwmtools).
Data and Software Availability
All sequencing data are available from GEO under series number GSE115926.
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SUPPLEMENTAL FIGURES
Figure S1: Schematic representation of the single-cell ID-seq work-flow, related to Figure 1. The 
scID-seq procedure entails crucial modifications compared to the original ID-seq protocol. First, cells 
are stained with the antibody-DNA conjugates in suspension, to allow single-cell sorting. Second, a pre-
amplification step increased the yield and complexity of the single-cell libraries. This pre-amplification is 
done prior to adding a cell-specific barcode to the PCR products. From this point on, the library preparation 
is the same as described for ID-seq. 
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Figure S2: Nine technical replicates per individual cell highlight the reproducibility of scID-seq, related 
to Figure 1. Cells were stained with a mixture of 45 antibody-DNA conjugates consisting of 5 different 
antibodies that were each separately conjugated to 9 independent DNA-barcodes. The Pearson correlation 
among the 9 measurements for each antibody across individual cells indicates the reproducibility of scID-
seq to quantify relative protein levels.
Figure S3: ITGB1 FACS strategy, related to Figure 2. (A-C) single cells were gated using forward and side-
scatter characteristics. (D) Cells stained with low ITGB1-FITC levels were gated and sorted into individual 
wells (ITGB1low). ITGB1+ cells were selected from the total population. (E) Secondary antibody only stained 
cells indicate the specificity of the ITGB1-FITC staining. 
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Figure S4: scID-seq on cells selected on ITGB1 level by FACS, related to Figure 2. (A) Cells with low 
ITGB1 surface levels represent differentiated keratinocytes. Cultured human keratinocytes were isolated 
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based on their ITGB1 surface expression by FACS and subjected to colony formation assays. (B) ITGB1+ 
and ITGB1low cells display distinct scID-seq profiles. Human keratinocytes were subjected to staining 
with a panel of 70 antibody-DNA conjugates, isolated based on their ITGB1 surface level by FACS and 
analysed with scID-seq. Principal component analysis separated the ITGB1+ and ITGB1low populations. 
(C) Individual antibodies display dynamics between ITGB1+ and ITGB1low cell populations. Distributions of 
scaled signals of ITGB1+ and ITGB1low populations for 70 antibody-DNA conjugates. Statistically different 
distributions are indicated (Kolmogorov-Smirnov test, p<0.001). 
Figure S5: Dynamics of known markers used to derive the pseudo-time line as assessed by 
immunohistochemical staining of human epidermis, related to Figure 2. Publicly available IHC staining 
of validated antibodies against the indicated epidermal marker proteins. Data from the human protein 
atlas.
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Figure S6: The BMP pathway target gene ID2 is induced during differentiation in a BMP-BMPR interaction 
dependent manner, related to Figure 3. (A) Human keratinocytes were induced to differentiate with the 
EGFR inhibitor AG1478 in the presence or absence of recombinant noggin for 48 hours and subjected to 
RT-qPCR analysis of the ID2 gene. (B) BMP2 and ID2 mRNA expression is induced during a time-course of 
calcium induced differentiation. 
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Figure S7: Stimulation with recombinant BMPs induces differentiation gene expression, related to 
Figure 3. (A) Recombinant BMPs stimulate endogenous TGM1 protein expression. Cells were stimulated 
with the indicated recombinant BMP proteins for 48 hours and subjected to In-Cell-Western analysis using 
TGM1 specific antibodies. Measurements were corrected for cell density using the DNA staining agent 
DRAQ5. n=3 -/+ SD (B) Recombinant BMPs and AG1478 synergise to stimulate endogenous TGM1 protein 
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expression. Cells were stimulated with the indicated recombinant BMP proteins for 48 hours in combination 
with the EGFR inhibitor AG1478 and subjected to In-Cell-Western analysis using TGM1 specific antibodies. 
Measurements were corrected for cell density using the DNA staining agent DRAQ5. n=3 -/+ SD. (C) 
Recombinant BMPs, AG1478 and the combined treatment lead to distinct transcriptional responses. Cells 
were stimulated with the indicated treatments for 48 hours and subjected to RNA-sequencing. Principal 
component analysis of differentially expressed genes indicates condition specific transcriptional effects. 
(D) Identification of differentially expressed genes per condition. Volcano plots indicate the log2 fold-change 
of mRNA expression between vehicle and the indicated condition on the x-axis. The y-axis represents the 
-log10 transformed p-value (FDR corrected t-test). (E) Hierarchical clustering highlights condition specific 
differences in transcriptional responses. Heat map of differentially expressed genes (z-score normalised 
across the samples) clustered on Pearson’s correlation with average linkage for both genes and samples. 
(F) 48 hours treatment with recombinant BMPs stimulates expression of transcription factors involved in 
late epidermal differentiation. 
Supplemental Table 1, related to Figure 1: 
Overview of the antibodies and DNA barcodes used in this study.
This data is available at [link to online data]
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GRAPHICAL ABSTRACT
In brief
Using transcriptomics and epigenomics, Qu et al. elucidate how mutant p63 associated 
with EEC syndrome alters the enhancer landscape in skin keratinocytes. The genome-wide 
redistribution of enhancers leads to the downregulation of epidermal genes and upregulation 
of non-epidermal genes, and affects the cell identity of skin keratinocytes. 
Highlights
•  Downregulated epidermal genes and upregulated non-epidermal genes in EEC 
keratinocytes 
•  A genome-wide redistribution of enhancers in EEC keratinocytes 
•  Gained enhancers are frequently bound by deregulated RUNX1 in EEC keratinocytes 
•  siRUNX1 partially rescued gene deregulation and the altered enhancer landscape
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SUMMARY 
Transcription factor p63 is a key regulator of epidermal keratinocyte proliferation and 
differentiation. Mutations in the p63 DNA-binding domain are associated with Ectrodactyly 
Ectodermal Dysplasia Cleft Lip/Palate (EEC) syndrome. Underlying molecular mechanism 
of these mutations however remain unclear. Here we characterized the transcriptome and 
epigenome of p63 mutant keratinocytes derived from EEC patients. The transcriptome of p63 
mutant keratinocytes deviated from the normal epidermal cell identity. Epigenomic analyses 
showed an altered enhancer landscape in p63 mutant keratinocytes contributed by loss of 
p63-bound active enhancers and by unexpected gain of enhancers. The gained enhancers 
were frequently bound by deregulated transcription factors such as RUNX1. Reversing RUNX1 
overexpression partially rescued deregulated gene expression and the altered enhancer 
landscape. Our findings identify an unreported disease mechanism whereby mutant p63 
rewires the enhancer landscape and affects epidermal cell identity, consolidating the pivotal 
role of p63 in controlling the enhancer landscape of epidermal keratinocytes.
INTRODUCTION
The transcription factor (TF) p63 is an ancient member of the p53 gene family. Different from p53 
that has a convincing function in tumour suppression, p63 is a key regulator for development of 
the epidermis, specifically in epidermal stem cell self-renewal, morphogenesis and directing 
differentiation programs (Mills et al., 1999; Yang et al., 1999; Candi et al., 2008). Several p63 
isoforms have been reported and all isoforms contain the DNA-binding domain (Kouwenhoven, 
van Bokhoven and Zhou, 2015).
 The role of p63 in epidermal development has been established by two independent p63 
knockout mouse models (Mills et al., 1999; Yang et al., 1999). These p63-deficient mice do 
not have the epidermis and epidermal related appendages. During embryonic development, 
p63-deficient mice develop a normal ectoderm with Krt8/Krt18 positive simple epithelial cells. 
However, they fail to initiate embryonic stratification and to produce mature Krt5/Krt14 positive 
epithelial and epidermal cells, termed as keratinocytes (Shalom-Feuerstein et al., 2011). 
These findings demonstrate that p63 is essential and required for the commitment to a proper 
epidermal cell fate during development. 
 In keratinocytes, p63 plays important roles for both proliferation and differentiation. The p63 
protein, mainly the ΔNp63α isoform, is expressed at a high level in proliferating keratinocytes 
in the basal layer of the epidermis. Upon stratification, its expression level is reduced (Candi 
et al., 2007). Knockdown of p63 in keratinocytes affects proliferation and prevents cells 
from differentiation (Amy B Truong et al., 2006). At the molecular level, knockdown of p63 
induces genes controlling cell cycle arrest such as p21 (CDKN1A) (LeBoeuf et al., 2010) and 
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downregulates genes that are important for epidermal differentiation such as PERP and KRT14 
(Ihrie et al., 2005; Romano, Birkaya and Sinha, 2007). These data show that p63 represses cell 
cycle arrest genes to promote proliferation, and activates epidermal differentiation genes to 
induce differentiation.
 In recent years, a number of epigenomic profiling studies established the master regulator 
role of p63 in the genome of keratinocytes, predominantly in controlling enhancers (Bao et 
al., 2015; Kouwenhoven et al., 2015; Rinaldi et al., 2016). p63 bookmarks genomic loci, and 
cooperates with specific TFs to activate epidermal genes via active enhancers. Consistently, 
ATAC-seq analysis showed that p63 binding sites are preferentially located in nucleosome-
enriched regions in epidermal keratinocytes, and these sites are inaccessible in cell types 
where p63 is not expressed (Bao et al., 2015). In keratinocytes, p63 cooperates with an ATP-
dependent chromatin remodelling factor BAF1 to make these regions accessible. It has also 
been shown that p63 directly regulates chromatin factors such as Satb1 and Brg1 that play 
roles in higher-order chromatin remodelling, covalent histone modifications, and nuclear 
assembly (Fessing et al., 2011; Mardaryev et al., 2014). These data suggest that p63 regulates 
epidermal cell fate determination and differentiation not only through direct target genes but 
also via modulating the chromatin landscape.
 The key role of p63 in epidermal development has also been demonstrated in human disease 
models. Heterozygous mutations of TP63 encoding p63 cause a spectrum of developmental 
disorders. Among them, Ectrodactyly-Ectodermal Dysplasia-Cleft Lip/Palate (EEC) syndrome 
is caused by point mutations located in the p63 DNA-binding domain, and manifests ectodermal 
dysplasia with defects in the epidermis and epidermal related appendages, limb malformation 
and cleft lip/palate (Rinne, Brunner and van Bokhoven, 2007). Five hotspot mutations affecting 
amino acids, R204, R227, R279, R280 and R304, have been found in approximately 90% of the 
EEC population, and these EEC mutations were shown to disrupt p63 DNA binding and result 
in impaired transactivation activity (Celli et al., 1999; Browne et al., 2011). Therefore, these 
mutant p63 proteins have been proposed to have a dominant negative effect towards the wild 
type p63, probably by abolishing DNA binding as a result of tetramerization of the wild type 
and mutant proteins (Brunner, Hamel and Van Bokhoven, 2002). Furthermore, mouse genetic 
studies support the dominant negative model. Heterozygous p63 knockout mice do not show 
any ectodermal phenotype (Mills et al., 1999; Yang et al., 1999), whereas heterozygous knock-in 
mice carrying an EEC mutation resemble the human phenotype (Vernersson Lindahl, Garcia 
and Mills, 2013). 
 Although the role of p63 in normal epidermal development and differentiation has been 
demonstrated, the molecular mechanism by which p63 mutations cause the epidermal 
phenotype in diseases is not yet understood. We previously reported that p63 mutant 
keratinocytes derived from EEC patients could not fully differentiate towards terminal 
stratification in both 2D and 3D cellular models (Shen et al., 2013). In this study, EEC patient 
keratinocytes carrying three hotspot mutations, R204W, R279H and R304W, were assessed by 
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transcriptomic and epigenomic analyses to identify the underlying molecular mechanism. Our 
data showed that deregulated gene expression accompanied by a rewired enhancer landscape 
leads to a less defined epidermal cell identity of p63 mutant keratinocytes, which potentially 
contributes to the pathogenic mechanism of EEC syndrome.
RESULTS
Loss of characteristic epidermal expression profiles in p63 mutant keratinocytes 
Using an established in vitro differentiation model of epidermal keratinocytes (Kouwenhoven 
et al., 2015), we characterized gene expression differences between keratinocytes derived 
from non-EEC individuals (control) and from EEC patients carrying mutations in the DNA-
binding domain of p63 (R204W, R279H and R304W, p63 mutant) (Figures 1A and B). Similar to 
our previous reports (Shen et al., 2013), p63 mutant keratinocytes retained largely unchanged 
morphology at the terminal stage of differentiation, as compared to the multilayer cell 
structures of control keratinocytes on day 7 (Figure S1A), indicating that they were unable to 
fully differentiate. To better characterize these mutant keratinocytes at the molecular level, 
we performed RNA-seq analyses. In Principal Component Analysis (PCA), gene expression of 
control keratinocytes from day 0 to day 7 moved along the PC1 axis (51%) that probably defines 
the differentiation process, whereas mutant keratinocytes remained at the left side of PC1 
(Figure 1C). Consistently, DAVID Gene Ontology (GO) annotation (Dennis et al., 2003) of the top 
500 genes associated with PC1 showed terms of ‘epidermis development’ and ‘keratinocyte 
differentiation’ (Tables S1A and B). Many deregulated genes were validated by RT-qPCR and 
at the protein level (Figure S1B). These molecular data confirmed the differentiation defect of 
p63 mutant keratinocytes.
 We next analyzed differentially expressed (DE) genes (P value < 0.05) between control 
and p63 mutant keratinocytes during differentiation. Overall, 3373 genes were upregulated 
and 4595 genes were downregulated in p63 mutant keratinocytes (Table S1D), which were 
distinguished into four clusters (Figure 1D and Table S1E). Among the upregulated genes 
(EC1), some were generally not expressed or expressed at a low level in control keratinocytes. 
There was an enrichment of genes involved in extracellular structure organization, actin 
cytoskeleton organization and muscle cell function (e.g. ACTG1 and MYH10) (Table S1F). TF 
genes in this cluster include SOX4, TEAD2, RUNX1 that are widely expressed in many cell 
types and a number of Antp homeobox family members such as HOX genes. Interestingly, TP63 
was also detected in EC1, and ∆Np63 was the isoform detected in both control and mutant 
keratinocytes (Figure S1C). Compared to the decreased p63 expression during differentiation 
in control keratinocytes, an increased p63 expression at the proliferation stage was observed 
in p63 mutant keratinocytes, which stayed at a high level through differentiation (Figure S1C). 
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 The 4595 downregulated genes whose expression was dynamically induced during 
differentiation in control keratinocytes remained low and largely unchanged in p63 mutant 
keratinocytes. These genes were grouped into three clusters (EC2, EC3, and EC4) (Tables S1G-I). 
Genes in EC2 showed a sharp increase in gene expression on day 7 in control keratinocytes. 
Many of these genes were involved in catabolic pathways and cell death (e.g. UBE4A and 
CDKN2D). Genes in EC3 were highly expressed at the proliferation stage on day 0 and expression 
went down during differentiation. They were mainly involved in cell cycle regulation (e.g. CDC20 
and KIFC1). Finally, genes in EC4 showed a progressive upregulation in control keratinocytes 
and many of them were involved in ectoderm development and keratinocyte differentiation. 
The TF genes in this cluster included OVOL1 and KLF4, and known p63 co-regulators, such 
as TFAP2A and NFE2L2. Of note, consistent with the morphological changes (Figure S1A), the 
deregulated gene expression was more evident in mutant keratinocytes carrying R204W and 
R304W than those carrying R279H (Figure 1D). Taken together, our RNA-seq analyses showed 
downregulation of epidermal differentiation genes and upregulation of non-epidermal genes 
in p63 mutant keratinocytes, suggesting that p63 mutant keratinocytes have a less defined 
epidermal cell identity. 
 To better visualize the interaction between DE genes, we carried out Weighted Gene-
Coexpression Correlation Network Analyses using the Cytoscape Network Analyzer (Tables 
S1J and K). Two significant co-expression modules were identified, of which many genes 
were involved in ‘keratinization’ (e.g. LOR and FLG) and ‘nucleosome assembly’ (Figures 1E 
and S2A, Table S1L). Most genes in both modules showed downregulated expression in p63 
mutant keratinocytes. The upregulated genes in p63 mutant keratinocytes did not generate 
significant main modules but several small sub-network modules. They likely played roles in 
‘extracellular matrix organization’ (Table S1L). However, the higher inter-modular connectivity 
between ‘keratinization’, ‘nucleosome assembly’ and ‘extracellular matrix organization’ 
modules suggests a biological relationship between these modules, indicating that changes 
in the chromatin landscape may contribute to gene deregulation. Consistent with this notion, 
many chromatin regulators were deregulated in p63 mutant keratinocytes (Figure S2B). 
These factors include KAT2B which is a histone acetyltransferase and SMYD3 which encodes 
a histone methyltransferase. The deregulation of these genes was confirmed with RT-qPCR 
(Figure S2C).
p63 orchestrates enhancer dynamics during epidermal differentiation 
Given the indicated relationship between p63 and the chromatin landscape, we first assessed 
the role of p63 in regulating the chromatin landscape during normal epidermal differentiation. We 
mapped histone modifications H3K27ac, H3K4me3, and H3K27me3, as well as p63 binding sites 
(BSs) of control keratinocytes to open chromatin regions detected by DNase I Hypersensitivity 
Sites (DHSs) in Normal Human Epidermal Keratinocytes (NHEK) reported byENCODE 
(Table S2). Two clusters of active enhancers (C3 and C4) were bound by p63 (Figures S3A-C).
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Figure 1: Transcriptome dynamics of control and p63 mutant keratinocytes during differentiation. (A) 
EEC p63 mutant keratinocytes used in this study. (B) The setup of in vitro differentiation of epidermal 
keratinocytes. (C) Principal component analysis (PCA) on RNA-seq data. Two independent control lines 
and three p63 mutant lines are indicated with different colors. Shapes indicate four stages. (D) Hierarchical 
clustering of differentially expressed genes (P value <0.05). Z-score was calculated based on log10 
(FPKM+0.01) of each gene. Enriched top two Gene Ontology (GO) terms of genes per gene expression 
cluster (EC) are shown. (E) Co-expression network of deregulated genes in p63 mutant keratinocytes 
during differentiation. Interactions with connectivity weight > 0.1 were shown. Two main co-expression 
modules were labelled with corresponding GO terms. The node color indicates the expression fold change 
between mutant and control keratinocytes. See also Figure S1, Figure S2 and Table S1.
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Regions in C3 showed higher p63 binding signals. GO annotation using the Genomic Regions 
Enrichment of Annotation Tool (GREAT) which permits functional interpretation of cis-
regulatory regions (McLean et al., 2010) showed that nearby genes were involved in ‘apoptosis’ 
and ‘epidermis development’. Regions in C4 had relatively lower p63 binding signals and 
nearby genes were involved in ‘keratinocyte differentiation’ (Figure S3C). Furthermore, cluster 
C7 represents a small group of open chromatin regions with H3K27me3 signals but devoid of 
p63 binding (Figure S3A). Genes near these regions were associated with ‘pattern specification 
process’, such as ‘neuron fate commitment’ (Figure S3C).
 To quantify chromatin dynamics, we used  ChromHMM (Ernst and Kellis, 2012) to analyze 
chromatin state transitions. With the combination of H3K27ac, H3K4me3 and H3K27me3, we 
obtained six classes of chromatin states; active enhancers, active promoters, weak promoters, 
heterochromatin regions, bivalent promoters and ‘unmodified’ regions that were not decorated 
with any of the three modifications (Figure 2A, Tables S2B and C). By pair-wise comparison 
between two adjacent stages of differentiation, we observed major transitions between active 
enhancers and unmodified regions as well as between unmodified regions and heterochromatin 
regions (Figure 2B). As expected, we found that the transition from unmodified regions to active 
enhancers was generally associated with gene upregulation; vice versa, the transition from 
active enhancers to unmodified regions was associated with gene downregulation, at least at 
early differentiation stages (day 0 to day 2, and day 2 to day 4) (Figure 2C), e.g. regulation of LOR 
(Figure 2D) and KRT1 (Figure S3D). Furthermore, there were also transitions between active 
promoters and unmodified regions (Figure S3E). Interestingly, many genes that are known to 
be expressed in cells of mesodermal origin, e.g. PAX2, were heavily marked by H3K27me3 
in proliferating keratinocytes (day 0). The repression was relieved at the end of the terminal 
differentiation of keratinocytes (Figure S3F). 
 Next, we asked whether specific TFs control the enhancer dynamics during differentiation. 
Therefore, we performed motif analysis of dynamic enhancers with the HOMER package 
(Figure 2E). We observed that bZIP, p53/p63, Zf, and TEA motifs were enriched in regions being 
activated from unmodified regions on day 0 to active enhancers on day 2, while p53/p63 was 
the only enriched motif in regions being activated from unmodified regions on day 2 to active 
enhancers on day 4. The bZIP motif was predominantly enriched in regions being activated 
from unmodified regions on day 4 to active enhancers on day 7, whereas the p53/p63 motif 
was the only enriched motif in regions changing from active enhancers on day 4 to unmodified 
regions on day 7 (Figure 2E). The temporal enrichment of p63 motifs in dynamic enhancers 
underscores the key role of p63 in orchestrating the enhancer landscape during keratinocyte 
differentiation. 
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Figure 2: Chromatin dynamics during control keratinocyte differentiation. (A) Emission states of the 
ChromHMM Hidden Markov Model distinguishing six combinations defined by three histone modifications: 
H3K27ac, H3K4me3, and H3K27me3. ‘Unmodified regions’ refers to genomic regions that do not have any 
of these modifications. (B) Alluvial plots of pair-wise chromatin state transitions during differentiation. 
The column height represents the percentage of each of the chromatin state relative to the sum of the 
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six states. Genomic regions defined as ‘unmodified regions’ at all differentiation stages were excluded in 
this analysis. The percentages of active enhancers, unmodified regions, and the heterochromatin were 
labelled. (C) Pair-wise comparison of differential gene expression (fold change) associated with genomic 
regions that shift between unmodified regions and active enhancers during differentiation, corresponding 
to (B). Data are shown as mean ± standard deviation, unpaired T-test, ** P value <0.01, *** P value <0.001. 
(D) Chromatin state dynamics of unmodified regions and active enhancers during differentiation at the 
locus of LOR. (E) Significantly enriched motifs in the dynamic enhancer regions. Red dots, motifs that 
were enriched in regions shifting from unmodified regions to active enhancers; blue dots, motifs that were 
enriched in regions shifting from active enhancers to unmodified regions. See also Figure S3 and Tables 
S2.
Decreased active enhancers associated with p63 binding deficiency in p63 mutant 
keratinocytes
Based on the DNA-binding deficiency of EEC mutants shown by various studies and the 
dominant negative model, we expected to detect DNA binding loss in p63 mutant keratinocytes. 
To characterize this and to evaluate the effect of p63 mutations on the enhancer landscape, 
we performed p63 ChIP-seq using a p63 antibody that is not affected by mutations in the p63 
DNA-binding domain (Figure S4A) (Shen et al., 2013), and H3K27ac ChIP-seq in all three 
p63 mutant keratinocytes. A total number of 33,366 p63 binding sites (BSs) detected in both 
control and mutant keratinocytes were analyzed, and we observed globally reduced p63 binding 
signals in p63 mutant keratinocytes as compared to the control keratinocytes (Figure 3A and 
Tables S3A-E). It should be noted that no clear increased p63 binding or de novo p63 BSs were 
observed in p63 mutant keratinocytes. K-means clustering analysis showed that p63 BSs can 
be clustered into three groups based on the binding signals. Clusters p63-C1 and p63-C2 had 
decreased p63 binding to a lesser extent, whereas loci in p63-C3 showed more dramatic to 
almost complete loss of p63 binding signals (Figure 3A). The p63 binding pattern was not much 
changed in mutant keratinocytes during differentiation (Figure S4D). Accordingly, the difference 
of H3K27ac signals at p63-C1 and p63-C2 between the control and p63 mutant keratinocytes 
was not obvious, whereas a decrease of H3K27ac signals was detected at p63 C3 in p63 mutant 
keratinocytes (Figure 3A and S4B).
 Using GREAT GO annotation to assess nearby genes, all three clusters of p63 BSs were 
significantly enriched for genes involved in ‘epidermis development’ (Figure 3B). We also 
performed human phenotype analyses to investigate the disease significance of these p63 
BSs, and detected disease terms were mainly related to ectodermal dysplasia such as ‘plantar 
hyperkeratosis’, ‘nail dystrophy’ and ‘alopecia’ (Figure S4C). We further explored whether 
a specific molecular mechanism controls the discordant p63 binding losses. We examined 
whether the cooperation with different co-regulating TFs contributes to the differential p63 
binding loss by motif scanning but did not find significant differential p63 co-regulators 
explaining the discordant p63 binding loss (Tables S3H-J). Next, using our previously established
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Figure 3: Decreased active enhancers associated with p63 binding deficiency. (A) K-means clustering of 
p63 binding sites (BSs) that are merged from control and p63 mutant keratinocytes groups p63 BSs into 
3 classes (k = 3, metric = Pearson). Heat maps and band plots are shown in a 4-kb window with summits 
of p63 BSs in the middle. Color intensity in heat maps represents normalized read counts. In the band 
plots, the median enrichment was visualized as the black line while 50% and 90% ranges were depicted 
in lighter color, respectively. (B) GREAT-based Gene Ontology biological process annotation of p63 BSs in 
each cluster. (C) p63 motif strength determined the selectivity of the loss of p63 binding. The top panel, 
pie charts showing the percentage of p63 BSs with a p63 motif; the bottom panel, box plot showing motif 
score distribution. Data are shown as mean ± standard deviation, one-way ANOVA, ***P value < 0.001. (D) 
Percentage of deregulated genes associated with all p63 BSs and p63 BSs from p63-C3 (p63 C3) compared 
with all annotated genes. Hypergeometric test, ***P value < 0.001. (E) ChIP-seq of p63 and RNA-seq data 
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at the RUNX1, EHF, SMYD3 and KAT2B loci in control and p63 mutant keratinocytes. Red bars represent 
p63 BSs that were lost/decreased in p63 mutant keratinocytes. See also Figure S4 and Table S3.
p63scan algorithm (Kouwenhoven et al., 2010), we found that p63-C3 BSs sites had the lowest 
percentage of BSs with p63 motif (85%) and the lowest average motif score (mean motif score 
of 8.3), as compared to p63-C1 (98% and mean motif score of 9.5) and p63-C2 (93% and mean 
motif score of 8.8) BSs (Figure 3C and Tables S3K-N). Our observations thus suggest that p63 
motif strength determines the selectivity of the loss of p63 binding.
 Lastly, we examined whether gene deregulation was associated with impaired p63 binding. 
Genes near p63 BSs (all three p63-C1, C2 and C3) had a significantly larger proportion of 
deregulated genes (34.8%, P value = 0, hypergeometric test) when compared to all annotated 
genes (12.5%) (Figure 3D and Table S3F). A significant difference in the percentage of 
deregulated genes was also found from genes associated with p63-C3 BSs (35.4%, P value = 0, 
hypergeometric test), as compared to all genes with p63 BSs (Table S3G). These data indicate 
that impaired p63 binding significantly contributed to deregulated gene expression, for both 
up- and down-regulation (Figure 3E). 
 In summary, we showed that EEC mutations can result in loss of p63 binding and loss 
of active enhancers. The loss of p63 binding is apparently motif strength-dependent. p63 
binding loss can lead to gene deregulation and potentially contribute to ectodermal dysplasia 
phenotypes.
Re-distribution of enhancers in p63 mutant keratinocytes
Although a significant percentage of the deregulated genes (~54%) associated with impaired 
p63 binding nearby, a large number of deregulated genes did not seem to be directly regulated 
by p63. Furthermore, we observed many enhancers with unexpected increased H3K27ac 
signals near deregulated genes in p63 mutant keratinocytes (Figure 4A, blue shaded regions). 
Therefore, we compared H3K27ac between control and p63 mutant keratinocytes with MAnorm 
(Shao et al., 2012). We identified 17,931 genomic regions that had significantly higher H3K27ac 
signals in mutant keratinocytes (referred to as ‘mutant-specific enhancers’), more than the 
15,057 regions that had significantly higher H3K27ac in control keratinocytes (referred to as 
‘control-specific enhancers’) (Figure S5A and 4B, Table S4). Two replicas of H3K27ac ChIP-seq 
in R304W mutant keratinocytes showed a high correlation (a Pearson correlation coefficient of 
0.94, Figure S5B), demonstrating the high reproducibility of these datasets. To validate these 
findings, H3K27ac ChIP-qPCR was performed on three ‘control-specific’ and three ‘mutant-
specific’ enhancer loci (Figure S5C). Genes nearby control-specific enhancers were associated 
with ‘keratinocyte differentiation’, whereas those nearby mutant-specific enhancers were 
involved in cell cycle regulation, migration and non-epithelial processes (Figure 4C). 
Furthermore, a significantly larger proportion of deregulated genes had either control-specific 
or mutant-specific H3K27ac sites (Figure 4D). As expected, control-specific enhancers were 
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associated with gene downregulation, whereas mutant-specific enhancers were associated 
with gene upregulation in p63 mutant keratinocytes (Figure 4E). Taken together, the observed 
genome-wide redistribution of enhancers marked by H3K27ac indicates that epigenome 
rewiring occurs in p63 mutant keratinocytes. 
 To investigate the underlying mechanisms of enhancer re-distribution, a de novo motif scan 
was performed. We detected the p53/p63 motif family as the top enriched motif among control-
specific enhancers (Figure 4F and Table S4I), consistent with the impaired p63 binding and 
loss of active enhancers in p63 mutant keratinocytes (Figure 3A). In contrast, motif analyses 
of mutant-specific enhancers captured motifs of bZIP, TEA, HMG and Runt family TFs (Table 
S4M). These data suggest that aberrant recruitment of TFs induces gain of enhancers. 
 One scenario of aberrant recruitment of TFs may result from the abnormal upregulation 
of TFs in mutant keratinocytes. To assess this possibility, we examined differential expression 
of TFs. Among 1581 examined TFs (Saeed et al., 2014), 106 and 103 TFs were down- and 
up-regulated, respectively, in p63 mutant keratinocytes (Figure S6). Interestingly, most 
downregulated TFs had p63 BSs nearby, and therefore they are potential p63 direct targets. 
In contrast, fewer upregulated TFs had p63 BSs. To predict candidate TFs that are potentially 
bound to mutant-specific enhancers, we used two criteria: i) TFs whose binding motifs were 
enriched in mutant-specific enhancers (Figure 4F); ii) TFs that were upregulated in all three 
p63 mutant keratinocytes at the proliferation stage (day 0) (Figure S6A). Among TFs that were 
consistently up-regulated in mutant keratinocytes, RUNX1 and SOX4 belong to the TF families 
whose motifs were enriched in mutant-specific enhancers. We performed RT-qPCR validation 
to confirm the higher expression of SOX4 in p63 mutant keratinocytes (Figure S6B). ChIP-
qPCR of SOX4 also confirmed a number of SOX4 BSs with higher binding signals in R304W 
mutant keratinocytes, as compared to control keratinocytes (Figure S6C). Interestingly, one 
of the candidate TFs RUNX1 is a known p63 target (Masse et al., 2012) and a potential p63 co-
regulator. RUNX1 had many lost p63 BSs in the gene locus and was consistently upregulated in 
p63 mutant keratinocytes (Figures 3E and S6A). 
CHAPTER 5
140
Figure 4: Redistribution of enhancers in p63 mutant keratinocytes. (A) Examples of re-distributed 
enhancers marked by H3K27ac signals between control and p63 mutant keratinocytes. Black boxes 
indicate lost p63 BS with lost/decreased H3K27ac signals. Blue shades indicate gained enhancers in p63 
mutant keratinocytes. (B) Heat maps of differential H3K27ac peaks in control and p63 mutant keratinocytes 
shown in a 4-kb window with summits of H3K27ac peaks in the middle. Colour intensity in heat maps 
represents normalized read counts. (C) GREAT-based GO biological process annotation of differential 
enhancers. (D) Percentage of deregulated genes relative to all genes associated with active enhancers, all 
or control- or mutant-specific enhancers. Hypergeometric test, ***P value < 0.001. (E) Differential gene 
expression (fold change) associated with control or mutant-specific enhancers. Data are shown as mean ± 
standard deviation, unpaired T-test, *** P value <0.001. (F) Highly enriched motifs found in control-specific 
or mutant-specific enhancers. See also Figure S5 and Table S4.
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Deregulated p63 and RUNX1 cooperation contributes to transcriptional rewiring in mutant 
p63 keratinocytes
To characterize p63 and RUNX1 co-regulation, we performed RUNX1 ChIP-seq in control 
keratinocytes. K-means clustering of RUNX1 BSs in combination with p63 binding and histone 
modification profiles showed that RUNX1 and p63 preferentially co-bound in active enhancer 
regions (Figure 5A). RUNX1 bound more frequently to active promoters marked by H3K4me3 
(RUNX1-C4) than p63 (RUNX1-C1 and RUNX1-C3) (Figure 5A and Table S5A). Genes near 
the co-regulated enhancers (RUNX1-C1 and RUNX1-C3, e.g. ITGB1 and EGFR) were mainly 
involved in ‘epidermis development’ and ‘programmed cell death’, respectively (Figures 5B and 
5C). The observed upregulation of RUNX1 expression (Figure 5D) and loss of p63 binding in the 
RUNX1 gene body in p63 mutant keratinocytes (Figure 3E) indicated that deregulation of RUNX1 
expression is probably due to loss of p63 control. To further confirm this, we performed siRNA 
knockdown of p63 in control keratinocytes. Similar to the upregulated RUNX1 expression in 
p63 mutant keratinocytes, RUNX1 expression was significantly increased in p63 knockdown 
keratinocytes (Figure 5E). 
Figure 5: RUNX1 is a co-regulator and target gene of p63. (A) K-means clustering of RUNX1 BSs in 
control keratinocytes. RUNX1 binding signals were shown in heat maps in a 4-kb window with summits 
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of RUNX1 BSs in the middle (k = 4, metric = Pearson). Color intensity represents normalized read counts. 
(B) GREAT-based GO biological process annotation of RUNX1 BSs in RUNX1 C1 and C3. (C) Representative 
example of RUNX1 and p63 co-regulated genes ITGB1 and EGFR. (D) Validation of RUNX1 gene expression 
by RT-qPCR and western blotting. In RT-qPCR analysis, relative gene expression was normalized to the 
reference gene hARP. Data are shown as mean ± standard deviation, technical replicates n=2, two-way 
ANOVA, NS P value > 0.05, *** P value <0.001. Actin was used as a loading control for the quantification of 
RUNX1 protein level (shown as percentage) in western blotting. (E) Gene expression analysis by RT-qPCR 
of TP63 and RUNX1 expression in TP63 knockdown (siTP63) compared to non-targeting siRNA (siNT) in 
control keratinocytes. Gene expression was normalized to the reference gene hARP. Data are shown as 
mean ± standard deviation, technical replicates n=2, two-way ANOVA, ***P value < 0.001. See also Figure 
S6 and Table S5.
To assess whether upregulated RUNX1 expression leads to its aberrant recruitment to 
mutant-specific enhancers in p63 mutant keratinocytes, we compared RUNX1 binding in 
control keratinocytes and R304W mutant keratinocytes (Figure 6A and Tables S5B-D). Among 
all RUNX1 BSs, there were 7,918 RUNX1 BSs with higher binding signals and 7,898 sites 
with lower binding signals in R304W mutant keratinocytes (Tables S5B-F). RUNX1 BSs with 
increased binding signals in R304W mutant keratinocytes were more often located in active 
enhancer regions accompanied by increased H3K27ac signals (Figure 6B and Table S5E), while 
those with decreased RUNX1 binding signals were more often located in promoter regions 
(Figures S7A and B, Table S5F). 
 To test whether increased RUNX1 expression is responsible for deregulating gene 
expression in p63 mutant keratinocytes, we performed RUNX1 knockdown in R304W mutant 
keratinocytes. As the proper RUNX1 expression level is important for cell proliferation (Hoi et 
al., 2010; Masse et al., 2012), we carefully titrated RUNX1 siRNA oligonucleotides to achieve a 
similar level of RUNX1 expression to that in control keratinocytes. RNA-seq analyses showed 
that the overall gene expression of siRUNX1-treated R304W mutant keratinocytes was more 
similar to that of control keratinocytes in PCA (Figure S7C). Among the 3,294 upregulated 
genes in R304W mutant keratinocytes, 276 genes were significantly rescued down-regulated 
upon siRUNX1 (Figure 6C, Tables S5H and I), e.g. KRT8 (Figure S7E). Many of the rescued 
genes were involved in adhesion and other non-epithelial functions such as ‘angiogenesis’. 
Importantly, among the 3,187 downregulated genes in R304W mutant keratinocytes, 218 genes 
were significantly rescued, with upregulated expression upon siRUNX1 (Figure 6D, Tables S5J 
and K), for example, KRT1 and HES5 (Figures 6E and S7D). Many of these genes are important 
for epidermal development and keratinocyte differentiation. The number of rescued genes 
was significantly higher than random expectations (276/3294, hypergeometric test P value < 
7.272e-102; 218/3184, hypergeometric test P value < 4.305e-54). Partial but significant rescues 
by siRUNX1 was expected, as deregulated genes caused by loss of p63 binding in p63 mutant 
keratinocytes could not simply be rescued by RUNX1 knockdown. RT-qPCR and western 
blotting experiments validated rescued gene expression of KRT1, SMYD3, and KRT18 in
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Figure 6: Increased RUNX1 binding contributes to gene deregulation. (A) K-means clustering of RUNX1 
BSs from control and R304W mutant keratinocytes were shown in heat maps in a 4 kb window with summits 
of merged RUNX1 BSs in the middle (k = 2, metric = Pearson). Color intensity represents normalized 
read counts. (B) Zoom-in re-clustering of increased RUNX1 BSs in R304W mutant keratinocytes, showing 
majority of RUNX1 BSs with increased signals are enhancers. (C) 276 significantly upregulated genes 
in R304W mutant keratinocytes that were rescued with siRUNX1 (P value <0.05). The significance of the 
overlap was calculated with hypergeometric test (P value < 7.272e-102). Expression (RNA-seq FPKM) of 
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rescued genes under different conditions are shown as mean ± standard deviation. T-test, ***P value 
< 0.001. DAVID-based GO biological process annotation is shown at the bottom. (D) 218 significantly 
downregulated genes in R304W mutant keratinocytes that were rescued with siRUNX1 (P value <0.05). 
The significance of the overlap was calculated with hypergeometric test (P value < 4.305e-54). (E) UCSC 
genome browser screenshots of RNA-seq data at the gene loci of KRT1 and KRT8 were shown, as examples 
of rescued genes by siRUNX1. (F) Gene expression analyses by RT-qPCR of RUNX1, KRT1 and SMYD3. 
Relative gene expression of these genes was normalized to the reference gene hARP. Data are shown as 
mean ± standard deviation, technical replicates n=2, two-way ANOVA, *P value < 0.1, **P value < 0.01, ***P 
value < 0.001. (G) Western blotting analysis of RUNX1 and KRT18. Actin was used as the loading control. (H) 
Decreased H3K27ac signals upon siRUNX1 treatment at the enhancers that had higher signals in R304W 
mutant keratinocytes (panel B enhancer regions). (I) The UCSC genome browser screenshot at gene locus 
of NRP1, as examples of rescued enhancers, highlighted in pink. See also Figure S7 and Table S5.
R304W mutant keratinocytes upon siRUNX1 (Figures 6F and G). To further investigate whether 
siRUNX1 can rescue the enhancer landscape in R304W mutant keratinocytes, we performed 
H3K27ac ChIP-seq in these cells. Indeed, we observed a clear decrease of H3K27ac signals at 
enhancers that had higher H3K27ac signals and bound by RUNX1 in p63 mutant keratinocytes 
(Figure 6B, N=6035) in two biological replicas (Figures 6H and S7E), e.g. enhancers near NRP1 
that is involved in angiogenesis (Figure 6I). Taken together, our data suggest that reversing 
upregulated RUNX1 expression can rescue deregulated gene expression and the enhancer 
landscape in p63 mutant keratinocytes.
DISCUSSION
The master regulator role of p63 in epidermal development has been established by many 
studies using in vitro and in vivo models. However, it remains unclear how p63 mutations affect 
the chromatin landscape and gene expression that contribute to diseases. In this study, we 
used EEC patient-derived skin keratinocytes carrying heterozygous p63 DNA-binding domain 
mutations as the cellular model to characterize the global gene regulatory alteration. We 
showed that the epidermal cell identity was compromised in p63 mutant keratinocytes, as 
indicated by downregulated epidermal genes and upregulated non-epithelial genes. In addition 
to loss of p63 binding leading to reduced p63-bound active enhancers, we unexpectedly observed 
abnormally induced active enhancers that were bound by upregulated p63 co-regulators such 
as RUNX1. Reversing RUNX1 upregulation in p63 mutant keratinocytes rescued a part of the 
deregulated gene expression and altered enhancer landscape. Our data suggest an intriguing 
model whereby rewiring of the enhancer landscape, contributed by both loss of p63-bound 
active enhancers and gain of active enhancers induced by overexpressed p63 co-regulators, 
gives rise to gene deregulation and phenotypes of EEC syndrome (Figure 7).  
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 Many epidermal genes were downregulated in mutant keratinocytes, consolidating the 
key role of p63 in epidermal development. In addition, upregulated mesenchymal genes and 
neuronal genes in mutant keratinocytes (Figure 1D) suggest that these cells have less defined 
epidermal cell fate. For example, mesodermal related genes such as ACTA2 and COL4A1 
which were upregulated during epidermal commitment of p63-depeleted embryonic stem cells 
(Shalom-Feuerstein et al., 2011) were also upregulated in p63 mutant keratinocytes (Table S1E). 
In agreement, gene co-expression network analyses showed that the scattered upregulated 
genes involved in ‘extracellular matrix organization’ were connected with two modules 
‘keratinization’ and ‘nucleosome assembly’ associated with downregulated genes in mutant 
keratinocytes (Figure 1E). This suggests that gene expression in p63 mutant keratinocytes 
deviates from the proper epidermal cell fate to establish a new differentiation direction through 
chromatin remodelling processes. In addition to directly regulating chromatin remodelling 
factors (Figure S2B), we showed in this study that p63 motif was most significantly enriched in 
active enhancers at early differentiation stages (Figure 2E). These results support the pivotal 
role of p63 in regulating enhancers to activate epidermal differentiation genes, especially at the 
initiation stage. 
 In addition to its activator role for epidermal genes, it has been shown that p63 can 
function as a repressor to repress p21 (CDKN1A) through recruiting HDAC1/2 (LeBoeuf et al., 
2010; Ramsey et al., 2011). RUNX1, a co-regulator of p63, is regulated by p63 in a complex 
fashion. Depending on the differentiation state of keratinocytes, p63 activates or represses 
RUNX1 expression (Masse et al., 2012). In our analyses, we detected upregulation of RUNX1 
in proliferating mutant keratinocytes (Figures 3E and 5D), consistent with the repressor 
role of p63 for these genes. However, p63-bound enhancers at the RUNX1 locus were active 
enhancers, marked by H3K27ac, in contrast to classically defined repressed regions that are 
marked by H3K27me3 and H3K9me3. Furthermore, no H3K27me3 or H3K9me3 repression mark 
was found at any p63 BS (Kouwenhoven et al., 2015), indicating that p63-bound enhancers are not 
repressed by the polycomb- or heterochromatin-related mechanisms. To reconcile the apparent 
contradiction that p63 binds to active enhancers to repress gene expression, we speculate 
that p63 binds to these active enhancers to fine tune expression of these genes by recruiting 
repressors such as HDACs.  When p63 expression or function is compromised, such as in p63 
mutant keratinocytes or in p63 knockdown cells (Figures 5D and E), the fine tuning or repression 
mechanisms are relieved and the expression of these genes is enhanced (Figure 7B). 
 In this study, we showed that p63 binding loss and loss of active enhancers occurs at a 
genome-wide scale in patient keratinocytes carrying heterozygous EEC mutations (Figure 3A). 
This indicates that the mutant p63 protein has a dominant negative effect on DNA binding 
over the wild type p63 that is also present in the cell, likely because the p63 protein is DNA-
binding competent as a tetramer (Serber et al., 2002; Dötsch et al., 2010). These genome-
wide findings corroborate the dominant negative model of EEC p63 mutations that has been 
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proposed by several previous studies using in vitro approaches and allele-specific knockdown 
of p63 mutant. 
 Unexpectedly, we observed a large number of gained active enhancers in all three p63 
mutant keratinocytes (Figures 4A and B, Figure S5A). These mutant-specific enhancers were 
enriched for motifs of TFs that normally cooperate with p63 in keratinocytes (Figure 4F). Many 
of these TFs were deregulated in p63 mutant keratinocytes (Figure S6), and are direct p63 
targets, such as RUNX1 (Figures 3E and 5D). This indicates that rewiring of the transcriptional 
program is not only contributed by loss of p63-bound active enhancers but also by an indirect 
effect of altered expression of p63 co-regulating TFs. ChIP-seq analyses revealed an altered 
RUNX1 binding profile in p63 mutant keratinocytes (Figure 6A). The increased RUNX1 binding 
was associated with increased H3K27ac signals (Figure 6B). Intriguingly, reversing RUNX1 
expression upon siRUNX1 could partially rescue gene deregulation and the enhancer landscape 
(Figures 6C-I), indicating that overexpression of RUNX1 in mutant keratinocytes contributes to 
gene deregulation and is at least partially responsible for the differentiation defects. Therefore, 
mutations in the p63 DNA-binding domain can give rise to an indirect gain-of-function effect 
by inducing aberrant binding of deregulated TFs to genome-wide enhancers (Figure 7C).
Figure 7: Model of p63-controlled gene regulation and cell identity in control and p63 mutant 
keratinocytes. (A) p63-mediated activation of epidermal genes. In control keratinocytes, p63 activates 
epidermal genes by binding to nearby active enhancers, in cooperation with co-regulating TFs and 
chromatin factors (CFs). In p63 mutant keratinocytes, mutant p63 cannot bind to these enhancers, which 
results in downregulation of epidermal genes. (B) p63-mediated fine tuning of its co-regulators. In control 
keratinocytes, p63 fine-tunes the expression of its co-regulators such as RUNX1 and SOX4. In p63 mutant 
keratinocytes, mutant p63 cannot bind to these enhancers and lose the fine-tuning control. (C) Indirect 
activation of enhancers due to lack of p63 control. Overexpressed p63 co-regulators such as RUNX1 can 
bind to less controlled open chromatin regions and enhancers to activate non-epidermal genes in p63 
mutant keratinocytes. 
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It should be noted that this gain-of-function model of p63 EEC mutations is different from 
the gain-of-function mechanism of a p63 mutation leading to phenotypically distinct ADULT 
syndrome (Rinne, Brunner and van Bokhoven, 2007) and p53 mutations that give rise to 
cancers. It has been shown that some p53 mutants involved in cancer cannot bind to bona fide 
p53 targets, but cooperate with normal p53 co-regulators and bind to ectopic genomic sites to 
activate abnormal gene expression (Zhou et al., 2014; Zhu et al., 2015), a classical paradigm 
of gain-of-function. The most apparent difference between p53 and p63 EEC mutations is that 
EEC mutant p63 does not seemingly bind to ectopic genomic loci, as we did not observe any 
novel p63 BS in mutant keratinocytes (Figure 3A). The indirect gain-of-function action of p63 
mutations is due to the overexpression of p63 co-regulating TFs such as RUNX1 and their 
aberrant recruitment to mutant-specific enhancers. 
 In the siRUNX1 experiment, we did not expect a full rescue in p63 mutant keratinocytes, 
as p63 binding loss could not simply be rescued by RUNX1 downregulation. With the same 
rationale, we also do not expect that overexpression of RUNX1 would fully mimic p63 mutant 
keratinocyte phenotypes. However, it would be interesting to test whether overexpression of 
RUNX1 in control keratinocytes can induce any differentiation defects. Furthermore, it is also 
of interest to further test the effect of other overexpressed p63 co-regulators such as TFs of the 
bZIP, TEA and HMG families (SOX4) (Figure 4F) in the EEC disease mechanism. It is conceivable 
that knockdown of multiple such overexpressed TFs may rescue differentiation defects of p63 
mutant keratinocytes to a better extent.
 In conclusion, we identified a rewired enhancer landscape as a common mechanism in EEC 
p63 mutant keratinocytes. The enhancer rewiring includes loss of p63-bound active enhancers 
that regulate epidermal genes (Figure 7A) and gain of enhancers bound by overexpressed 
TFs that are normally fine-tuned by p63 (Figures 7B and C). It is conceivable that, in EEC p63 
mutant keratinocytes, the chromatin environment is less tightly controlled, and deregulated 
TFs can therefore bind to more exposed enhancers. The rewired enhancer landscape gives 
rise to gene deregulation that contributes to the less-defined epidermal cell fate and skin 
phenotypes of the disease. Taken together, the enhancer landscape rewiring contributes to the 
disease mechanism of p63 mutations, and may be common to many other diseases. 
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STAR METHODS
CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will 
be fulfilled by the Lead Contact, Huiqing Zhou (j.zhou@science.ru.nl; jo.zhou@radboudumc.nl).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Human primary keratinocyte
All procedures for establishing and maintaining human primary keratinocytes were approved 
by the ethical committee of the Radboud university medical centre (“Commissie Mensgebonden 
Onderzoek Arnhem-Nijmegen”). Informed consent was obtained from all donors of a skin 
biopsy. Primary keratinocytes were established previously from skin biopsies of three EEC 
syndrome patients carrying heterozygous mutations in the p63 DNA-binding domain, R204W 
(van Bokhoven et al., 2001), R279H (Brunner, Hamel and Van Bokhoven, 2002), and R304W 
(Celli et al., 1999), as well as of two healthy volunteers (Dombi23 and PCK19, referred to as 
Control) (Rheinwald and Green, 1977). Sex of the control keratinocytes is unknown because 
they are derived from the anonymous donors. 
METHOD DETAILS
Cell culture
Primary keratinocytes were cultured in Keratinocyte Basal Medium supplemented with 100 
U/mL Penicillin/Streptomycin, 0.1 mM ethanolamine, 0.1 mM O-phosphoethanolamine, 
0.4% (vol/vol) bovine pituitary extract, 0.5 µg/mL hydrocortisone, 5 µg/mL insulin and 10 ng/
mL epidermal growth factor. Medium was refreshed every other day. When cells were more 
than 90% confluent (day 0), differentiation was induced by depletion of growth factors in 
addition to cell contact inhibition, as described previously (Van Ruissen et al., 1996). Cells 
were collected at four differentiation stages, proliferation (day 0), early differentiation (day 
2), mid differentiation (day 4), and late differentiation (day 7) for subsequent experiment. No 
mycoplasma contamination is found during cell culture.
RNA extraction and quantitative real-time reverse transcription PCR (RT–qPCR)
Total RNA was isolated using the NucleoSpin RNA kit and quantified with NanoDrop. cDNA 
synthesis from 1 µg freshly prepared total RNA was carried out using the iScript cDNA 
synthesis kit. Reverse transcription quantitative PCR (RT-qPCR) primers were designed using 
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Primer3 to obtain exon spanning primers wherever possible. Each primer set has been tested 
for its linear amplification dynamic range. RT-qPCRs were performed in the CFX96 Real-
Time system (Bio-Rad) by using iQ SYBR® Green Supermix according to the manufacturer’s 
protocol. The human acidic ribosomal protein (hARP) or glucuronidase beta (GusB) was used 
as the housekeeping gene for normalization. Differences in the expression of each gene during 
differentiation (relative expression) were calculated by 2ΔΔCt method (Livak and Schmittgen, 
2001). Sequences of all RT-qPCR primers were provided in Table S1C. 
Western blotting
A total of 12.5 µg protein was loaded for each sample. The actin antibody (1:100,000) was used 
to control equal protein loading. Protein extracts were run on SDS PAGE and transferred to 
PVDF membranes using the NuPAGE system (Life Technologies). LumiGLO (Cell Signaling 
Technology Inc.) was used for chemiluminescent detection by the Bio-Rad Universal Hood Gel 
Imager (Bio-Rad Laboratories). Antibodies used in this study include LOR (1:2500), RUNX1 
(1:50), K18 (1:500). All the original blots were provided in Table S6.
RNA-seq and analysis pipeline
RNA-seq experiment was performed as described previously (Kouwenhoven et al., 2015) with 
the starting material of 500 ng total RNA, to obtain double-strand cDNA (ds-cDNA). After 
purification with the MinElute Reaction Cleanup Kit, 3 ng ds-cDNA was processed for library 
construction using KAPA Hyper Prep Kit according to the standard protocol except that a 
15-minute USER enzyme incubation step was added before library amplification. The prepared 
libraries were quantified with the KAPA Library Quantification Kit, and then sequenced in 
a paired-ended manner using the NextSeq 500 (Illumina) according to standard Illumina 
protocols.
 Sequencing reads were aligned to human genome assembly hg19 (NCBI version 37) 
using STAR 2.5.0 (Dobin et al., 2013) with default options. A detailed summary of RNA-seq 
data generated in this study was shown in Table S6A. For data visualization, wigToBigWig 
from the UCSC genome browser tools was used to generate bigwig files and uploaded to 
UCSC genome browser. Genes with the mean of DESeq2-normalized counts (“baseMean”)> 
10 were considered to be expressed. Differential gene expression (adjusted P value < 0.05) 
and principal-component analysis were performed with the R package DESeq2 using read 
counts per gene (Love, Huber and Anders, 2014). Hierarchical clustering was performed based 
on log10 (FPKM+0.01). Functional annotation of genes was performed with DAVID (Huang, 
Sherman and Lempicki, 2009). For Weighted Gene Co-expression Network Analysis (WGCNA 
(Langfelder and Horvath, 2008)), only high variance genes (adjusted P value < 0.01, sum of 
baseMean > 100, 3162 genes) between control keratinocytes and p63 mutant keratinocytes 
during differentiation were included. WGCNA clustering within p63 mutant keratinocyte 
samples was performed using power of 26 and the minimum module size of 15. A total of 16 
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co-expression modules were identified based on gene co-expression patterns (Table S1J). To 
visualize the gene network organization, only nodes (genes) with connectivity weight > 0.1 were 
kept (Table S1K). Cytoscape (Smoot et al., 2011) was used for gene network visualization.
ChIP-seq and analysis pipeline
Chromatin for ChIP was prepared as previously described (Kouwenhoven et al., 2010). ChIP 
assays were performed following a standard protocol (Novakovic et al., 2016) with minor 
modifications. Antibodies against H3K27ac (1.2 µg), H3K4me3 (1 µg), H3K27me3 (1.5 µg), p63 
(1 µg, recognizing the C-terminal α tail of p63) and RUNX1 (4 µg) were used in each ChIP assay. 
Resulted DNA fragments from four independent ChIP assays were purified and subjected 
to a ChIP-qPCR quality check. Afterwards 5ng DNA fragments were pooled and proceeded 
on with library construction using KAPA Hyper Prep Kit according to the standard protocol. 
The prepared libraries were then sequenced using the NextSeq 500 (Illumina) according to 
standard Illumina protocols.
 Sequencing reads were aligned to human genome assembly hg19 (NCBI version 37) 
using BWA (Li and Durbin, 2009). Mapped reads were filtered for quality, and duplicates were 
removed for further analysis. A detailed summary of ChIP-seq data generated in this study was 
shown in Table S6B. In addition, the bamCoverage script was used to generate and normalize 
bigwig files with the RPKM formula. The peak calling was performed with the MACS2 (Zhang 
et al., 2008) against a reference input sample from the same cell line with standard settings 
and a q value of 0.05. Only peaks with a P value < 10e-5 were used for differential analysis with 
MAnorm (Shao et al., 2012). Association of peaks to genes and associated GO annotation were 
performed with GREAT (McLean et al., 2010). P values were computed with a hypergeometric 
distribution with FDR correction. k-means clustering and heat map and band plot generation 
were carried out with a Python package fluff (Georgiou and van Heeringen, 2016). H3K27ac 
ChIP-seq analyses of control and mutant keratinocytes, including those performed in siRUNX1 
experiments, were performed in duplicates. The ‘plotCorrelation’ function from the deepTools 
package was used and the Pearson correlation coefficient was calculated accordingly (Ramírez 
et al., 2014).
ChomHMM analysis
Chromatin states were characterized using ChromHMM v1.11 (Ernst and Kellis, 2012). The peak 
files from three tracks (H3K27me3, H3K4me3, and H3K27ac) across four stages were used as 
input. The six-emission state model was determined to be optimal which could sufficiently 
capture the biological variation in co-occurrence of chromatin marks. The segmentation files 
of the six emission states per stage were binned into 200 bp intervals. An M × N matrix was 
created, where M corresponds to the 200 base pair intervals and N to the developmental stages 
(N=4). Each element x (m, n) represents the chromatin state of interval m at stage n. For each 
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chromatin group, occurrences were counted per stage N (Table S2C). The changes between 
stage N and N+1 were plotted pair-wise using Sankey diagrams (http://sankeymatic.com/).
Motif analysis
Previously described p63scan algorithm was used for p63 motif evaluation (Kouwenhoven 
et al., 2010). HOMER (http://homer.salk.edu/homer/motif/) was used for motif scan against 
corresponding background sequences. 
siRNA nucleofection
Nucleofection was performed as described previously (Mulder et al., 2012) using the Amaxa 
96-well shuttle system (Lonza, program FF113). In short, keratinocytes were harvested with 
Accutase® solution and resuspended in nucleofector buffer SF (Lonza). Each 20 µL transfection 
reaction contained 200,000 cells mixed with 2 µM validated siRNA (Silencer Select siRNAs, 
Ambion/Applied Biosystems). In siRUNX1 experiments, siRUNX1-1 oligo was used for the RNA-
seq experiment and siRUNX1-2 oligo was used for the western blot experiment. Both siRUNX1 
oligoes were used in the RT-qPCR and H3K27ac ChIP-seq experiments. After transfection, 
the samples were incubated for 10 minutes at room temperature before resuspension in KBM 
and seeding at 50.000 cells per well (12 well plate). Medium was refreshed each day for the 
indicated periods till the end of experiments.
QUANTIFICATION AND STATISTICAL ANALYSIS
Data are expressed as mean ± standard deviation error of the mean unless otherwise specified. 
Data set statistics were analysed using the GraphPad Prism software. Differences under P < 0.05 
were considered statistically significant, NS P value > 0.05, * P value <0.05, ** P value <0.01, *** 
P value <0.001. Gene expression analysis by RT-qPCR was performed in biological duplicates 
(n>=2); data are shown as mean ± standard deviation, two-way ANOVA. The comparison of 
gene expression (fold change) was analyzed with the unpaired T-test. Hypergeometric test 
was performed with the online tool GeneProf. The comparison of gene expression after siRNA 
knockdown was performed with T-test. Other statistical methods used in this study were 
specified in the Figure legends.
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DATA AND SOFTWARE AVAILABILITY
To review dataset of control cells, go to GEO database (accession GSE98483) (https://www. 
ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE98483). To review our complete dataset in Genome 
Browser, please go to https://genome.ucsc.edu/cgi-bin/hgTracks?hgS_doOtherUser= 
submit&hgS_otherUserName=Jieqiong%20QU&hgS_otherUserSessionName=hg19_p63_
RUNX1_Jieqiong
 To review dataset of p63 patient cells, go to dbGaP database (accession phs001737.v1.p1) 
with controlled access (https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_
id=phs001737.v1.p1). 
 All data supporting the findings of the study and in-house codes are available on request.
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SUPPLEMENTAL FIGURES
Figure S1: Differentiation defects in p63 mutant keratinocytes, related to Figure 1. (A) Morphology 
difference observed between control and p63 mutant keratinocytes. Multi-layer structures are indicated 
with red circles. All scale bars, 50 µm. (B) Gene expression validation analysis by RT-qPCR and western 
blot. Gene expression was normalized to the expression of GusB (reference gene). Primer information is 
provided in Table S1C. Data are shown as mean ± standard deviation, n=2, two-way ANOVA, NS P value 
> 0.05, * P value <0.05, ** P value <0.01, *** P value <0.001. Expression of the epidermal marker gene, 
Loricrin, was also validated by western blot at the protein level. Actin was used as a loading control. (C) 
A UCSC genome browser screenshot of RNA-Seq tracks at the TP63 gene loci. Expression of TA-specific 
exons were not detected.  
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Figure S2: Deregulated gene network and chromatin factors in p63 mutant keratinocytes, related to 
Figure 1: (A) Visualization of representative hub genes in ‘nucleosome assembly’ module and ‘keratinization’ 
module using the Cytoscape Network Analyzer. (B) Gene expression heatmap of differentially regulated 
chromatin factors (P value <0.01 and fold change >2) in p63 mutant keratinocytes. Nearby p63 binding sites (p63 
BSs) of these genes are indicated, black, with at least one p63BS; white, without p63BS. Z-score is calculated 
based on log10 (FPKM+0.01) of each gene. (C) Gene expression analysis by RT-qPCR of KAT2B and SMYD3. 
Relative gene expression is shown based on normalization to expression the reference gene GusB. Data are 
shown as mean ± standard deviation, n=2, two-way ANOVA, * P value <0.05, ** P value <0.01, *** P value <0.001. 
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Figure S3: Characterization of the epigenetic landscape during control keratinocytes differentiation, 
related to Figure 2. (A) Signal heat map of several histone marks during keratinocyte differentiation at 
open chromatin regions detected by DNase I Hypersensitivity Sites (DNase I). K-means clustering groups 
DNase I peaks into seven classes (k = 7, metric = Pearson). Heat maps are plotted in a 4 kb window with 
summits of DNase I peaks in the middle. Colour intensity represents normalized read counts. (B) Band 
plots that quantifies the signals in the heat map shown in (A). The number of regions in each cluster 
is illustrated at the bottom. (C) Characterization of the active enhancer clusters and heterochromatin 
cluster. Top bar charts, the distance between detected regions and their putatively regulated genes; 
bottom bar charts, top three enriched GO biological processes annotated with GREAT. (D) An example of 
chromatin state dynamics (unmodified regions and active enhancers) during differentiation at the gene loci 
of KRT1. (E) An example of chromatin state dynamics (unmodified regions and active promoters) during 
differentiation at the gene loci of KRT10. (F) An example of chromatin state dynamics (heterochromatin 
regions and unmodified regions) during differentiation at the gene loci of PAX2. 
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Figure S4: Decreased H3K27ac and p63 signals in p63 mutant keratinocytes, related to Figure 3. (A) 
p63 antibody can recognize mutant p63 as well as wild type p63. Proteins were isolated from control 
keratinocytes infected with virus expressing wild type, R304W, or T533P mutant p63 at proliferation and 
differentiation stages. a-tubulin was used as the loading control. (B) Band plots of H3K27ac ChIP-seq 
signals in each p63 cluster. The median enrichment was visualized as a black line while 50% and 90% 
ranges were depicted in lighter colour, respectively. (E) GREAT-based human phenotype annotation of p63 
BSs in each cluster. (D) Stable p63 binding pattern in R304W mutant keratinocytes during differentiation 
on day 0, day 2, and day 7. 
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Figure S5: Transcriptional rewiring in p63 mutant keratinocytes, related to Figure 4. (A) Differential 
H3K27ac signals in control and p63 mutant keratinocytes shown by the MAplots. Each dot represents 
an H3K27ac peak. Blue dots represent regions with significantly higher H3K27ac signals in control 
keratinocytes (Control-specific enhancers, P value <e10-5, M value >1); red dots represent regions with 
significantly higher H3K27ac signals in p63 mutant keratinocytes (R279H, R204W, and R304W-specific 
enhancers, from left to right, P value < 10e-5, M value < -1). Gray dots indicate non-differential peaks. 
(B) Scatterplot showing correlation of signal intensity of H3K27ac peaks between the two replicas. 
Value displayed is the Pearson correlation coefficient. (C) H3K27ac ChIP-qPCR validation of differential 
enhancers detected in the MAplots. Information about these three ‘control-specific’ enhancers and three 
‘mutant-specific’ enhancers is detailed in Table S1C. Input normalized fold change is relative to both input 
DNA and negative control loci (myo). Data are shown as mean ± standard deviation, n=2, two-way ANOVA, 
NS P value > 0.05, ** P value <0.01, *** P value <0.001. 
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Figure S6: Deregulated TFs, related to Figure 4. (A) Significantly downregulated (left) and upregulated 
(right) TFs in p63 mutant keratinocytes (P value <0.01 and fold change >2) shown by heat maps. Nearby 
p63 BS of these genes are indicated, black, with at least one p63 BS; white, without p63 BS. TFs are 
grouped according to families. Z-score is calculated based on log10 (FPKM+0.01) to indicate the level of 
expression. (B) Validation of SOX4 gene expression analysis by RT-qPCR. Gene expression is normalized 
to the expression of GusB (reference gene). Primer information is provided in Table EV1C. Data are shown 
as mean ± standard deviation, n=2, two-way ANOVA, NS P value > 0.05, *** P value <0.001. (C) SOX4 ChIP-
qPCR performed in control and R304W mutant keratinocytes. Primer information about these SOX4 binding 
sites is detailed in Table EV1C. Input normalized fold change is relative to both input DNA and negative 
control loci (myo). Data are shown as mean ± standard deviation, n=2, two-way ANOVA, *** P value <0.001.
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Figure S7: Reversing upregulated RUNX1 expression in p63 mutant keratinocytes can partially rescue 
deregulated gene expression and enhancer landscape, related to Figure 6. (A) K-means clustering of 
merged RUNX1 binding sites combined from control keratinocytes and R304W mutant keratinocytes are 
shown in heat maps in a 4 kb window with summits of RUNX1 in the middle (k = 2, metric = Pearson). Colour 
intensity represents normalized read counts. (B) Zoom-in re-clustering of decreased RUNX1 binding sites 
in R304W mutant keratinocytes. (C) PCA plot on RNA-Seq data of RUNX1 knockdown in R304W mutant 
keratinocytes (R304W siRUNX1) and non-targeting siRNA treated keratinocytes (R304W siNT). The gene 
expression pattern of R304W siRUNX1 (red triangle) is closer to control keratinocytes (black triangle) 
than that of R304W siNT (pink triangle) and that of R304W mutant keratinocytes (grey triangle) at the 
proliferation condition. (D) An example of rescued downregulated genes by RUNX1 knockdown. The UCSC 
genome browser screenshot of RNA-Seq tracks at gene loci of HES5. (E) Scatterplot showing correlation 
of signal intensity of H3K27ac peaks between the two biological replicas in R304W mutant keratinocytes 
treated with siRUNX1. Value displayed is the Pearson correlation coefficient.  
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SUPPLEMENTARY TABLES
These files are available online at https://www.sciencedirect.com/science/article/pii/
S2211124718318023?via%3Dihub
Table S1. Transcriptomic characterization, related to Figures 1, S2 and S6.
Gene loadings of top 500 genes in PCA analysis. Lists of differential expressed genes and GO 
annotation in different clusters between control keratinocytes and mutant keratinocytes during 
differentiation. Lists of genes in different modules from the co-expression network analysis.
Table S2. Chromatin state characterization, related to Figures 2 and S3.
ChromHMM analysis of chromatin states. Chromatin landscape clustering during control 
keratinocytes differentiation.
Table S3. p63 binding difference, related to Figure 3.
Lists of p63 BSs in control keratinocytes and p63 mutant keratinocytes. Lists of p63 BSs in 
different clusters. List of motif scan results in each cluster.
Table S4. Enhancer redistribution, related to Figures 4 and S5.
Lists of H3K27ac BSs in control keratinocytes and p63 mutant keratinocytes. Significantly 
stronger H3K27ac BSs in control keratinocytes compared with p63 mutant keratinocytes on 
day0 with MAnorm (p<e10-5). Significantly stronger H3K27ac BSs in p63 mutant keratinocytes 
compared with control keratinocytes on day0 with MAnorm (p<e10-5). GREAT annotation of 
control-specific enhancer peaks and mutant-specific enhancer peaks. Lists of Homer known 
motif enriched in control-specific enhancers and mutant-specific enhancers.
Table S5. RUNX1 binding difference, related to Figures 5, 6 and S7.
Clustering of RUNX1 binding in control keratinocytes. Lists of RUNX1 BSs in control 
keratinocytes and R304W mutant keratinocytes. Lists of increased and decreased RUNX1 BSs 
in R304W mutant keratinocytes. Lists of rescued upregulated and downregulated genes in 
R304W mutant keratinocytes compared to control keratinocytes with RUNX1 knockdown. 
Table S6. Original data, related to Figures S1, 5, 6 and the STAR Methods.
RNA-seq and ChIP-seq dataset summary and original western blots.
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As our understanding of biological processes improves, so does our appreciation for their 
complexity. There is an astonishing number of genes working together regulating tissue 
homeostasis, repair and proliferation. This is of particular importance for epithelial tissues 
such as the intestinal track, breast tissue or the skin as these are continuously renewed. 
This high renewal rate requires tight regulation of gene expression programs governing the 
balance between proliferation and differentiation. It is important that this is strictly controlled, 
because aberrant regulation of gene expression programs governing these processes could 
lead to uncontrolled growth or differentiation defects, which can disturb the barrier function. 
In the work presented in this thesis, we studied regulatory mechanisms controlling the 
balance between proliferation and differentiation in epidermal stem cells. These are in place 
to ensure that erroneous regulation and its consequences are kept at a minimum to avoid the 
development of serious malignancies such as for instance cancer or psoriasis. 
 To truly understand the system, we need to appreciate how processes are interconnected 
and how they influence each other. This knowledge would allow proper interrogation of new 
treatment strategies in a comprehensive way, taking along as many variables as possible. 
Cellular responses are the result of the combination of the states of all these variables, which 
are regulated in carefully coordinated sequence of events. This often starts from internal or 
external cues which are transmitted through signalling pathways, frequently leading to changes 
in the gene expression program. Throughout these steps genes work together providing control 
over these cellular responses, on the level of DNA, RNA or protein. We characterised parts of 
this regulatory system using different approaches, considering the contribution of signalling 
pathways, transcriptional and post-transcriptional mechanisms. We furthermore considered 
how these genes and mechanisms work together regulating epidermal self-renewal and 
differentiation, discovering functional interactions between seemingly unconnected genes.
 Here, I will consider the contribution of these different elements and mechanisms to 
epidermal homeostasis starting from the role of signalling pathways and their interplay, 
continuing with transcription factor networks and functional interactions between genes. It is 
important to understand how genes and biological processes are interconnected as this can 
provide us with important new insights into healthy and perturbed systems.
THE EGF PATHWAY IN EPIDERMAL BIOLOGY
Although the DNA can be considered the cellular blueprint, the regulatory mechanisms that 
are responsible for proper gene expression regulation shape the cellular response. Changes 
in gene expression happen often downstream of signalling pathways which transmit internal 
or external cues. In the skin, EGF signalling is one of the most important signalling pathways 
regulating proliferation of epidermal stem cells. Its activity controls gene expression directly 
but also activation of or interplay with other signalling pathways.
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The switch from proliferating to differentiating is accompanied by a decrease in EGF-signalling 
activity and an increase in activity of other, differentiation related, signalling pathways. This 
means that its activity is important for the proliferative state, but its timely de-activation might 
be important for differentiation.
The interplay between EGF signalling and adhesion/BMP signalling 
Keratinocytes in the basal layer mainly receive proliferative signals from EGF and their 
connection to the basal membrane. The interplay between EGF and adhesion related 
signalling is necessary to maintain a proliferative population as cells do not proliferate in 
absence of activity of either of these pathways (Moreno-Layseca and Streuli, 2014). There is 
also mechanistic link between these pathways, as integrin mediated adhesion leads to the 
assembly of a macromolecular complex that can phosphorylate the EGFR (Moro et al., 2002). 
Furthermore, this link plays an important role in scar formation, where mechano-sensoring of 
tissue stiffness via adhesion related signalling can mediate EGF signalling (Kenny et al., 2018). 
 This interplay between EGF- and adhesion related- signalling is just one example of 
functional connections between signalling pathways. There is also evidence for crosstalk 
between EGF- and Notch- signalling (Kolev, Mandinova, Guinea-Viniegra, Hu, Lefort, 
Lambertini, Neel, Dummer, Erwin F Wagner, et al., 2008) and EGF- and Wnt- signalling (Ji 
et al., 2009) in keratinocyte biology. Notch signalling is negatively regulated by EGF signalling 
through a mechanism involving transcriptional repression of p53 via the activation of c-Jun. 
Wnt- signalling is also affected by activation of EGF signalling, as EGFR activation causes the 
disruption of α- and β- catenin complex.
 EGF signalling activity itself does not necessarily have to be related to activity of other 
signalling pathways. On the contrary, its absence might enable the activation of other pathways, 
marking a consecutive phase in differentiation. In Chapter 4, we found that the inhibition of EGF 
signalling triggers the activation of BMP signalling. Moreover, we show that the expression of 
a late differentiation transcription program is dependent on the activation of this signalling 
pathway. This group of genes contains several which are important for cornification and several 
which have been implicated in diseases (including SPINK5, (Netherton syndrome), PKP1, CDH3 
and Nectin4 (Epidermal displacia), DSP (Keratoderma)). 
The role of expression dynamics and heterogeneity in signalling activity in a cell 
population
Epidermal differentiation is defined by a carefully coordinated sequence of events in which 
signalling pathways play an important role in communicating the state of interconnected 
systems. The activation of BMP signalling following inhibition of the EGFR might in this case 
mark the initiation of the next phase in differentiation. The interdependency between signalling 
pathways and their activation dynamics during differentiation make signalling pathways key 
players in a potentially timed mechanism.
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 Such a mechanism could aid the coordination of epidermal differentiation to ensure proper 
organisation of the differentiated layers. Cells need to synchronize their differentiation states as 
they move up through the different layers of the skin, fine-tuning the expression of appropriate 
markers and functional structures. Next to regulating these gene expression programs, 
signalling pathways facilitate in cell to cell communication, as they can initiate responses 
that propagate through neighbouring cells (Gaudet and Miller-Jensen, 2016). An important 
example of this phenomena is the activation of ERK pulses after sustained stimulation of the 
EGFR. With a pulse frequency depending on the concentration of EGF and cell-density, the 
activation of ERK propagates to adjacent cells and regulates cell proliferation (Aoki et al., 
2013). Possibly, these and other mechanisms of autocrine and paracrine signals around the 
cells create gradients of signalling molecules similar to gradients of morphogens determining 
developmental axes in a developing embryo (Briscoe and Small, 2015). In the skin, this might 
be recapitulated in the activation of different signalling pathways during different phases of 
epidermal differentiation, creating distinct areas that are associated with differentiation state. 
This would allow synchronisation of the cell states that are in the same layer making sure 
cornification proceeds in a coordinated manner. Although such a mechanism would make the 
cells behave similarly, it does not mean all the cells are doing the same thing. There might be 
zones within the layers based on gradients of signalling molecules with cells that direct certain 
cellular responses. In chick epidermis for instance, there are specific growth zones that are 
mediated by Wnt signalling (Chodankar et al., 2003) showing that zonated activity of signalling 
pathways can also comprise heterogeneity.
 Similar as in tissues, a stem cell population in in vitro cultures can also harbour cells 
with different cell states. We captured some of this heterogeneity based on activation of 
signalling pathways in Chapter 4. There, we use a single cell based technique enabling the 
characterisation of the states of signalling pathways in a stem cell population; scID-seq. Cells 
were sorted based on the expression of ITGB1 and stained with antibody-DNA conjugates. By 
ranking the cells based on differentiation state reflected by ITGB1 levels we found different 
levels of signalling pathway activities correlated with differentiation. This showed the variety of 
different states for signalling pathway activity in this stem cell population (Chapter 4, Figure 
2F-H). This technique could be used to study the activation patterns of signalling pathways 
in groups of cells in time, or to identify rare cells. Additionally, the actual characterisation of 
signalling pathways and how they are functionally interconnected is interesting in light of how 
they can represent the state of the system. By understanding their interplay and regulation, 
we could use their activation state as a readout and possibly improve predictions of (clinical) 
outcome or design more efficient (combinatorial) therapies.
 Ultimately, many of the signals that are transmitted lead to changes in gene expression 
that facilitate the appropriate response. The transitions in morphology and general cell 
structure require major changes in transcription programs, which is regulated by genes that 
are downstream of signalling pathways.
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Gene expression downstream of EGF signalling
There are many genes directly regulated by modulation of EGF signalling, most importantly via 
some transcription factors regulating proliferation and differentiation. The AP-1 transcription 
factor for instance regulates gene expression programs that mediate in the proliferative state 
or repress initiation of differentiation (Eckert et al., 2013). Some of these genes seem more 
specifically attuned to EGF signalling and the proliferative state of the keratinocytes, as we 
discovered for BLNCR, a lncRNA that is adjacent to ITGB1 (Chapter 3). 
 The proximity of this lncRNA to the ITGB1 locus made us wonder if there was a mechanistic 
link between these genes. Given the interplay between EGF- and adhesion related signalling 
this would be an interesting possibility. Hypothetically, the transcriptional activity at the 
lncRNA locus could enhance expression of ITGB1, either via a direct (in cis-) interaction or via 
increasing the local concentration of transcription factor machinery (Engreitz et al., 2016).
 We used siRNAs and esiRNAs to transiently knockdown BLNCR to evaluate if the expression 
of ITGB1 would be affected. Additionally, this would show if the downregulation of the lncRNA is 
enough to start epidermal differentiation, informing us on the potential role of this transcript. 
Unfortunately, both the esiRNAs and the siRNAs did not efficiently reduce the mRNA levels 
of the lncRNA (data not shown). Because of the proximity of the two genes and the possibility 
that the promotor region of BLNCR interacts with the ITGB1 gene we did not try to make 
(CRISPR-Cas9) knockouts. In that case, we would not have been able to distinguish between 
the possibility that either the presence of the BLNCR transcript affects ITGB1 expression or 
that this is regulated by the promotor of BLNCR. Blocking the promotor using a CRISPR-dCas 
system would also lead to inconclusive results as the presence of the repressor not just prevents 
transcription of the transcript but might also interfere with promotor/enhancer-promotor 
interactions. Alternatively, it could be that the expression of BLNCR is not functionally related 
to the expression of ITGB1 but rather is a side-product of ITGB1 expression. I do not think this 
is the case, because if the expression of BLNCR is only a result of a high concentration of 
transcription machinery in the proximity of the important ITGB1 locus its expression dynamics 
would be similar to that of ITGB1. Instead, it is downregulated faster than ITGB1 and seems 
to coincide with the reduction in proliferation for keratinocytes treated with AG1478. The then 
following downregulation of ITGB1 coincides with the reduction in adhesive capacity after 
treatment with AG1478. 
 Although we were not able to find out if there was a mechanistic link between BLNCR 
and ITGB1, we were able to link the expression of the lncRNA to the proliferative state of 
keratinocytes. It would be interesting to check the expression of this lncRNA in different types 
of cancer, to see if its expression persists in cells that remain proliferative in general or that 
this is related to keratinocytes. Additionally, it would be interesting to find out if downregulation 
of BLNCR is a prerequisite for epidermal differentiation. However, this would require better 
reagents to knockdown or remove the transcript without interfering the potential 3D interactions 
between the TSSs of ITGB1 and BLNCR. 
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Although it is clear that BLNCR expression is sensitive for EGF signalling and activity of MEK 
was shown to be necessary for BLNCR expression, this link hardly represents the whole 
regulatory mechanism. Activation of a signalling pathway is followed by a flurry of activity 
of that involves multiple processes and genes. These jointly regulate the cellular response, 
working together on the level of signalling, transcriptional and post-transcriptional processes. 
TRANSCRIPTION FACTOR NETWORKS – REGULATORY NETWORKS IN 
EPIDERMAL DIFFERENTIATION
As with the interplay between signalling pathways, transcription factors also form intricate 
networks that regulate epidermal differentiation. It is not surprising that master regulator 
P63 is in the midst of these regulatory transcription factor networks. Binding of P63 regulates 
the expression of genes that are important for the regulation of epidermal self-renewal 
and differentiation, which includes a number of transcription factors. In some cases, one 
transcription factor can regulate the expression of the next, leading to complex regulatory 
loops. These transcription factor networks can be used as visualisation of how gene expression 
is regulated by multiple transcription factors, working in parallel or through sequential 
activation.
A transcription factor network downstream of P63
As the spider in the web of epidermal differentiation it is also not surprising that mutations 
in this gene can lead to serious problems during skin development and homeostasis. The 
dominant negative mutations in the DNA binding domain of P63 contribute to 90% of EEC 
syndrome cases. This syndrome leads to ectodermal dysplasia and severe defects in the 
epidermis and its appendage, limb malformation and cleft lip/palate (Rinne, Brunner and van 
Bokhoven, 2007). In Chapter 5, we studied the altered binding of mutated P63, showing that 
this causes deregulation of the expression of several transcription factor families (bZIP, TEA, 
HMG and RUNX families). The overexpression of these co-regulators also contributes to the 
observed phenotype as they can in their turn cause aberrant expression. This leads to the 
expression of genes from non-epidermal lineages such as the mesenchymal and neuronal 
fate lead which are less relevant for the epidermal lineage. This undoubtedly contributes to 
the observed defects in differentiation in vivo and in vitro, where these cells fail to produce a 
fully stratified epidermis. Interestingly, it was possible to partially reverse the phenotype by 
silencing RUNX1, suggesting that combinatorial correction of the overexpressed transcription 
factors might improve this further.
 This again emphasizes the importance of considering how genes work together regulating 
biological processes. It shows that one mutation does not only affect the processes it directly 
regulates but also downstream processes, reverberating through the whole system. By looking 
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at transcriptional control from a network based perspective we would be able to appreciate how 
processes are linked, which genes form important hubs and which genes might be redundant.
Adding the next layer of regulation; a transcription factor network downstream of BMP 
signalling
Ideally, such a network would also incorporate signalling pathway activity, as these interpret 
and translate internal and external cues and can determine the outcome of a cellular response. 
In Chapter 4, we show that the MAF/MAFB/ZNF750 axis is activated downstream of BMP 
signalling. ZNF750 controls a gene expression program that includes important regulators 
of epidermal differentiation such as fillagrin, loricrin LCE3B, ALOXE3 and SPINK5 (Sen et al., 
2012). Its promoter is bound by p63 and MAF/MAFB (Sen et al., 2012; Lopez-Pajares et al., 
2015) which regulate its expression. We showed that ZNF750 is not a direct target of BMP 
signalling, but seems to be activated as a secondary effect through activation of MAF/MAFB 
which are more directly downstream of BMP signalling (Chapter 4, Figure 4). Interestingly, the 
activation of this axis is also controlled by other important regulators of the epidermal fate; 
lncRNAs TINCR and ANCR (Lopez-Pajares et al., 2015), as well as by master regulator P63 
(Miyai et al., 2016). Combining our observations with the ones described in literature presents 
a multifaceted regulatory mechanism for ZNF750 expression involving signalling pathways, 
non-coding RNAs and transcription factors. This is yet another example of the complexity of 
transcriptional regulation and how regulation of biological processes is interconnected on 
multiple levels. The sequential activation of transcription factors is an important element in 
the carefully timed regulation of gene expression programs during the different phases of 
epidermal differentiation.
 Although the connections between these genes has been validated, the observations are 
based on global profiling techniques such as RNA sequencing and ChIP- sequencing. These 
types of experiments are based on abundance and dependent on detection limits but do not 
consider for instance transcript functionality. Additionally, biological activity of enzymes and 
other proteins is also dependent on affinity or threshold amounts that are necessary in order to 
work properly. These parameters can change depending on the state of the cell and possibly the 
abundance or activity of other (seemingly unrelated) transcripts. Although the global profiling 
techniques are great to characterise biological systems and their response to perturbations, 
finding functional interactions requires a different approach. 
HOW GENES WORK TOGETHER; THE POWER OF PREDICTING FUNCTIONAL 
INTERACTIONS
To find out the contribution of genes to the regulation of epidermal differentiation we performed 
large scale siRNA based screen as described in Chapter 2. This produced phenotypic profiles 
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describing the effect of expression perturbation in five different conditions during epidermal 
differentiation. The phenotypic profiles are compared and genes that affect differentiation 
similarly and possibly share functional connections predicted using an elegant Bayesian 
mixture model. 
 This approach allows for the exploration of functional interactions between genes, as the 
prediction does not require elaborate combinatorial knock down or knockout experiments 
as with normal genetic interaction screens. Based on the effect of their perturbation during 
for instance epidermal differentiation, it can predict if genes regulate similar processes. This 
is based on the idea that if genes share a functional connection, their perturbation results 
in a similar effect on the phenotype (Costanzo et al., 2010). Finding these interactions aids 
in identifying functional redundancy between genes, which is important when trying to 
understand a deregulated system. Additionally, this experimental set-up also makes it possible 
to determine if there is a (functional) dependency on a gene during epidermal differentiation. 
Functional interaction predictions reveal a regulatory role for ZMAT2
Through the usage of the Bayesian mixture model we identified a link between genes active 
in processes that were previously thought unconnected. The predictions revealed a functional 
connection between genes involved in diverse epigenetic mechanisms and ZMAT2 (Chapter 2). 
It is interesting to speculate about the potential regulatory mechanism behind our observations 
and the information found in literature. Previously published data on the structure of and 
interactions within the spliceosome indicate that ZMAT2 theoretically does not interact with 
the spliced transcript and argues for a more general regulatory role in the process of splicing. 
However, our observations suggest a distinct role for ZMAT2 in epidermal differentiation, which 
is potentially regulated by a splicing mediated mechanism.
 Arguing against a more general, non-targeted mechanism for ZMAT2 controlled splicing 
are the nature of the transcripts associated with ZMAT2, the more distinct differential exonic 
region usage and the effect on the differentiation state of the cells. Firstly, the physical 
association of adhesion related transcripts with ZMAT2 is a very strong indicator that ZMAT2 
and its interactors associate with a distinct group of transcripts. This is not solely based on 
abundance, as the GAPDH transcript which is highly expressed is not among this group. 
Secondly, when comparing the differential usage of exonic regions of silencing SRSF1 and 
ZMAT2, the effect of silencing SRSF1 is far more extensive than that of ZMAT2. SRSF1 has a 
confirmed role in splicing and is potentially active in the same stages as ZMAT2, as we showed 
it to be an interactor of ZMAT2 (Chapter 2, Figure 4B). Silencing SRSF1 leads to more exonic 
regions differentially used which affects more different genes and biological processes. This 
is also recapitulated in differential expression analysis comparing siZMAT2 with siSRSF1 (data 
not shown, differentially expressed genes: siSRSF1: 496 genes, siZMAT2: 47 genes). Thirdly, 
based on the expression of differentiation markers, silencing SRSF1 or ZMAT2 also affect 
the differentiation state different functionally. Although SRSF1 is clearly important for proper 
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regulation of epidermal biology (Chapter 2, Figure S6) silencing the gene did not impact the 
differentiation state as dramatically as silencing ZMAT2 did. This means that functionally, 
ZMAT2 has a more specific role in the regulation of epidermal biology, arguing against a 
general, non-targeted mechanism for ZMAT2. These combined observations strongly indicate 
that ZMAT2 is involved in the regulation of epidermal self-renewal (and possibly differentiation) 
via a mechanism that involves spliceosomal activity.
 These findings make the earlier mentioned functional interactions with the epigenetic factors 
extra interesting, as it means we discovered a functional connection between transcriptional 
and post-transcriptional processes. Although it makes sense that downstream processes 
are connected, it is interesting that we have identified genes that are active across different 
mechanisms that regulate the same process. This means that with this approach it is possible 
to identify interactions without a bias, transcending the labelling of a gene based on regulatory 
mechanism. Furthermore, although a connection between processes that are downstream of 
each other sounds logical, it is not always a given that genes share functional connections. 
For instance, based on experimental data it is doubtful that SRSF1 would end up in the same 
functional interaction network as ZMAT2. Even though the two genes are both interactors of 
the pre-spliceosome, they affected the differentiation state differentially. Functionally, the role 
of SRSF1 targeted transcripts seems to concern more general processes, whereas ZMAT2 and 
the other functional network interactors are involved in the regulation of adhesion. 
The versatility of the experimental setup allows the interrogation of other systems or 
processes
The experimental set-up of the screens described in Chapter 2 is very well suited to expand 
into other types of genes and processes. If the reagents are sufficiently effective in perturbing 
the expression of kinases, miRNAs and lncRNAs, the functional network could be expanded 
including their contributions. Alternatively, instead of perturbing expression of genes, 
inhibitors that impact the kinase activity and other enzymes could also be applied. These 
experiments could also be used to answer different questions, by changing the cell type and 
induced biological process. As long as the readout antibodies are of sufficient quality the siRNA 
based screen could be used to identify functional interactions in all sorts of processes. One 
interesting option would be to check for the acquisition of epithelial mesenchymal transition 
(EMT) related markers in epithelial carcinoma cells upon siRNA based perturbation of genes 
and induction of EMT. EMT is a process in which cells that have adopted the epithelial fate shift 
to a more migratory or invasive fate and can be used as a model for metastasis (Nieto et al., 
2016). Performing the siRNA based screens in such a system would not only identify genes 
that are involved in this process but would also enable the prediction of functional interactions 
between these genes. This would provide vital information about how genes cooperate to 
regulate EMT and would potentially give us important insights in the regulation of metastasis.
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 Something that could improve the quality of the predictions further would be using more 
markers as a read-out. The current experimental set-up relies on the expression of TGM1 and 
although this has proven to be a reliable marker for differentiation, including more markers 
would increase its power. Using the current immunofluorescence based in cell western would 
mean amplification of the already high number of samples, as combining measurements 
in the same population is limited by spectral overlap. Another possibility is using ID-seq; a 
method that allows multiplexing of protein-level measurements in the same population (van 
Buggenum et al., 2016, 2018). By labelling antibodies with DNA barcodes and combining them 
in a library preparation procedure, high through-put measurements of multiple phenotypes 
becomes a possibility. These measurements could be combined to generate even more complex 
phenotypic profiles and potentially more confident predictions of functional interactions.
Functional interactions provide another layer of regulatory information
The functional connections are important to consider when designing combinatorial 
treatments. By identifying functional interactions between genes from seemingly unrelated 
processes a disease can be targeted via multiple fronts, potentially increasing the efficiency 
and reducing side-effects. By using the Bayesian network prediction algorithm, the genes 
are sorted by functional association and through this, we here identified an alliance of genes 
regulating adhesion. This shows the power of this platform and its potential to contribute to 
the identification of other functional connections. It is vital to look at biological systems from a 
systems view and taking transcript functionality into consideration to be able to identify these 
connections adding a new layer of regulatory information.
CONCLUDING REMARKS AND FUTURE PERSPECTIVES
The work presented in this thesis clearly shows that epidermal biology is regulated on many 
different levels. The interplay between signalling pathways, transcription factors and splicing 
paints a complex picture describing mechanisms controlling proliferation and differentiation. 
The exciting part is that this is just the tip of the iceberg and that there is much more to explore. 
The effect of the 3D environment on stem cell behaviour
One factor that should be carefully considered in epithelial systems is the effect of the 3D 
environment on stem cell behaviour. In the epidermis, it is well established that adhesion plays 
an important role in the regulation of proliferation and differentiation. The physical properties 
of the matrix surrounding the cells not only determines spacial constraints but the nature 
of the interactions and stiffness of the matrix is also important. The concentration of ECM 
components such as integrins, type IV collagen and fibronectin plays a role in epidermal 
differentiation, but biophysical factors such as growth area and the stiffness of the material 
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might be more determinant for the stem cell fate (Chermnykh, Kalabusheva and Vorotelyak, 
2018; Kenny et al., 2018).
 Another interesting thing to consider in relation is if the ECM and connections between 
cells contribute to the distribution of the gradients of signalling molecules surrounding the 
cells. These gradients of signalling molecules that are excreted are important to keep the 
cells synchronised as they go through the different layers of the skin. Although differentiation 
might be a process following expression programs adhering to strict timing per phase, it is 
likely that this is regulated through the changing composition of the gradient. Something 
similar is proposed to explain the role of morphogen gradients in developing embryos (French 
Flag model) but other theories are also considered (Wolpert, 1969; Gordon and Gordon, 2016). 
For the adult skin, these transitions in gradients seem to be confined to certain areas in the 
epidermis, which could be the result of an actively timed process or one that is more passive. On 
the one hand, the gradients might be maintained actively by the cells, which as they go through 
the different phases of differentiation secrete different molecules. On the other hand, the cells 
might be more attuned to the extracellular environment and the changing nature of physical 
interactions between cells. Moving up through the different layers of the skin these structural 
changes might impact tissue stiffness and limit diffusion of signalling molecules through 
interactions based on electrostatics, hydrophobicity or possibly even sterical hinderance.
 The biophysical constraints the cells face, as well as the nature of the gradient of signalling 
molecules that surround them represent yet another important layer of regulation to consider 
when studying cellular behaviour. However, this would require a multi-layered system that 
cannot be captured in regular cultures. Two-dimensional cultures can be perfectly used to 
find interesting leads, findings should be functionally validated in a 3D environment. Although 
animal models have been used a lot in this regard and provide unparalleled possibilities to 
study biological systems in (early) development, these are not always the best option. Fact 
remains that there are many differences with the human system which sometimes results in 
failure to translate a promising lead to the human system.
 One interesting option is to use 3D organotypic models such as the one described in Chapter 2. 
This system offers the possibility to culture primary human cells, either from healthy donors 
or from patient’s cells. This makes it possible to study the effect of expression perturbations 
or lead compounds in a functionally relevant environment. Another added advantage would be 
that this system also enables co-culture set-ups in which the interaction with immune-cells 
or micro-organisms can be studied (Niehues et al., 2018). Although such an elaborate culture 
set-up would capture more of the involved regulatory levels, it however remains an artificial 
system and findings should therefore be critically evaluated.
The importance of appreciating how genes and processes are connected 
The connections between regulatory levels via signalling pathways, transcription factor 
networks and functional interaction networks should be carefully considered. In case of for 
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instance the mutated DNA binding domain of P63 described in chapter 5 there is a clear 
indication that downstream deregulated transcription factors contribute to the phenotype. 
Moreover, correction of the overexpression of RUNX1 even partially reverted the phenotype. 
Combinatorial strategies targeting some of the deregulated transcription factors might be 
more efficient than solely trying to correct the malfunctioning protein. Additionally, by looking 
for synergistic connections the dosage of drugs might be decreased, reducing the impact 
of side-effects in parallel. This is an important reason to continue searching for (functional) 
interactions between genes. 
 Two important factors to take into account for this are tissue heterogeneity and redundancy 
between genes and processes. Tissue heterogeneity is important to determine, especially 
in case of cancer, where the heterogeneity of aberrant cells is often correlated with faster 
adaptation to or resistance against chemotherapy. In this regard, single cell based techniques 
will become increasingly important in research, but also in diagnostics.
 Considering the impact of redundancy is very important when trying to understand 
deregulated biological systems in cancer. The biology of cancer is an evolutionary and highly 
dynamic process in which cells use redundant genes or pathways to compensate the effect 
of a treatment. Although these mechanisms lead to a more robust system in healthy cells, in 
for instance cancerous cells they can contribute to resistance to diverse treatments. These 
mechanisms allow tumour cells to survive and adapt, sometimes leading into a multidrug 
resistant state (Gillet and Gottesman, 2010). To avoid this or to successfully treat this we 
need to understand how these redundant mechanisms contribute to the therapy-resistance 
mechanisms. This requires interdisciplinary research that considers the contribution of 
heterogeneity, redundancy and functional connections to eventually build a functional tumour 
network. Capturing the highly dynamic and constantly evolving features of cancer calls for 
re-evaluation of current methods, as these preferably should also include information about 
redundancy (based on genetics, biological function and biochemical function) (Lavi, 2015).
 Together, this work shows the importance of understanding biological systems from 
a network based perspective. This includes considering the interplay between signalling 
pathways and the contributions of transcription factor networks and functionally connected 
genes. The experimental set-up of the screen allows for the exploration of these functional 
interactions, as the predicted connections can identify true genetic interactions and redundancy. 
Identifying redundancy between genes or biological processes is important to consider in light 
of resistance against therapies or other undesired or unwanted effects of treatments. Mapping 
functional interactions and other types of regulatory networks can aid in understanding the 
system in a way that surpasses classification of genes based on regulatory mechanisms. This 
could lead to important new insights which could potentially make existing therapies more 
efficient or lead to the development of new, combinatorial therapies.
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SUMMARY
“Once upon a time there was a kingdom named Epidermis. In this kingdom, all subjects 
worked together to protect the rest of the World from invaders and dehydration and collectively 
ensured a healthy climate for the inhabitants of the World. This important task was entrusted 
to the Kingdom of Epidermis because of their intricate laws and their commitment to live 
according to these laws.
 The rest of the World was very interested in these laws, as the Kingdom of Epidermis 
was using them very successfully for as long as they could remember. Although they did not 
know the details they could see from the outside that decisions made by individuals affected 
the whole kingdom, for the good or for the bad. Most of the inhabitants worked together in 
maintaining the kingdom of Epidermis by a constant process of self-renewal and differentiation. 
In this process, the children of self-renewal change their outer composition to form one 
interconnected network forming the boundary that protect the rest of the World. 
 To understand the behaviour of, and tight cooperation between, the citizens of Epidermis 
several studies were started looking into their responses to perturbations. The studies 
focussed on different types of regulatory systems and how they work together, interpreting 
the different types of messages to infer a behavioural code. This knowledge was recorded in 
a Thesis, which showed the sophistication and robustness of the Epidermal society and how 
tightly everything worked together. In the future, by using these strategies it could be possible 
to efficiently identify individuals that divert from the paved paths, disrupting the barrier function 
or even migrating towards other parts of the World, causing all kinds of trouble. This would 
also contribute to the understanding of similar systems in the World, enabling the citizens of 
the World to live happily ever after”. 
Although a simplified representation of the projects I have been working on, the fairy tale I 
have written for a writing course nicely covers the main objective of this thesis. The last couple 
of years I have worked to contribute to the laws describing epidermal homeostasis to be able 
to predict the consequences of perturbations of the system. I have worked on understanding 
expression dynamics of coding and non-coding genes, and the signalling pathways or 
transcription factors that regulate this. Moreover, I have looked at how genes and transcription 
factors work together, transcending classification of genes based on regulatory mechanism. 
Non-transient perturbations such as genetic mutations can be studied in detail and can lead to 
important new insights that might be translated into therapeutical strategies. This framework 
of knowledge allows for proper interrogation of new treatment strategies targeting for instance 
downstream effectors or combinations of genes in a comprehensive way, taking along as many 
variables as possible. 
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 Cellular responses are the result of the combination of the states of all these variables, 
so it is important to consider how these influence each other and how they work together. In 
Chapter 2, I showed that comparing these responses to transient expression perturbations 
can identify groups of genes that are functionally connected. I showed that ZMAT2 is a factor 
involved in splicing and plays an important role in epidermal differentiation through regulation 
of adhesion related genes. Moreover, I validated a functional connection between chromatin 
factors and ZMAT2, showing a connection between transcriptional and post-transcriptional 
processes. The prediction of these functional interactions are a powerful tool to interrogate a 
system for connections between processes and how they might work together.
 The expression dynamics of genes might also give an indication of cell state. In Chapter 3, I 
report the identification of lncRNA BLNCR that is located closely to the epidermal self-renewal 
marker ITGB1. The expression dynamic of BLNCR suggest that its involved in processes 
prior or during initiation of differentiation. Upon initiation of differentiation BLNCR is rapidly 
downregulated and I showed that its expression is sensitive to the activity of the EGF pathway. 
The downregulation of this gene might mark the switch from a proliferative state towards 
terminal differentiation in epidermal stem cells.
 Next to transcriptional and post-transcriptional regulation, signalling pathway activity 
provides yet another level of gene expression regulation. In Chapter 4, we adapted the ID-
seq technology to measure protein expression in single cells and validated that the activity 
of the BMP signalling pathway was shown to be necessary for proper expression of late 
differentiation markers. This showed the regulatory loops involved in proper execution of 
epidermal differentiation, which involves both signalling pathways and transcription factor 
networks.
 In Chapter 5, the importance of the epigenetic landscape and proper transcriptional 
regulation of epidermal differentiation was shown. In patient cells carrying a mutation in 
master regulator p63 we noticed that its altered binding caused deregulation of genes involved 
in different lineages. Moreover, we showed that the phenotype could be partially reversed by 
silencing one of these genes. This indicated the importance of studying regulatory processes 
downstream of a mutation in light of perturbing deregulated processes in potential therapeutic 
strategies.
 Combined, this work shows the importance of considering how genes and biological 
processes work together. From signalling pathways to transcriptional and post-transcriptional 
regulation to epigenetic mechanisms, everything is linked in the regulation of coding and non-
coding transcripts. In the end, the key to correcting a mistake that leads to a deregulated 
system lies in the different mechanisms, layers of regulation, expression dynamics and the 
connections between them.
SUMMARY
183
7
CHAPTER 7
184
NEDERLANDSE SAMENVATTING
185
7
NEDERLANDSE SAMENVATTING
“Er was eens een Koninkrijk genaamd Epidermis waar alle onderdanen samenwerkten om 
de Wereld te beschermen tegen indringers en uitdroging en er zo samen zorgden voor een 
gezond klimaat voor alle inwoners van de Wereld. Deze belangrijke taak was het Koninkrijk 
toevertrouwd door hun complexe wetten en toewijding om ernaar te leven.
 De rest van de Wereld was erg geïnteresseerd  in deze wetten, aangezien het Koninkrijk 
Epidermis deze al succesvol toepaste voor zolang men zich kon herinneren. Hoewel ze de 
details niet kenden zagen ze dat beslissingen van individuen het hele Koninkrijk konden 
treffen, maar dat de onderdanen goed samenwerkten in het onderhouden van hun domain. In 
een process genaamd differentiatie veranderden de cellen hun compositie om uiteindelijk een 
goed verbonden barriere te vormen welke de rest van de Wereld kon beschermen.
 Om het gedrag, de wetten en de goed georganiseerde samenwerking van de inwoners 
van Epidermis te leren begrijpen werden er verschillende studies gestart waarbij gekeken 
werd naar het effect van verstoringen van het systeem. De studies concentreerden zich op 
verschillende types van regulatoire systemen en hoe deze samen werken om de verschillende 
type boodschappen te interpreteren en hieruit een gedragscode af te leiden. Deze kennis werd 
vastgelegd in een Thesis, welke de geraffineerdheid en kracht van de Epidermale samenleving 
weergaf en hoe strak alles hierin georganiseerd is. In de toekomst zouden we de kennis die 
via deze strategieen vergaard is kunnen gebruiken voor het indentificeren van inwoners die 
afwijkend gedrag vertonen, de barriere verstoren of zelfs migreren naar andere delen van 
de Wereld, waar ze allerlei problemen veroorzaken. De kennis zou ook een bijdrage kunnen 
leveren aan het begrijpen van vergelijkbare systemen in de Wereld, waarna de inwoners van 
de Wereld nog lang en gelukkig leefden”
Hoewel dit een versimpelde versie is van de projecten waar ik aan gewerkt heb, is het sprookje 
wat ik geschreven heb voor een schrijf cursus een mooie metafoor voor het onderzoek wat ik 
de afgelopen jaren heb gedaan. Ik heb gewerkt aan projecten die een bijdrage leveren aan het 
begrijpen van de wetten die epidermale homeostase beschrijven. Ik heb hierbij gekeken naar 
de rol en expressie van coderende en niet-coderende genen en naar de signalerings paden 
en transcriptie factoren die dit reguleren. Belangrijker nog, ik heb onbevooroordeeld gekeken 
naar hoe genen samen werken, dus zonder rekening te houden met eventuele classificatie 
van genen in een bepaald mechanisme. Ook het bestuderen van permanente mutaties 
in bijvoorbeeld het DNA kan leiden tot belangrijke nieuwe inzichten welke kunnen worden 
vertaald naar therapeutische strategieen. Dit raamwerk van kennis kan worden gebruikt bij 
het testen of ontwikkelen van nieuwe behandelingen die bijvoorbeeld combinaties van genen 
in acht nemen of daarbij zoveel mogelijk variabelen meenemen.
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 Het gedrag van cellen is het resultaat van de combinatie van al die variabelen, dus het is 
belangrijk om te begrijpen hoe ze elkaar beinvloeden en hoe ze samenwerken. In Hoofdstuk 2 
laat ik door het vergelijken van effecten van tijdelijke verstoring van expressie zien dat hiermee 
functionele interacties tussen genen kunnen worden geïdentificeerd. Ik laat hier zien dat ZMAT2 
een eiwit is dat betrokken is bij een proces genaamd splicing en een belangrijke rol speelt in de 
regulatie van epidermal differentiatie door de regulatie van adhesie gerelateerde genen. Ik laat 
bovendien zien dat dit gen functionele interacties deelt met een aantal chromatine factoren, 
waarmee ik een connectie tussen transcriptionele en post-transcriptionele processen aantoon. 
De voorspelling van functionele interacties is een krachtige tool om een biologisch system te 
onderzoeken op connecties tussen verschillende processen en kan een indicatie geven over 
hoe ze samen werken.
 Gen-expressie dynamiek kan ook een indicatie geven over de staat van de cel. In Hoofdstuk 
3 indentificeer ik een lncRNA, BLNCR, welke dichtbij epidermale stam cell marker ITGB1 tot 
expressie komt. De dynamiek van de expressie van BLNCR suggereert dat het betrokken zou 
kunnen zijn bij processen rondom, of voorafgaand aan, initiatie van differentiatie. Wanneer 
differentiatie is geïnduceerd neemt de expressie van deze lncRNA snel af en daarnaast laat 
ik zien dat de expressie gevoelig lijkt te zijn voor activiteit van het groei-gerelateerde EGF 
signalerings pad. Uiteindelijk lijkt de afname van expressie van BLNCR de verandering van een 
proliferatieve staat naar een differentiërende staat te markeren.
 Naast transcriptionele en post-transcriptionele regulatie bieden signalerings paden nog 
een laag van regulatie van gen-expressie. In Hoofdstuk 4 meten we eiwitten in individuele 
cellen met een adaptatie van de ID-seq techniek. Hiermee meten we vervolgens dynamiek in 
verschillende signalerings paden en laten we zien dat het BMP signalerings pad belangrijk is 
voor de juiste expressie van late differentiatie markers. Hierbij blijkt dat de connectie tussen 
activatie van signalerings paden en transcriptie factor netwerken nodig is voor het correct 
uitvoeren van epidermale differentiatie. 
 In Hoofdstuk 5 laten we de impact van het epigenetische landschap en correcte 
transcriptionele regulatie tijdens epidermale differentiatie zien. In patient cellen met een 
mutatie in “master-regulator” p63 laten we zien dat de alternatieve binding van het eiwit 
deregulatie van genen betrokken bij andere cel typen veroorzaakt. Dat deze deregulatie een 
belangrijke consequentie is in het ziektebeeld werd duidelijk nadat remming van RUNX1, 
een van de genen die in deze patient cellen hoger tot expressie komt, het phenotype deels 
kon herstellen. Deze studie laat duidelijk zien dat het belangrijk is om ook de regulatoire 
processen volgend op een gemuteerd gen te bestuderen met het oog op de ontwikkeling van 
therapeutische strategieën. 
 Samengevat laat dit werk het belang zien van het beschouwen van hoe genen en 
biologische processen met elkaar samenwerken. Signalerings-paden, transcriptionele, post-
transcriptionele tot epigenetische mechanismen, alles is aan elkaar gelinkt in de regulatie van 
coderende en niet-coderende transcripten. In de veelvoud aan verschillende mechanismen en 
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expressie dynamieken en de verbanden ertussen ligt uit eindelijk de sleutel tot het begrijpen 
van het systeem en de mogelijkheid een gedereguleerd systeem te kunnen corrigeren. 
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Hoewel de summary van deze thesis leest als een sprookje, was het zonder de hulp van 
onderstaande mensen maar een weinig betoverende ervaring geworden. Tijdens het praktische 
werk, het afronden van manuscripten en natuurlijk dit boekje stonden zij, ieder op hun eigen 
manier, aan mijn zijde om mijn hersenspinsels, zorgen, irritaties, blijdschap, zin en onzin aan 
te horen. Uiteindelijk hebben al deze functionele interacties (ja dit is echt de laatste keer dat 
je deze combinatie van woorden hoeft te lezen) eraan bijgedragen dat ik deze periode met een 
ontzettend tevreden gevoel kan afsluiten.
Allereerst natuurlijk Klaas, ontzettend bedankt voor de ongelooflijk mooie tijd in jouw lab. 
Hoewel ik natuurlijk ook Gert-Jan als promotor wil bedanken voor deze mooie kans, heb ik toch 
vooral met jou, Klaas samengewerkt! Ik kreeg veel ruimte voor mijn persoonlijke ontwikkeling, 
wat een enorme impact heeft gehad op de persoon die ik geworden ben en aan het worden 
ben. Daarnaast heb ik door je stijl van begeleiden ook in het lab sprongen kunnen maken in 
mijn ontwikkeling als wetenschapper. Bij dit bedankje moet ik natuurlijk eigenlijk vooral je 
geduld roemen, je hebt vooral in de eerste 2 jaar veel flauwe grappen moeten verduren (ben 
ik toch volwassener geworden blijkbaar!). Zo heb ik erg genoten van je reacties op plakband 
door je hele labjas, afgeknipte en te kleine handschoenen in je bakje en de keren dat we (/ik 
<- ik geef het toe) in je afwezigheid je kantoor op zijn kop hebben gezet. Alles in bubbeltjes 
plastic na afloop van je wintersport (je zou toch maar bij terugkomst je been breken!) of het 
tropische thema na afloop van je zomervakantie (met PBS cocktail!). Ik caal er nog steeds 
van dat ik dat badje onder je bureau toen niet gewoon gevuld heb (maar je kantoorgenote Jo 
was onverbiddelijk). Gelukkig krijg ik daar de komende jaren wellicht nog wel de kans voor, 
aangezien ik de komende jaren nog als post-doc in je lab zal blijven werken.
Dan natuurlijk ook Jessie ontzettend bedankt! Jij was tijdens dit traject mijn rots in de 
branding. We startten bijna tegelijk aan onze PhD-reis en hebben elkaar door heel wat lief en 
leed gesteund. Niet alleen lab-gerelateerde onderwerpen, maar ook leven-gerelateerde issues 
waren dagelijkse kost. Bedankt voor de soepele samenwerking aan verschillende projecten en 
je (bijna) altijd vrolijke humeur! Ik heb smakelijk kunnen lachen om je chaos en je pogingen die 
te bedwingen met duizend en één verschillende manieren van plannen. Als ik ooit nog een keer 
voedselvergiftiging zou krijgen is er niemand anders met wie ik liever in een door kakkerlakken 
vergeven huisje zou willen zitten.
Dan mijn tweede rots in de branding, zonder jou was het sowieso allemaal in het honderd 
gelopen, Mark, bedankt voor alles! Je kwam stage bij mij lopen, bent daarna nog werkzaam 
geweest bij ons als technician en nu zijn we op het punt dat ik bij jou stage wil komen lopen. 
De cirkel is rond! Ik heb heel veel gehad aan onze celkweek sessies, je humor, je afkeer 
APPENDICES
196
voor chocolade (meer voor mij!), de duw-Sabine-op haar-bureaustoel door de hele afdeling 
(eindigend in de lift) en altijd opgewekte humeur. Nou ja, meestal opgewekte humeur 😉 zolang 
je collega’s er geen bende van maakten. Ook natuurlijk niet te vergeten is je acceptatie van mijn 
wil-je-mijn-paranimf-zijn aanzoek! 
Roderick, jij begon een half jaar na mij aan een aantal ambitieuze projecten, en bent 
ondertussen ook al bijna klaar met je PhD. Bedankt voor alle goede en minder goede grappen 
(al waren het natuurlijk veelal hele goede), het lachen en de samenwerking in het lab. Jan, jij 
kwam als grote volwassen post-doc bij ons in het lab, waarbij je in die rol menig overstresste 
PhD student gerust kon stellen met relativerende woorden. Daarnaast was je ook altijd 
beschikbaar voor retorische Illustrator vragen, vrijdagmiddag snacks, goede quotes (die van 
Scooter blijft favoriet; it is nice to be important, but it is more important to be nice) en kletsen 
over hobbies. Bedankt! 😊
Rebecca, als master student heb je het langst bij mij in het lab gewerkt, waar je ontzettend veel 
werk hebt verzet. Ontzettend bedankt voor je inzet, positieve vibe, de interessante discussies 
en de lekkere hapjes die je meebracht 😊. Vind het heel leuk dat ik de komende jaren een U’tje 
met je mag delen :D
Ook wil ik natuurlijk de andere studenten die de afgelopen jaren in het lab stage hebben 
gelopen bij mij, Vivian, Samuel en Shannon, bedanken voor hun inzet! 😊. I would also like to 
thank Elif Senem Köksal, who did some great work for the story on BLNCR which can be found 
as a published chapter in the thesis!
I would also like to thank the rest of the lab (MolBio/MolDevBio/ProteChroBio) for all the 
feedback during presentations, but also the borrels, labretreats and gezelligheid! Simon en 
Wout voor hun hulp met de analyses, Pascal voor je altijd goede humeur 😉  en hulp bij mass spec 
gerelateerde experimenten en Eva voor alle hulp bij het sequencen en Rita voor erna. Maria en 
Anita, bedankt voor alle raad en daad bij algemene vragen, verzoekjes en bestellingen! Siebe, 
bedankt voor de technische ondersteuning in het lab waarbij je altijd met raad en daad klaar 
stond, of gewoon met een goede 10 tot 15 minuten kletsen over mountainbiken. De weekendjes 
weg met de club hebben een mooie bijdrage geleverd aan mijn mentale gezondheid, die we 
vervolgens tot grote vermoeidheid van andere collega’s tot in detail bespraken tijdens de lunch. 
Jo, I would also like to thank you and Jieqiong for the nice collaboration on the p63 story which 
resulted in a very nice publication and chapter in this thesis. I am also grateful for the usage 
of your group’s data for the selection of the siRNA panel for the transcription factor screen. 
Christa jij ook bedankt voor het faciliteren van de wekelijkse yoga-uurtjes samen met Jessie 
en Naomi, we waren je proefkonijnen maar profiteerden van de ontspanning! Daarnaast vond 
ACKNOWLEDGEMENTS/DANKWOORD
197
7
ik het ook fijn om het wel en wee rondom het schrijven van de laatste loodjes van deze thesis 
met jullie te kunnen delen tijdens de gezamelijke bieb-sessies!
Verder wil ik ook graag de afdeling Dermatologie bedanken voor de hulp bij het opzetten van 
de 3D kweek met onze cellen; Ellen, Hanna, Diana en Ivonne! Uiteindelijk is het niet gelukt dit 
succesvol te combineren met de transfecties, maar ik heb ontzettend veel van jullie geleerd!
I would also like to thank Markus Kretz and Bianca Förstl and Andrea Eder, for the 
collaboration on the role of ZMAT2 in epidermal differentiation/development which proved to 
be an important addition to the publication and Chapter 2.
Dan wil ik nog de mensen die de tot standkoming van dit boekje hebben mogelijk gemaakt door 
het leveren van feedback: natuurlijk Klaas, maar ook Jan en Jessie! Daarnaast wil ik ook de 
manuscript commissie bedanken voor het kritisch doorlezen van mijn thesis; Martijn Huijnen, 
Annemiek van Spriel en Fred van Leeuwen.
Wat me voor een groot deel mentaal op de been heeft gehouden tijdens dit hele traject is 
natuurlijk het mountainbiken! Dank aan ieder die samen met mij talloze uren op de fiets heeft 
doorgebracht! In het bijzonder Nynke en Simone, ook voor de uren naast de fiets 😊. Simone, 
de Transalp samen met jou en Huub was echt een ontzettend mooi avontuur! Nynke, als ik ooit 
met iemand 4 weken op stap moet dan kies ik jou. En chips. En cola. Daarnaast moet ik dan 
natuurlijk ook Renee, de familie van Houten, de MillManTrail groep en de rest van de Gran 
Canaria crew bedanken (die laatste groep vooral voor het aanhoren van de thesis stress en de 
rest van het geblaat. Wil je chips?).
Ook mijn jaarclub heeft een rol gespeeld bij de mentale gezondheid met alle etentjes, 
kerstdiners en feestjes. Rozemarijn, Heleen, Stéphanie, Annelies en Marjolein, bedankt voor 
jullie gezelligheid en jullie geduld bij het aanhoren van gelukte en mislukte experimenten of 
papers. Ik ben ontzettend blij dat ik getuige heb mogen zijn van hoe jullie massa’s burgerpunten 
binnensprokkelde met huizen, lease-auto’s, bruiloften en binnenkort een jaarclub-baby!
Yvonne en Coen, ik wil jullie ook bedanken voor jullie steun en de inspiratie die ik uit jullie 
beiden kan putten! Jullie hebben me buiten het inhoudelijke deel van deze PhD ontzettend 
geholpen bij verhuizingen, auto’s kopen en nog heel veel meer. Het is heel fijn om te weten 
dat ik altijd bij jullie terecht kan met grote en minder grote problemen (want hoe was je nou 
eigenlijk een auto?). Maarten en Marjoleine, jullie ook bedankt voor de komische noot tijdens 
de familiebezoekjes, altijd fijn om mayonaise in mijn cola te hebben of om hilarische saboteur 
spelletjes te spelen! Bianca, jij kunt dit boekje natuurlijk van voor tot achter lezen en dat heb je 
natuurlijk ook gedaan, waarvoor dank! 
APPENDICES
198
Dan last but not least, Moeders, jij ook heel erg bedankt! Ook al zet je jezelf graag weg als 
iemand op de achtergrond heb je voor mij toch echt een hele belangrijke rol gespeeld. Ik ben 
best wel eigenwijs, maar je hebt me op een aantal moeilijkere momenten bijgestaan bij het 
inzien van dingen en het maken van beslissingen. Het was ontzettend fijn om te weten dat 
ik op je kon terugvallen en dat je altijd hebt vertrouwd in wat ik deed, ook al zag ik het soms 
zelf even niet. Daarnaast wil ik je ook bedanken voor de pijn in mijn buik van het lachen om 
je interessante interpretatie van spelregels van spelletjes van Maarten en hoe je je creativiteit 
kwijt kunt in grappen uithalen met ons, wat altijd een goede bron van inspiratie voor me is 
geweest!
Sabine
ACKNOWLEDGEMENTS/DANKWOORD
199
7
CHAPTER 7
200
REFERENCES
201
7
REFERENCES
ABERDAM, D. et al. (2008) ‘miRNAs, “stemness” and skin’, Trends in Biochemical Sciences, 33(12), pp. 
583–591. doi: 10.1016/j.tibs.2008.09.002.
Adams, J. C. and Watt, F. M. (1989) ‘Fibronectin inhibits the terminal differentiation of human keratinocytes’, 
Nature, 340(6231), pp. 307–309. doi: 10.1038/340307a0.
Adelman, K. and Lis, J. T. (2012) ‘Promoter-proximal pausing of RNA polymerase II: emerging roles in 
metazoans.’, Nature reviews. Genetics. NIH Public Access, 13(10), pp. 720–31. doi: 10.1038/nrg3293.
Albino, D. et al. (2012) ‘ESE3/EHF Controls Epithelial Cell Differentiation and Its Loss Leads to Prostate 
Tumors with Mesenchymal and Stem-like Features’, Cancer Research, 72(11), pp. 2889–2900. doi: 
10.1158/0008-5472.CAN-12-0212.
Altschuler, S. J. and Wu, L. F. (2010) ‘Cellular heterogeneity: do differences make a difference?’, Cell, 
141(4), pp. 559–63. doi: 10.1016/j.cell.2010.04.033.
Amendt, C. et al. (2002) ‘Resistance of keratinocytes to TGFbeta-mediated growth restriction and apoptosis 
induction accelerates re-epithelialization in skin wounds.’, Journal of cell science, 115(Pt 10), pp. 
2189–98. Available at: http://www.ncbi.nlm.nih.gov/pubmed/11973359 (Accessed: 13 April 2018).
Anders, S., Reyes, A. and Huber, W. (2012) ‘Detecting differential usage of exons from RNA-seq data.’, 
Genome research, 22(10), pp. 2008–17. doi: 10.1101/gr.133744.111.
Anders, S., Reyes, A. and Huber, W. (2012) ‘Detecting differential usage of exons from RNA-seq data’, 
Genome Research, 22(10), pp. 2008–2017. doi: 10.1101/gr.133744.111.
Angel, P., Szabowski, A. and Schorpp-Kistner, M. (2001) ‘Function and regulation of AP-1 subunits in skin 
physiology and pathology’, Oncogene. Nature Publishing Group, 20(19), pp. 2413–2423. doi: 10.1038/
sj.onc.1204380.
Anthony T. Annunziato (2008) DNA Packaging: Nucleosomes and Chromatin | Learn Science at Scitable, 
Nature Education. Available at: https://www.nature.com/scitable/topicpage/dna-packaging-
nucleosomes-and-chromatin-310 (Accessed: 6 August 2018).
Aoki, K. et al. (2013) ‘Stochastic ERK activation induced by noise and cell-to-cell propagation regulates 
cell density-dependent proliferation.’, Molecular cell. Elsevier, 52(4), pp. 529–40. doi: 10.1016/j.
molcel.2013.09.015.
Backes, C. et al. (2007) ‘GeneTrail--advanced gene set enrichment analysis’, Nucleic Acids Res. 2007/05/29, 
35(Web Server issue), pp. W186-92. doi: gkm323 [pii]10.1093/nar/gkm323.
Bao, X. et al. (2013) ‘ACTL6a Enforces the Epidermal Progenitor State by Suppressing SWI/SNF-Dependent 
Induction of KLF4’, Cell stem cell. NIH Public Access, 12(2), p. 193. doi: 10.1016/J.STEM.2012.12.014.
Bao, X. et al. (2015) ‘A novel ATAC-seq approach reveals lineage-specific reinforcement of the open 
chromatin landscape via cooperation between BAF and p63’, Genome Biology. BioMed Central, 16(1), 
p. 284. doi: 10.1186/s13059-015-0840-9.
Barrandon, Y. et al. (2012) ‘Capturing epidermal stemness for regenerative medicine’, Seminars in Cell & 
Developmental Biology, 23(8), pp. 937–944. doi: 10.1016/j.semcdb.2012.09.011.
Barrandon, Y. and Green, H. (1987) ‘Three clonal types of keratinocyte with different capacities for 
multiplication.’, Proceedings of the National Academy of Sciences of the United States of America. 
National Academy of Sciences, 84(8), pp. 2302–6. doi: 10.1073/PNAS.84.8.2302.
Baryshnikova, A. et al. (2010) ‘Quantitative analysis of fitness and genetic interactions in yeast on a genome 
scale’, Nature Methods. Nature Publishing Group, 7(12), pp. 1017–1024. doi: 10.1038/nmeth.1534.
Beck, B. and Blanpain, C. (2012) ‘Mechanisms regulating epidermal stem cells’, The EMBO journal. 
2012/03/22, 31(9), pp. 2067–2075. doi: 10.1038/emboj.2012.67.
Bhaduri, A. et al. (2015) ‘Network Analysis Identifies Mitochondrial Regulation of Epidermal Differentiation 
by MPZL3 and FDXR’, Developmental Cell. Elsevier Ltd, 35(4), pp. 444–457. doi: 10.1016/j.
devcel.2015.10.023.
CHAPTER 7
202
Biggs, L. C. et al. (2012) ‘Interferon Regulatory Factor 6 Is Necessary, but Not Sufficient, for Keratinocyte 
Differentiation’, Journal of Investigative Dermatology, 132(1), pp. 50–58. doi: 10.1038/jid.2011.272.
Blanpain, C. and Fuchs, E. (2006) ‘Epidermal stem cells of the skin’, Annu Rev Cell Dev Biol. 2006/07/11, 
22, pp. 339–373. doi: 10.1146/annurev.cellbio.22.010305.104357.
Blanpain, C. and Fuchs, E. (2009) ‘Epidermal homeostasis: a balancing act of stem cells in the skin.’, 
Nature reviews. Molecular cell biology. NIH Public Access, 10(3), pp. 207–17. doi: 10.1038/nrm2636.
Blanpain, C. and Fuchs, E. (2014) ‘Stem cell plasticity. Plasticity of epithelial stem cells in tissue 
regeneration.’, Science (New York, N.Y.). American Association for the Advancement of Science, 
344(6189), p. 1242281. doi: 10.1126/science.1242281.
van den Bogaard, E. H. et al. (2015) ‘Genetic and pharmacological analysis identifies a physiological role 
for the AHR in epidermal differentiation.’, The Journal of investigative dermatology, 135(5), pp. 1320–
1328. doi: 10.1038/jid.2015.6.
van Bokhoven, H. et al. (2001) ‘p63 Gene mutations in eec syndrome, limb-mammary syndrome, and 
isolated split hand-split foot malformation suggest a genotype-phenotype correlation.’, American 
journal of human genetics. Elsevier, 69(3), pp. 481–92. doi: 10.1086/323123.
Bolha, L., Ravnik-Glavač, M. and Glavač, D. (2017) ‘Long Noncoding RNAs as Biomarkers in Cancer.’, 
Disease markers. Hindawi Limited, 2017, p. 7243968. doi: 10.1155/2017/7243968.
Botchkarev, V. A. (2003) ‘Bone morphogenetic proteins and their antagonists in skin and hair follicle biology’, 
Journal of Investigative Dermatology. Elsevier Masson SAS, 120(1), pp. 36–47. doi: 10.1046/j.1523-
1747.2003.12002.x.
Botchkarev, V. A. et al. (2012) ‘Epigenetic regulation of gene expression in keratinocytes.’, The Journal of 
investigative dermatology. Elsevier, 132(11), pp. 2505–21. doi: 10.1038/jid.2012.182.
Botchkarev, V. A. (2015) ‘Integration of the Transcription Factor-Regulated and Epigenetic Mechanisms 
in the Control of Keratinocyte Differentiation.’, The journal of investigative dermatology. Symposium 
proceedings. NIH Public Access, 17(2), pp. 30–2. doi: 10.1038/jidsymp.2015.37.
Botchkarev, V. A. and Sharov, A. A. (2004) ‘BMP signaling in the control of skin development and hair 
follicle growth’, Differentiation. International Society of Differentiation, 72(9–10), pp. 512–526. doi: 
10.1111/j.1432-0436.2004.07209005.x.
Botti, E. et al. (2011) ‘Developmental factor IRF6 exhibits tumor suppressor activity in squamous cell 
carcinomas.’, Proceedings of the National Academy of Sciences of the United States of America. 
National Academy of Sciences, 108(33), pp. 13710–5. doi: 10.1073/pnas.1110931108.
Bourke, L. M. et al. (2017) ‘Loss of Rearranged L-Myc Fusion (RLF) results in defects in heart development 
in the mouse’, Differentiation, 94, pp. 8–20. doi: 10.1016/j.diff.2016.11.004.
Briscoe, J. and Small, S. (2015) ‘Morphogen rules: design principles of gradient-mediated embryo 
patterning.’, Development (Cambridge, England). Oxford University Press for The Company of 
Biologists Limited, 142(23), pp. 3996–4009. doi: 10.1242/dev.129452.
Browne, G. et al. (2011) ‘Differential altered stability and transcriptional activity of ΔNp63 mutants in 
distinct ectodermal dysplasias.’, Journal of cell science. The Company of Biologists Ltd, 124(Pt 13), 
pp. 2200–7. doi: 10.1242/jcs.079327.
Brunner, H. G., Hamel, B. C. J. and Van Bokhoven, H. (2002) ‘The p63 gene in EEC and other syndromes.’, 
Journal of medical genetics. BMJ Publishing Group Ltd, 39(6), pp. 377–81. doi: 10.1136/JMG.39.6.377.
van Buggenum, J. A. G. L. et al. (2016) ‘A covalent and cleavable antibody-DNA conjugation strategy for 
sensitive protein detection via immuno-PCR’, Scientific Reports. Nature Publishing Group, 6(1), p. 
22675. doi: 10.1038/srep22675.
van Buggenum, J. A. G. et al. (2018) ‘Immuno-detection by sequencing enables large-scale high-
dimensional phenotyping in cells’, Nature Communications. Nature Publishing Group, 9(1), p. 2384. 
doi: 10.1038/s41467-018-04761-0.
REFERENCES
203
7
Cabral, R. M. et al. (2012) ‘The DSPII splice variant is crucial for desmosome-mediated adhesion in HaCaT 
keratinocytes.’, Journal of cell science. The Company of Biologists Ltd, 125(Pt 12), pp. 2853–61. doi: 
10.1242/jcs.084152.
Candi, E. et al. (2007) ‘TAp63 and ΔNp63 in Cancer and Epidermal Development’, Cell Cycle, 6(3), pp. 
274–284. doi: 10.4161/cc.6.3.3797.
Candi, E. et al. (2008) ‘p63 in epithelial development’, Cellular and Molecular Life Sciences. Birkhäuser-
Verlag, 65(20), pp. 3126–3133. doi: 10.1007/s00018-008-8119-x.
Candi, E., Schmidt, R. and Melino, G. (2005) ‘The cornified envelope: a model of cell death in the skin’, 
Nature Reviews Molecular Cell Biology. Nature Publishing Group, 6(4), pp. 328–340. doi: 10.1038/
nrm1619.
Castro, M. A. et al. (2012) ‘RedeR: R/Bioconductor package for representing modular structures, nested 
networks and multiple levels of hierarchical associations.’, Genome Biology. BioMed Central, 13(4), p. 
R29. doi: 10.1186/gb-2012-13-4-r29.
Celli, J. et al. (1999) ‘Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC 
syndrome.’, Cell. Elsevier, 99(2), pp. 143–53. doi: 10.1016/S0092-8674(00)81646-3.
Chermnykh, E., Kalabusheva, E. and Vorotelyak, E. (2018) ‘Extracellular Matrix as a Regulator of Epidermal 
Stem Cell Fate.’, International journal of molecular sciences. Multidisciplinary Digital Publishing 
Institute  (MDPI), 19(4). doi: 10.3390/ijms19041003.
Chodankar, R. et al. (2003) ‘Shift of localized growth zones contributes to skin appendage morphogenesis: 
role of the Wnt/beta-catenin pathway.’, The Journal of investigative dermatology. Elsevier, 120(1), pp. 
20–6. doi: 10.1046/j.1523-1747.2003.12008.x.
Chung, K. et al. (2013) ‘Structural and molecular interrogation of intact biological systems.’, Nature. 
Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved., 497(7449), 
pp. 332–7. doi: 10.1038/nature12107.
Clapier, C. R. and Cairns, B. R. (2009) ‘The Biology of Chromatin Remodeling Complexes’, Annual Review of 
Biochemistry. Annual Reviews, 78(1), pp. 273–304. doi: 10.1146/annurev.biochem.77.062706.153223.
Cohen, I. et al. (2012) ‘ZNF750 Is Expressed in Differentiated Keratinocytes and Regulates Epidermal Late 
Differentiation Genes’, PLoS ONE. Edited by J. M. Brandner. Public Library of Science, 7(8), p. e42628. 
doi: 10.1371/journal.pone.0042628.
Connelly, J. T. et al. (2010) ‘Actin and serum response factor transduce physical cues from the 
microenvironment to regulate epidermal stem cell fate decisions’, Nature Cell Biology. Nature 
Publishing Group, 12(7), pp. 711–718. doi: 10.1038/ncb2074.
Connelly, J. T. et al. (2010) ‘Actin and serum response factor transduce physical cues from the 
microenvironment to regulate epidermal stem cell fate decisions’, Nat Cell Biol. 2010/06/29, 12(7), 
pp. 711–718. doi: ncb2074 [pii]10.1038/ncb2074.
Costanzo, M. et al. (2010) ‘The Genetic Landscape of a Cell’, Science, 327(5964), pp. 425–431. doi: 10.1126/
science.1180823.
Cox, J. and Mann, M. (2008) ‘MaxQuant enables high peptide identification rates, individualized p.p.b.-
range mass accuracies and proteome-wide protein quantification.’, Nature biotechnology, 26(12), pp. 
1367–72. doi: 10.1038/nbt.1511.
Di Croce, L. and Helin, K. (2013) ‘Transcriptional regulation by Polycomb group proteins’, Nature Structural 
& Molecular Biology. Nature Publishing Group, 20(10), pp. 1147–1155. doi: 10.1038/nsmb.2669.
Dang, L. T. et al. (2018) ‘Trawler Web: An online de novo motif discovery tool for next-generation sequencing 
datasets’, BMC Genomics, 19(1). doi: 10.1186/s12864-018-4630-0.
Dennis, G. et al. (2003) ‘DAVID: Database for Annotation, Visualization, and Integrated Discovery’, Genome 
Biology. BioMed Central, 4(9), p. R60. doi: 10.1186/gb-2003-4-9-r60.
Derrien, T. et al. (2012) ‘The GENCODE v7 catalog of human long noncoding RNAs: analysis of their 
gene structure, evolution, and expression.’, Genome research, 22(9), pp. 1775–89. doi: 10.1101/
gr.132159.111.
CHAPTER 7
204
Dobin, A. et al. (2013) ‘STAR: ultrafast universal RNA-seq aligner’, Bioinformatics, 29(1), pp. 15–21. doi: 
10.1093/bioinformatics/bts635.
Dötsch, V. et al. (2010) ‘p63 and p73, the ancestors of p53.’, Cold Spring Harbor perspectives in biology. Cold 
Spring Harbor Laboratory Press, 2(9), p. a004887. doi: 10.1101/cshperspect.a004887.
Droop, J. et al. (2017) ‘Diagnostic and prognostic value of long noncoding RNAs as biomarkers in urothelial 
carcinoma’, PLOS ONE. Edited by F. X. Real. Public Library of Science, 12(4), p. e0176287. doi: 10.1371/
journal.pone.0176287.
Ebisuya, M. et al. (2008) ‘Ripples from neighbouring transcription’, Nature Cell Biology. Nature Publishing 
Group, 10(9), pp. 1106–1113. doi: 10.1038/ncb1771.
Eckert, R. L. et al. (1997) ‘The epidermis: genes on - genes off.’, The Journal of investigative dermatology, 
109(4), pp. 501–9. Available at: http://www.ncbi.nlm.nih.gov/pubmed/9326381 (Accessed: 17 April 
2018).
Eckert, R. L. et al. (2005) ‘Transglutaminase Function in Epidermis’, Journal of Investigative Dermatology. 
Elsevier, 124(3), pp. 481–492. doi: 10.1111/J.0022-202X.2005.23627.X.
Eckert, R. L. et al. (2013) ‘AP1 Transcription Factors in Epidermal Differentiation and Skin Cancer’, Journal 
of Skin Cancer, 2013, pp. 1–9. doi: 10.1155/2013/537028.
Engreitz, J. M. et al. (2016) ‘Local regulation of gene expression by lncRNA promoters, transcription and 
splicing.’, Nature, 539(7629), pp. 452–455. doi: 10.1038/nature20149.
Ernst, J. and Kellis, M. (2012) ‘ChromHMM: automating chromatin-state discovery and characterization’, 
Nature Methods. Nature Publishing Group, 9(3), pp. 215–216. doi: 10.1038/nmeth.1906.
Esteller, M. (2011) ‘Non-coding RNAs in human disease.’, Nature reviews. Genetics. Nature Publishing 
Group, a division of Macmillan Publishers Limited. All Rights Reserved., 12(12), pp. 861–74. doi: 
10.1038/nrg3074.
Fan, J. et al. (2015) ‘Long non-coding RNA ROR decoys gene-specific histone methylation to promote 
tumorigenesis.’, Genome biology, 16(1), p. 139. doi: 10.1186/s13059-015-0705-2.
Feng, L. et al. (2018) ‘Plasma long non-coding RNA BACE1 as a novel biomarker for diagnosis of Alzheimer 
disease’, BMC Neurology. BioMed Central, 18(1), p. 4. doi: 10.1186/s12883-017-1008-x.
Fessing, M. Y. et al. (2010) ‘BMP signaling induces cell-type-specific changes in gene expression programs 
of human keratinocytes and fibroblasts’, Journal of Investigative Dermatology. Elsevier Masson SAS, 
130(2), pp. 398–404. doi: 10.1038/jid.2009.259.
Fessing, M. Y. et al. (2011) ‘p63 regulates Satb1 to control tissue-specific chromatin remodeling during 
development of the epidermis’, J Cell Biol. Rockefeller University Press, 194(6), pp. 825–839. doi: 
10.1083/JCB.201101148.
Fuchs, E. (2007) ‘Scratching the surface of skin development.’, Nature, 445(7130), pp. 834–42. doi: 10.1038/
nature05659.
Gandarillas, A. and Watt, F. M. (1997) ‘c-Myc promotes differentiation of human epidermal stem cells.’, 
Genes & development. Cold Spring Harbor Laboratory Press, 11(21), pp. 2869–82. Available at: http://
www.ncbi.nlm.nih.gov/pubmed/9353256 (Accessed: 12 October 2017).
Gaudet, S. and Miller-Jensen, K. (2016) ‘Redefining Signaling Pathways with an Expanding Single-
Cell Toolbox.’, Trends in biotechnology. NIH Public Access, 34(6), pp. 458–469. doi: 10.1016/j.
tibtech.2016.02.009.
Georgiou, G. and van Heeringen, S. J. (2016) ‘fluff: exploratory analysis and visualization of high-throughput 
sequencing data’, PeerJ. PeerJ Inc., 4, p. e2209. doi: 10.7717/peerj.2209.
Ghaffarizadeh, A., Podgorski, G. J. and Flann, N. S. (2014) ‘Modeling and Visualizing Cell Type Switching’, 
Computational and Mathematical Methods in Medicine, 2014, pp. 1–10. doi: 10.1155/2014/293980.
Gillet, J.-P. and Gottesman, M. M. (2010) ‘Mechanisms of Multidrug Resistance in Cancer’, in Methods in 
molecular biology (Clifton, N.J.), pp. 47–76. doi: 10.1007/978-1-60761-416-6_4.
REFERENCES
205
7
Gordon, N. K. and Gordon, R. (2016) ‘The organelle of differentiation in embryos: the cell state splitter’, 
Theoretical Biology and Medical Modelling. BioMed Central, 13(1), p. 11. doi: 10.1186/s12976-016-
0037-2.
Gosselet, F. P. et al. (2007) ‘BMP2 and BMP6 control p57(Kip2) expression and cell growth arrest/terminal 
differentiation in normal primary human epidermal keratinocytes’, Cell Signal. 2006/11/23, 19(4), pp. 
731–739. doi: S0898-6568(06)00265-8 [pii]10.1016/j.cellsig.2006.09.006.
Green, H. (2008) ‘The birth of therapy with cultured cells’, Bioessays. 2008/08/12, 30(9), pp. 897–903. doi: 
10.1002/bies.20797.
Guha, U. et al. (2004) ‘Bone Morphogenetic Protein Signaling Regulates Postnatal Hair Follicle 
Differentiation and Cycling’, The American Journal of Pathology. American Society for Investigative 
Pathology, 165(3), pp. 729–740. doi: 10.1016/S0002-9440(10)63336-6.
Guo, J. U. et al. (2011) ‘Hydroxylation of 5-Methylcytosine by TET1 Promotes Active DNA Demethylation in 
the Adult Brain’, Cell, 145(3), pp. 423–434. doi: 10.1016/j.cell.2011.03.022.
Hashimshony, T., Senderovich, N., Avital, G., Klochendler, A., de Leeuw, Y., Anavy, L., Gennert, D., Li, S., 
Livak, K. J., et al. (2016) ‘CEL-Seq2: sensitive highly-multiplexed single-cell RNA-Seq.’, Genome 
biology, 17(1), p. 77. doi: 10.1186/s13059-016-0938-8.
Hegde, S. and Raghavan, S. (2013) ‘A Skin-depth Analysis of Integrins: Role of the Integrin Network in 
Health and Disease’, Cell Communication & Adhesion. Taylor & Francis, 20(6), pp. 155–169. doi: 
10.3109/15419061.2013.854334.
Heijmans, B. T. et al. (2008) ‘Persistent epigenetic differences associated with prenatal exposure to famine 
in humans.’, Proceedings of the National Academy of Sciences of the United States of America. 
National Academy of Sciences, 105(44), pp. 17046–9. doi: 10.1073/pnas.0806560105.
Hirsch, T. et al. (2017) ‘Regeneration of the entire human epidermis using transgenic stem cells’, Nature. 
Nature Publishing Group, 551(7680), pp. 327–332. doi: 10.1038/nature24487.
Hoi, C. S. L. et al. (2010) ‘Runx1 directly promotes proliferation of hair follicle stem cells and epithelial 
tumor formation in mouse skin.’, Molecular and cellular biology. American Society for Microbiology 
Journals, 30(10), pp. 2518–36. doi: 10.1128/MCB.01308-09.
Horn, T. et al. (2011) ‘Mapping of signaling networks through synthetic genetic interaction analysis by 
RNAi’, Nature Methods. Nature Publishing Group, 8(4), pp. 341–346. doi: 10.1038/nmeth.1581.
Huang, D. W., Sherman, B. T. and Lempicki, R. A. (2009) ‘Systematic and integrative analysis of large 
gene lists using DAVID bioinformatics resources’, Nature Protocols. Nature Publishing Group, 4(1), 
pp. 44–57. doi: 10.1038/nprot.2008.211.
Ihrie, R. A. et al. (2005) ‘Perp is a p63-regulated gene essential for epithelial integrity.’, Cell. Elsevier, 
120(6), pp. 843–56. doi: 10.1016/j.cell.2005.01.008.
Ingraham, C. R. et al. (2006) ‘Abnormal skin, limb and craniofacial morphogenesis in mice deficient for 
interferon regulatory factor 6 (Irf6)’, Nature Genetics. Nature Publishing Group, 38(11), pp. 1335–1340. 
doi: 10.1038/ng1903.
Janes, S. M. et al. (2009) ‘PI3-kinase-dependent activation of apoptotic machinery occurs on commitment 
of epidermal keratinocytes to terminal differentiation.’, Cell research, 19(3), pp. 328–39. doi: 10.1038/
cr.2008.281.
Ji, H. et al. (2009) ‘EGF-induced ERK activation promotes CK2-mediated disassociation of alpha-Catenin 
from beta-Catenin and transactivation of beta-Catenin.’, Molecular cell. Elsevier, 36(4), pp. 547–59. 
doi: 10.1016/j.molcel.2009.09.034.
Jones, P. H., Harper, S. and Watt, F. M. (1995) ‘Stem cell patterning and fate in human epidermis’, Cell, 
80(1), pp. 83–93. doi: 10.1016/0092-8674(95)90453-0.
Jones, P. H. and Watt, F. M. (1993) ‘Separation of human epidermal stem cells from transit amplifying cells 
on the basis of differences in integrin function and expression.’, Cell, 73(4), pp. 713–24. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/8500165 (Accessed: 11 September 2017).
CHAPTER 7
206
van Kappel, E. C. and Maurice, M. M. (2017) ‘Molecular regulation and pharmacological targeting of 
the β-catenin destruction complex’, British Journal of Pharmacology, 174(24), pp. 4575–4588. doi: 
10.1111/bph.13922.
Katz, Y. et al. (2010) ‘Analysis and design of RNA sequencing experiments for identifying isoform regulation’, 
Nature Methods. Nature Publishing Group, 7(12), pp. 1009–1015. doi: 10.1038/nmeth.1528.
Kenny, F. N. et al. (2018) ‘Tissue stiffening promotes keratinocyte proliferation through activation of 
epidermal growth factor signaling.’, Journal of cell science. The Company of Biologists Ltd, 131(10), 
p. jcs215780. doi: 10.1242/jcs.215780.
Kivioja, T. et al. (2012) ‘Counting absolute numbers of molecules using unique molecular identifiers’, 
Nature Methods, 9(1), pp. 72–74. doi: 10.1038/nmeth.1778.
Kohtz, J. D. et al. (1994) ‘Protein–protein interactions and 5’-splice-site recognition in mammalian mRNA 
precursors’, Nature, 368(6467), pp. 119–124. doi: 10.1038/368119a0.
Kolev, V., Mandinova, A., Guinea-Viniegra, J., Hu, B., Lefort, K., Lambertini, C., Neel, V., Dummer, R., 
Wagner, E. F., et al. (2008) ‘EGFR signalling as a negative regulator of Notch1 gene transcription and 
function in proliferating keratinocytes and cancer.’, Nature cell biology. NIH Public Access, 10(8), pp. 
902–11. doi: 10.1038/ncb1750.
Kondo, S. et al. (2002) ‘Mutations in IRF6 cause Van der Woude and popliteal pterygium syndromes’, Nature 
Genetics. Nature Publishing Group, 32(2), pp. 285–289. doi: 10.1038/ng985.
Koster, M. I. and Roop, D. R. (2004) ‘The role of p63 in development and differentiation of the epidermis’, J 
Dermatol Sci. 2004/02/06, 34(1), pp. 3–9. doi: S0923181103002238 [pii].
Koster, M. I. and Roop, D. R. (2007) ‘Mechanisms Regulating Epithelial Stratification’, Annual Review 
of Cell and Developmental Biology. Annual Reviews, 23(1), pp. 93–113. doi: 10.1146/annurev.
cellbio.23.090506.123357.
Kouwenhoven, E. N. et al. (2010) ‘Genome-wide profiling of p63 DNA-binding sites identifies an element 
that regulates gene expression during limb development in the 7q21 SHFM1 locus’, PLoS Genet. 
2010/09/03, 6(8), p. e1001065. doi: 10.1371/journal.pgen.1001065.
Kouwenhoven, E. N. et al. (2015) ‘Transcription factor p63 bookmarks and regulates dynamic enhancers 
during epidermal differentiation’, EMBO reports, 16(7), pp. 863–878. doi: 10.15252/embr.201439941.
Kouwenhoven, E. N., van Bokhoven, H. and Zhou, H. (2015) ‘Gene regulatory mechanisms orchestrated 
by p63 in epithelial development and related disorders’, Biochimica et Biophysica Acta (BBA) - Gene 
Regulatory Mechanisms. Elsevier, 1849(6), pp. 590–600. doi: 10.1016/J.BBAGRM.2015.03.003.
Kouzarides, T. (2007) ‘Chromatin Modifications and Their Function’, Cell. Cell Press, 128(4), pp. 693–705. 
doi: 10.1016/J.CELL.2007.02.005.
Kretz, M., Siprashvili, Z., et al. (2012) ‘Control of somatic tissue differentiation by the long non-coding RNA 
TINCR’, Nature. Nature Publishing Group, 493(7431), pp. 231–235. doi: 10.1038/nature11661.
Kretz, M., Webster, D. E., et al. (2012) ‘Suppression of progenitor differentiation requires the long noncoding 
RNA ANCR.’, Genes & development. Cold Spring Harbor Laboratory Press, 26(4), pp. 338–43. doi: 
10.1101/gad.182121.111.
Krishnamurthy, S. and Hampsey, M. (2009) ‘Eukaryotic transcription initiation.’, Current biology : CB. 
Elsevier, 19(4), pp. R153-6. doi: 10.1016/j.cub.2008.11.052.
Langfelder, P. and Horvath, S. (2008) ‘WGCNA: an R package for weighted correlation network analysis’, 
BMC Bioinformatics. BioMed Central, 9(1), p. 559. doi: 10.1186/1471-2105-9-559.
Laufer, C. et al. (2013) ‘Mapping genetic interactions in human cancer cells with RNAi and multiparametric 
phenotyping.’, Nature methods. Nature Publishing Group, a division of Macmillan Publishers Limited. 
All Rights Reserved., 10(5), pp. 427–31. doi: 10.1038/nmeth.2436.
Lavi, O. (2015) ‘Redundancy: a critical obstacle to improving cancer therapy.’, Cancer research. American 
Association for Cancer Research, 75(5), pp. 808–12. doi: 10.1158/0008-5472.CAN-14-3256.
LeBoeuf, M. et al. (2010) ‘Hdac1 and Hdac2 act redundantly to control p63 and p53 functions in epidermal 
progenitor cells.’, Developmental cell. Elsevier, 19(6), pp. 807–18. doi: 10.1016/j.devcel.2010.10.015.
REFERENCES
207
7
Lechler, T. and Fuchs, E. (2005) ‘Asymmetric cell divisions promote stratification and differentiation of 
mammalian skin’, Nature. Nature Publishing Group, 437(7056), pp. 275–280. doi: 10.1038/nature03922.
Leclerc, E. A. et al. (2014) ‘Mice deficient for the epidermal dermokine and isoforms display transient 
cornification defects’, Journal of Cell Science, 127(13), pp. 2862–2872. doi: 10.1242/jcs.144808.
Lee, C.-H. et al. (2012) ‘Structural basis for heteromeric assembly and perinuclear organization of keratin 
filaments’, Nature Structural & Molecular Biology. Nature Publishing Group, 19(7), pp. 707–715. doi: 
10.1038/nsmb.2330.
Levy, L. et al. (2000) ‘beta1 integrins regulate keratinocyte adhesion and differentiation by distinct 
mechanisms.’, Molecular biology of the cell. American Society for Cell Biology, 11(2), pp. 453–66. 
Available at: http://www.ncbi.nlm.nih.gov/pubmed/10679006 (Accessed: 12 April 2018).
Lewis, C. J. et al. (2014) ‘Bone Morphogenetic Protein Signaling Suppresses Wound-Induced Skin Repair by 
Inhibiting Keratinocyte Proliferation and Migration’. Elsevier Masson SAS, pp. 827–837. doi: 10.1038/
jid.2013.419.
Li, A. G., Koster, M. I. and Wang, X. J. (2003) ‘Roles of TGFbeta signaling in epidermal/appendage 
development’, Cytokine Growth Factor Rev. 2003/03/26, 14(2), pp. 99–111. doi: S1359610103000054 
[pii].
Li, H. and Durbin, R. (2009) ‘Fast and accurate short read alignment with Burrows-Wheeler transform’, 
Bioinformatics. Oxford University Press, 25(14), pp. 1754–1760. doi: 10.1093/bioinformatics/btp324.
Livak, K. J. and Schmittgen, T. D. (2001) ‘Analysis of Relative Gene Expression Data Using Real-Time 
Quantitative PCR and the 2−ΔΔCT Method’, Methods. Academic Press, 25(4), pp. 402–408. doi: 
10.1006/METH.2001.1262.
Lock, F. E. et al. (2012) ‘Differential Regulation of Adhesion Complex Turnover by ROCK1 and ROCK2’, PLoS 
ONE. Edited by R. A. Arkowitz, 7(2), p. e31423. doi: 10.1371/journal.pone.0031423.
Lopez-Pajares, V. et al. (2015) ‘A LncRNA-MAF:MAFB transcription factor network regulates epidermal 
differentiation.’, Developmental cell. NIH Public Access, 32(6), pp. 693–706. doi: 10.1016/j.
devcel.2015.01.028.
Love, M. I., Huber, W. and Anders, S. (2014) ‘Moderated estimation of fold change and dispersion for RNA-
seq data with DESeq2’, Genome Biology. BioMed Central, 15(12), p. 550. doi: 10.1186/s13059-014-
0550-8.
Luger, K. et al. (1997) ‘Crystal structure of the nucleosome core particle at 2.8 Å resolution’, Nature. Nature 
Publishing Group, 389(6648), pp. 251–260. doi: 10.1038/38444.
Luis, N. M. et al. (2011) ‘Regulation of human epidermal stem cell proliferation and senescence requires 
polycomb- dependent and -independent functions of Cbx4.’, Cell stem cell. Elsevier, 9(3), pp. 233–46. 
doi: 10.1016/j.stem.2011.07.013.
Mani, R. et al. (2008) ‘Defining genetic interaction.’, Proceedings of the National Academy of Sciences 
of the United States of America. National Academy of Sciences, 105(9), pp. 3461–6. doi: 10.1073/
pnas.0712255105.
Mardaryev, A. N. et al. (2014) ‘p63 and Brg1 control developmentally regulated higher-order chromatin 
remodelling at the epidermal differentiation complex locus in epidermal progenitor cells’, 
Development. Oxford University Press for The Company of Biologists Limited, 141(1), pp. 101–111. doi: 
10.1242/DEV.103200.
Marthaler, A. M. et al. (2017) ‘Identification of C/EBPα as a novel target of the HPV8 E6 protein regulating 
miR-203 in human keratinocytes’, PLOS Pathogens. Edited by R. F. Kalejta. Public Library of Science, 
13(6), p. e1006406. doi: 10.1371/journal.ppat.1006406.
Masse, I. et al. (2012) ‘Functional interplay between p63 and p53 controls RUNX1 function in the transition 
from proliferation to differentiation in human keratinocytes’, Cell Death & Disease. Nature Publishing 
Group, 3(6), pp. e318–e318. doi: 10.1038/cddis.2012.62.
McLean, C. Y. et al. (2010) ‘GREAT improves functional interpretation of cis-regulatory regions’, Nature 
Biotechnology. Nature Publishing Group, 28(5), pp. 495–501. doi: 10.1038/nbt.1630.
CHAPTER 7
208
Mehic, D. et al. (2005) ‘Fos and jun proteins are specifically expressed during differentiation of human 
keratinocytes.’, The Journal of investigative dermatology. Elsevier, 124(1), pp. 212–20. doi: 
10.1111/j.0022-202X.2004.23558.x.
Michael, M. et al. (2014) ‘BPAG1-e restricts keratinocyte migration through control of adhesion stability.’, 
The Journal of investigative dermatology, 134(3), pp. 773–782. doi: 10.1038/jid.2013.382.
Mills, A. A. et al. (1999) ‘p63 is a p53 homologue required for limb and epidermal morphogenesis’, Nature. 
Nature Publishing Group, 398(6729), pp. 708–713. doi: 10.1038/19531.
Miyai, M. et al. (2016) ‘Transcription Factor MafB Coordinates Epidermal Keratinocyte Differentiation’, 
Journal of Investigative Dermatology, 136(9), pp. 1848–1857. doi: 10.1016/j.jid.2016.05.088.
Moreno-Layseca, P. and Streuli, C. H. (2014) ‘Signalling pathways linking integrins with cell cycle 
progression’, Matrix Biology, 34, pp. 144–153. doi: 10.1016/j.matbio.2013.10.011.
Moro, L. et al. (2002) ‘Integrin-induced epidermal growth factor (EGF) receptor activation requires c-Src 
and p130Cas and leads to phosphorylation of specific EGF receptor tyrosines.’, The Journal of 
biological chemistry. American Society for Biochemistry and Molecular Biology, 277(11), pp. 9405–14. 
doi: 10.1074/jbc.M109101200.
Mou, H. et al. (2016) ‘Dual SMAD Signaling Inhibition Enables Long-Term Expansion of Diverse Epithelial 
Basal Cells’, Cell Stem Cell, 19(2), pp. 217–231. doi: 10.1016/j.stem.2016.05.012.
Mulder, K. W. et al. (2012) ‘Diverse epigenetic strategies interact to control epidermal differentiation.’, 
Nature cell biology. Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights 
Reserved., 14(7), pp. 753–63. doi: 10.1038/ncb2520.
Nagarajan, P. et al. (2010) ‘Ets1 blocks terminal differentiation of keratinocytes and induces expression of 
matrix metalloproteases and innate immune mediators’, Journal of Cell Science, 123(20), pp. 3566–
3575. doi: 10.1242/jcs.062240.
Naso, M. F. et al. (2007) ‘Dermokine: An Extensively Differentially Spliced Gene Expressed in Epithelial 
Cells’, Journal of Investigative Dermatology, 127(7), pp. 1622–1631. doi: 10.1038/sj.jid.5700779.
Niehues, H. et al. (2018) ‘3D skin models for 3R research: The potential of 3D reconstructed skin models to 
study skin barrier function’, Experimental Dermatology. Wiley/Blackwell (10.1111), 27(5), pp. 501–511. 
doi: 10.1111/exd.13531.
Nieto, M. A. et al. (2016) ‘EMT: 2016.’, Cell. Elsevier, 166(1), pp. 21–45. doi: 10.1016/j.cell.2016.06.028.
Novakovic, B. et al. (2016) ‘β-Glucan Reverses the Epigenetic State of LPS-Induced Immunological 
Tolerance.’, Cell. Elsevier, 167(5), p. 1354–1368.e14. doi: 10.1016/j.cell.2016.09.034.
Perdigoto, C. N. et al. (2012) ‘Epigenetic regulation of skin: focus on the Polycomb complex.’, Cellular and 
molecular life sciences : CMLS. NIH Public Access, 69(13), pp. 2161–2172. doi: 10.1007/s00018-012-
0920-x.
Perry, R. B.-T. and Ulitsky, I. (2016) ‘The functions of long noncoding RNAs in development and stem cells.’, 
Development (Cambridge, England), 143(21), pp. 3882–3894. doi: 10.1242/dev.140962.
Plaschka, C., Lin, P.-C. and Nagai, K. (2017) ‘Structure of a pre-catalytic spliceosome’, Nature. Nature 
Publishing Group, 546(7660), p. 617. doi: 10.1038/nature22799.
Pradeepa, M. M. (2017) ‘Causal role of histone acetylations in enhancer function’, Transcription. Taylor & 
Francis, 8(1), pp. 40–47. doi: 10.1080/21541264.2016.1253529.
Ramírez, F. et al. (2014) ‘deepTools: a flexible platform for exploring deep-sequencing data.’, Nucleic acids 
research. Oxford University Press, 42(Web Server issue), pp. W187-91. doi: 10.1093/nar/gku365.
Ramsey, M. R. et al. (2011) ‘Physical association of HDAC1 and HDAC2 with p63 mediates transcriptional 
repression and tumor maintenance in squamous cell carcinoma.’, Cancer research. American 
Association for Cancer Research, 71(13), pp. 4373–9. doi: 10.1158/0008-5472.CAN-11-0046.
Rappsilber, J., Mann, M. and Ishihama, Y. (2007) ‘Protocol for micro-purification, enrichment, pre-
fractionation and storage of peptides for proteomics using StageTips.’, Nature protocols, 2(8), pp. 
1896–906. doi: 10.1038/nprot.2007.261.
REFERENCES
209
7
Rheinwald, J. G. and Green, H. (1975) ‘Serial cultivation of strains of human epidermal keratinocytes: 
the formation of keratinizing colonies from single cells.’, Cell, 6(3), pp. 331–43. doi: 10.1016/s0092-
8674(75)80001-8.
Rheinwald, J. G. and Green, H. (1977) ‘Epidermal growth factor and the multiplication of cultured 
human epidermal keratinocytes’, Nature. Nature Publishing Group, 265(5593), pp. 421–424. doi: 
10.1038/265421a0.
Richard, P. and Manley, J. L. (2009) ‘Transcription termination by nuclear RNA polymerases.’, Genes & 
development. Cold Spring Harbor Laboratory Press, 23(11), pp. 1247–69. doi: 10.1101/gad.1792809.
Rinaldi, L. et al. (2016) ‘Dnmt3a and Dnmt3b Associate with Enhancers to Regulate Human Epidermal 
Stem Cell Homeostasis’, Cell Stem Cell. Elsevier, 19(4), pp. 491–501. doi: 10.1016/j.stem.2016.06.020.
Rinn, J. L. and Chang, H. Y. (2012) ‘Genome regulation by long noncoding RNAs.’, Annual review of 
biochemistry, 81(1), pp. 145–66. doi: 10.1146/annurev-biochem-051410-092902.
Rinne, T., Brunner, H. G. and van Bokhoven, H. (2007) ‘p63-Associated Disorders’, Cell Cycle. Taylor & 
Francis, 6(3), pp. 262–268. doi: 10.4161/cc.6.3.3796.
Rishi, V. et al. (2010) ‘CpG methylation of half-CRE sequences creates C/EBPalpha binding sites that activate 
some tissue-specific genes.’, Proceedings of the National Academy of Sciences of the United States of 
America. National Academy of Sciences, 107(47), pp. 20311–6. doi: 10.1073/pnas.1008688107.
Roguev, A. et al. (2013) ‘Quantitative genetic-interaction mapping in mammalian cells.’, Nature methods. 
NIH Public Access, 10(5), pp. 432–7. doi: 10.1038/nmeth.2398.
Romano, R.-A., Birkaya, B. and Sinha, S. (2007) ‘A Functional Enhancer of Keratin14 Is a Direct 
Transcriptional Target of ΔNp63’, Journal of Investigative Dermatology. Elsevier, 127(5), pp. 1175–
1186. doi: 10.1038/SJ.JID.5700652.
Roseboom, T., de Rooij, S. and Painter, R. (2006) ‘The Dutch famine and its long-term consequences for adult 
health’, Early Human Development. Elsevier, pp. 485–491. doi: 10.1016/j.earlhumdev.2006.07.001.
Ruhrberg, C. et al. (1997) ‘Periplakin, a novel component of cornified envelopes and desmosomes that 
belongs to the plakin family and forms complexes with envoplakin.’, The Journal of cell biology, 139(7), 
pp. 1835–49. Available at: http://www.ncbi.nlm.nih.gov/pubmed/9412476 (Accessed: 15 May 2018).
Van Ruissen, F. et al. (1996) ‘Induction of normal and psoriatic phenotypes in submerged keratinocyte 
cultures’, Journal of Cellular Physiology. Wiley-Blackwell, 168(2), pp. 442–452. doi: 10.1002/(SICI)1097-
4652(199608)168:2<442::AID-JCP23>3.0.CO;2-3.
Saeed, S. et al. (2014) ‘Epigenetic programming of monocyte-to-macrophage differentiation and trained 
innate immunity’, Science, 345(6204), pp. 1251086–1251086. doi: 10.1126/science.1251086.
Saladi, S. V. et al. (2017) ‘ACTL6A Is Co-Amplified with p63 in Squamous Cell Carcinoma to Drive YAP 
Activation, Regenerative Proliferation, and Poor Prognosis’, Cancer Cell. Cell Press, 31(1), pp. 35–49. 
doi: 10.1016/J.CCELL.2016.12.001.
Saunders, A., Core, L. J. and Lis, J. T. (2006) ‘Breaking barriers to transcription elongation’, Nature Reviews 
Molecular Cell Biology. Nature Publishing Group, 7(8), pp. 557–567. doi: 10.1038/nrm1981.
Scotto–Lavino, E., Du, G. and Frohman, M. A. (2007) ‘5′ end cDNA amplification using classic RACE’, Nature 
Protocols, 1(6), pp. 2555–2562. doi: 10.1038/nprot.2006.480.
Sen, G. L. et al. (2010) ‘DNMT1 maintains progenitor function in self-renewing somatic tissue’, Nature, 
463(7280), pp. 563–567. doi: 10.1038/nature08683.
Sen, G. L. et al. (2012) ‘ZNF750 Is a p63 Target Gene that Induces KLF4 to Drive Terminal Epidermal 
Differentiation’, Developmental Cell. Cell Press, 22(3), pp. 669–677. doi: 10.1016/J.DEVCEL.2011.12.001.
Serber, Z. et al. (2002) ‘A C-terminal inhibitory domain controls the activity of p63 by an intramolecular 
mechanism.’, Molecular and cellular biology. American Society for Microbiology Journals, 22(24), pp. 
8601–11. doi: 10.1128/MCB.22.24.8601-8611.2002.
Sercu, S. et al. (2008) ‘Interaction of Extracellular Matrix Protein 1 with Extracellular Matrix Components: 
ECM1 Is a Basement Membrane Protein of the Skin’, Journal of Investigative Dermatology. Elsevier, 
128(6), pp. 1397–1408. doi: 10.1038/SJ.JID.5701231.
CHAPTER 7
210
Shahi, P. et al. (2017) ‘Abseq : Ultrahigh-throughput single cell protein profiling with droplet microfluidic 
barcoding’, Nature Publishing Group. Nature Publishing Group, (November 2016), pp. 1–12. doi: 
10.1038/srep44447.
Shalom-Feuerstein, R. et al. (2011) ‘ΔNp63 is an ectodermal gatekeeper of epidermal morphogenesis.’, 
Cell death and differentiation. Nature Publishing Group, 18(5), pp. 887–96. doi: 10.1038/cdd.2010.159.
Shao, Z. et al. (2012) ‘MAnorm: a robust model for quantitative comparison of ChIP-Seq data sets’, Genome 
Biology. BioMed Central, 13(3), p. R16. doi: 10.1186/gb-2012-13-3-r16.
Shen, J. et al. (2013) ‘APR-246/PRIMA-1(MET) rescues epidermal differentiation in skin keratinocytes 
derived from EEC syndrome patients with p63 mutations.’, Proceedings of the National Academy of 
Sciences of the United States of America. National Academy of Sciences, 110(6), pp. 2157–62. doi: 
10.1073/pnas.1201993110.
Shlyueva, D., Stampfel, G. and Stark, A. (2014) ‘Transcriptional enhancers: From properties to genome-
wide predictions’, Nature Reviews Genetics. Nature Publishing Group, pp. 272–286. doi: 10.1038/
nrg3682.
Smits, A. H. et al. (2013) ‘Stoichiometry of chromatin-associated protein complexes revealed by label-
free quantitative mass spectrometry-based proteomics.’, Nucleic acids research, 41(1), p. e28. doi: 
10.1093/nar/gks941.
Smits, P. et al. (2000) ‘Differentiation-dependent alternative splicing and expression of the extracellular 
matrix protein 1 gene in human keratinocytes.’, The Journal of investigative dermatology, 114(4), pp. 
718–24. doi: 10.1046/j.1523-1747.2000.00916.x.
Smoot, M. E. et al. (2011) ‘Cytoscape 2.8: new features for data integration and network visualization’, 
Bioinformatics. Oxford University Press, 27(3), pp. 431–432. doi: 10.1093/bioinformatics/btq675.
Soares, E. and Zhou, H. (2018) ‘Master regulatory role of p63 in epidermal development and disease’, 
Cellular and Molecular Life Sciences. Springer International Publishing, 75(7), pp. 1179–1190. doi: 
10.1007/s00018-017-2701-z.
Soares, L. M. et al. (2017) ‘Determinants of Histone H3K4 Methylation Patterns.’, Molecular cell. Elsevier, 
68(4), p. 773–785.e6. doi: 10.1016/j.molcel.2017.10.013.
Solanas, G. and Benitah, S. A. (2013) ‘Regenerating the skin: a task for the heterogeneous stem cell pool 
and surrounding niche.’, Nature reviews. Molecular cell biology. Nature Publishing Group, 14(11), pp. 
737–748. doi: 10.1038/nrm3675.
Spartz, A. K., Herman, R. K. and Shaw, J. E. (2004) ‘SMU-2 and SMU-1, Caenorhabditis elegans Homologs 
of Mammalian Spliceosome-Associated Proteins RED and fSAP57, Work Together To Affect Splice 
Site Choice’, Molecular and Cellular Biology, 24(15), pp. 6811–6823. doi: 10.1128/MCB.24.15.6811-
6823.2004.
Stoll, S. W. et al. (2016) ‘The EGF receptor ligand amphiregulin controls cell division via FoxM1.’, Oncogene, 
35(16), pp. 2075–86. doi: 10.1038/onc.2015.269.
Tang, L., Nogales, E. and Ciferri, C. (2010) ‘Structure and function of SWI/SNF chromatin remodeling 
complexes and mechanistic implications for transcription’, Progress in Biophysics and Molecular 
Biology. Pergamon, 102(2–3), pp. 122–128. doi: 10.1016/J.PBIOMOLBIO.2010.05.001.
Thomason, H. A. et al. (2010) ‘Cooperation between the transcription factors p63 and IRF6 is essential 
to prevent cleft palate in mice.’, The Journal of clinical investigation. American Society for Clinical 
Investigation, 120(5), pp. 1561–9. doi: 10.1172/JCI40266.
Tribioli, C., Robledo, R. F. and Lufkin, T. (2002) ‘The murine fork head gene Foxn2 is expressed in craniofacial, 
limb, CNS and somitic tissues during embryogenesis.’, Mechanisms of development, 118(1–2), pp. 
161–3. Available at: http://www.ncbi.nlm.nih.gov/pubmed/12351180 (Accessed: 13 April 2018).
Truong, A. B. et al. (2006) ‘p63 regulates proliferation and differentiation of developmentally mature 
keratinocytes’, Genes & Development, 20(22), pp. 3185–3197. doi: 10.1101/gad.1463206.
Tsai, M.-C. et al. (2010) ‘Long noncoding RNA as modular scaffold of histone modification complexes.’, 
Science (New York, N.Y.), 329(5992), pp. 689–93. doi: 10.1126/science.1192002.
REFERENCES
211
7
Tsuji, G. et al. (2018) ‘The role of the OVOL1-OVOL2 axis in normal and diseased human skin.’, Journal of 
dermatological science. doi: 10.1016/j.jdermsci.2018.02.005.
Ulrich, A. K. C. and Wahl, M. C. (2017) ‘Human MFAP1 is a cryptic ortholog of the Saccharomyces cerevisiae 
Spp381 splicing factor.’, BMC evolutionary biology, 17(1), p. 91. doi: 10.1186/s12862-017-0923-1.
Vernersson Lindahl, E., Garcia, E. L. and Mills, A. A. (2013) ‘An allelic series of Trp63 mutations defines 
TAp63 as a modifier of EEC syndrome’, American Journal of Medical Genetics Part A. John Wiley & 
Sons, Ltd, 161(8), pp. 1961–1971. doi: 10.1002/ajmg.a.36074.
Vizcaíno, C., Mansilla, S. and Portugal, J. (2015) ‘Sp1 transcription factor: A long-standing target in 
cancer chemotherapy’, Pharmacology & Therapeutics. Pergamon, 152, pp. 111–124. doi: 10.1016/J.
PHARMTHERA.2015.05.008.
Wang, J. et al. (2014) ‘Chromosome boundary elements and regulation of heterochromatin spreading.’, 
Cellular and molecular life sciences : CMLS. NIH Public Access, 71(24), pp. 4841–52. doi: 10.1007/
s00018-014-1725-x.
Wang, K. C. and Chang, H. Y. (2011) ‘Molecular mechanisms of long noncoding RNAs.’, Molecular cell, 
43(6), pp. 904–14. doi: 10.1016/j.molcel.2011.08.018.
Wang, X. et al. (2012) ‘Posterior association networks and functional modules inferred from rich 
phenotypes of gene perturbations.’, PLoS computational biology, 8(6), p. e1002566. doi: 10.1371/
journal.pcbi.1002566.
Watt, F. M. (2002) ‘Role of integrins in regulating epidermal adhesion, growth and differentiation’, EMBO J. 
2002/07/30, 21(15), pp. 3919–3926. doi: 10.1093/emboj/cdf399.
Watt, F. M., Lo Celso, C. and Silva-Vargas, V. (2006) ‘Epidermal stem cells: an update’, Curr Opin Genet Dev. 
2006/08/22, 16(5), pp. 518–524. doi: S0959-437X(06)00157-2 [pii]10.1016/j.gde.2006.08.006.
Watt, F. M. and Huck, W. T. S. (2013) ‘Role of the extracellular matrix in regulating stem cell fate’, Nature 
Reviews Molecular Cell Biology. Nature Publishing Group, 14(8), pp. 467–473. doi: 10.1038/nrm3620.
Watt, F. M. and Jones, P. H. (1993) ‘Expression and function of the keratinocyte integrins’, Dev Suppl, pp. 
185–192.
Wells, J. et al. (2009) ‘Ovol2 suppresses cell cycling and terminal differentiation of keratinocytes by directly 
repressing c-Myc and Notch1’, Journal of Biological Chemistry, 284(42), pp. 29125–29135. doi: 
10.1074/jbc.M109.008847.
Wolpert, L. (1969) ‘Positional information and the spatial pattern of cellular differentiation’, Journal of 
Theoretical Biology. Academic Press, 25(1), pp. 1–47. doi: 10.1016/S0022-5193(69)80016-0.
Wu, M. and Singh, A. K. (2012) ‘Single-cell protein analysis.’, Current opinion in biotechnology, 23(1), pp. 
83–8. doi: 10.1016/j.copbio.2011.11.023.
Yang, A. et al. (1999) ‘p63 is essential for regenerative proliferation in limb, craniofacial and epithelial 
development’, Nature. Nature Publishing Group, 398(6729), pp. 714–718. doi: 10.1038/19539.
Yang, L. et al. (2006) ‘Bone morphogenetic protein-2 modulates Wnt and frizzled expression and enhances 
the canonical pathway of Wnt signaling in normal keratinocytes’, J Dermatol Sci, (42), pp. 111–119. 
doi: 10.1016/j.jdermsci.2005.12.011.
Yi, R. et al. (2008) ‘A skin microRNA promotes differentiation by repressing “stemness”’, Nature, 452(7184), 
pp. 225–229. doi: 10.1038/nature06642.
Zeng, W. et al. (2010) ‘HP1: heterochromatin binding proteins working the genome.’, Epigenetics. NIH Public 
Access, 5(4), pp. 287–92. Available at: http://www.ncbi.nlm.nih.gov/pubmed/20421743 (Accessed: 22 
November 2018).
Zhang, Y. et al. (2008) ‘Model-based Analysis of ChIP-Seq (MACS)’, Genome Biology. BioMed Central, 9(9), 
p. R137. doi: 10.1186/gb-2008-9-9-r137.
Zhou, G. et al. (2014) ‘Gain-of-function mutant p53 promotes cell growth and cancer cell metabolism 
via inhibition of AMPK activation.’, Molecular cell. Elsevier, 54(6), pp. 960–74. doi: 10.1016/j.
molcel.2014.04.024.
CHAPTER 7
212
Zhu, J. et al. (2015) ‘Gain-of-function p53 mutants co-opt chromatin pathways to drive cancer growth’, 
Nature. Nature Publishing Group, 525(7568), pp. 206–211. doi: 10.1038/nature15251.
Zhu, M. et al. (2017) ‘LncRNAs act as prognostic biomarkers in gastric cancer: A systematic review 
and meta-analysis’, Frontiers in Laboratory Medicine. Elsevier, 1(2), pp. 59–68. doi: 10.1016/J.
FLM.2017.05.003.
REFERENCES
213
7

